
<html lang="en"     class="pb-page"  data-request-id="d26bafef-7d39-4063-989a-1d76432dcb6d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01531;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase" /></meta><meta name="dc.Creator" content="Christopher R.  Butler" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Anthony  Harris" /></meta><meta name="dc.Creator" content="Zhen  Huang" /></meta><meta name="dc.Creator" content="Laura A.  McAllister" /></meta><meta name="dc.Creator" content="Christopher W.  am Ende" /></meta><meta name="dc.Creator" content="Kimberly  Fennell" /></meta><meta name="dc.Creator" content="Timothy L.  Foley" /></meta><meta name="dc.Creator" content="Kari  Fonseca" /></meta><meta name="dc.Creator" content="Steven J.  Hawrylik" /></meta><meta name="dc.Creator" content="Douglas S.  Johnson" /></meta><meta name="dc.Creator" content="John D.  Knafels" /></meta><meta name="dc.Creator" content="Scot  Mente" /></meta><meta name="dc.Creator" content="G. Stephen  Noell" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Tracy B.  Phillips" /></meta><meta name="dc.Creator" content="Justin R.  Piro" /></meta><meta name="dc.Creator" content="Bruce N.  Rogers" /></meta><meta name="dc.Creator" content="Tarek A.  Samad" /></meta><meta name="dc.Creator" content="Jane  Wang" /></meta><meta name="dc.Creator" content="Shuangyi  Wan" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Description" content="Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic a..." /></meta><meta name="Description" content="Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 5, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01531" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01531" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01531" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01531" /></link>
        
    
    

<title>Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01531" /></meta><meta property="og:title" content="Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0015.jpeg" /></meta><meta property="og:description" content="Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic acid (AA), a precursor to the proinflammatory eicosannoids such as prostaglandins. Herein we describe highly efficient MAGL inhibitors, identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of azetidine and piperidine-derived carbamates. The discovery and optimization of 3-substituted azetidine carbamate irreversible inhibitors of MAGL were aided by the generation of inhibitor-bound MAGL crystal structures. Compound 6, a highly efficient and selective MAGL inhibitor against recombinant enzyme and in a cellular context, was tested in vivo and shown to elevate central 2-AG levels at a 10 mg/kg dose." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01531"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01531">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01531&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01531&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01531&amp;href=/doi/10.1021/acs.jmedchem.7b01531" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9860-9873</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01525" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01590" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Butler">Christopher R. Butler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Harris">Anthony Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhen++Huang">Zhen Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+A.++McAllister">Laura A. McAllister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+W.++am+Ende">Christopher W. am Ende</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8832-9641" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Fennell">Kimberly Fennell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+L.++Foley">Timothy L. Foley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kari++Fonseca">Kari Fonseca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+J.++Hawrylik">Steven J. Hawrylik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+S.++Johnson">Douglas S. Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Knafels">John D. Knafels</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scot++Mente">Scot Mente</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G.+Stephen++Noell">G. Stephen Noell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracy+B.++Phillips">Tracy B. Phillips</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin+R.++Piro">Justin R. Piro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+N.++Rogers">Bruce N. Rogers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tarek+A.++Samad">Tarek A. Samad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Wang">Jane Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuangyi++Wan">Shuangyi Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pfizer Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-395-0670. E-mail: <a href="/cdn-cgi/l/email-protection#dab9b2a8b3a9aeb5aab2bfa8f4a8f4b8afaeb6bfa89aaabcb3a0bfa8f4b9b5b7"><span class="__cf_email__" data-cfemail="89eae1fbe0fafde6f9e1ecfba7fba7ebfcfde5ecfbc9f9efe0f3ecfba7eae6e4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01531&amp;href=/doi/10.1021%2Facs.jmedchem.7b01531" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9860–9873</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 17, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 October 2017</li><li><span class="item_label"><b>Published</b> online</span>5 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01531" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01531</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9860%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BR.%2BButler%252C%2BElizabeth%2BM.%2BBeck%252C%2BAnthony%2BHarris%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D23%26contentID%3Dacs.jmedchem.7b01531%26title%3DAzetidine%2Band%2BPiperidine%2BCarbamates%2Bas%2BEfficient%252C%2BCovalent%2BInhibitors%2Bof%2BMonoacylglycerol%2BLipase%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9873%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01531"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2728</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01531" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Butler&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Harris&quot;},{&quot;first_name&quot;:&quot;Zhen&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;A. McAllister&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;W. am Ende&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Fennell&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;L. Foley&quot;},{&quot;first_name&quot;:&quot;Kari&quot;,&quot;last_name&quot;:&quot;Fonseca&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;J. Hawrylik&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;S. Johnson&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Knafels&quot;},{&quot;first_name&quot;:&quot;Scot&quot;,&quot;last_name&quot;:&quot;Mente&quot;},{&quot;first_name&quot;:&quot;G.&quot;,&quot;last_name&quot;:&quot;Stephen Noell&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;B. Phillips&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;R. Piro&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;N. Rogers&quot;},{&quot;first_name&quot;:&quot;Tarek&quot;,&quot;last_name&quot;:&quot;A. Samad&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Shuangyi&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9860-9873&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01531&quot;},&quot;abstract&quot;:&quot;Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic acid (AA), a precursor to the proinflammatory eicosannoids such as prostaglandins. Herein we describe highly efficient MAGL inhibitors, identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of azetidine and piperidine-derived carbamates. The discovery and optimization of 3-substituted azetidine carbamate irreversible inhibitors of MAGL were aided by the generation of inhibitor-bound MAGL crystal structures. Compound 6, a highly efficient and selective MAGL inhibitor against recombinant enzyme and in a cellular context, was tested in vivo and shown to elevate central 2-AG levels at a 10 mg/kg dose.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01531&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01531" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01531&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01531" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01531&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01531" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01531&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01531&amp;href=/doi/10.1021/acs.jmedchem.7b01531" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01531" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01531" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01531%26sid%3Dliteratum%253Aachs%26pmid%3D29148769%26genre%3Darticle%26aulast%3DButler%26date%3D2017%26atitle%3DAzetidine%2Band%2BPiperidine%2BCarbamates%2Bas%2BEfficient%252C%2BCovalent%2BInhibitors%2Bof%2BMonoacylglycerol%2BLipase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D23%26spage%3D9860%26epage%3D9873%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/jmcmar.2017.60.issue-23/20171214/jmcmar.2017.60.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic acid (AA), a precursor to the proinflammatory eicosannoids such as prostaglandins. Herein we describe highly efficient MAGL inhibitors, identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of azetidine and piperidine-derived carbamates. The discovery and optimization of 3-substituted azetidine carbamate irreversible inhibitors of MAGL were aided by the generation of inhibitor-bound MAGL crystal structures. Compound <b>6</b>, a highly efficient and selective MAGL inhibitor against recombinant enzyme and in a cellular context, was tested in vivo and shown to elevate central 2-AG levels at a 10 mg/kg dose.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65083" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65083" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inflammation serves as an evolutionarily conserved protective mechanism to reduce infections and clear antigens as well as cellular debris to minimize tissue damage and promote subsequent tissue healing following the resolution of the inflammatory cascade. Exaggerated or persistent inflammatory response in the periphery or the central nervous system (CNS) can become pathological, leading to chronic inflammatory conditions. Neuronal homeostasis in the CNS is particularly vulnerable to chronic inflammation, and most neurological disorders are associated with an imbalanced inflammatory response in the brain. Hallmarks of neuroinflammation include activation of resident immune cells (microglia and astrocytes), production of proinflammatory cytokines and chemokines, as well as deterioration of the blood–brain barrier. This cascade leads to heightened risk of neuronal dysfunction and neurodegeneration and in some cases infiltration of peripheral cells and proteins into the CNS.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">We have previously shown that monoacylglycerol lipase (MAGL), an enzyme that terminates the signaling of the endocannabinoid 2-arachidonoylglycerol (2-AG), also controls arachidonic acid (AA) production in the brain.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> MAGL catalyzes the hydrolytic conversion of 2-AG to arachidonic acid and glycerol.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> 2-AG accounts for 50% of the production of AA in the brain,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> whereas phospholipid hydrolysis by phospholipase A2 (PLA2) serves as the primary source of arachidonic acid production in the periphery. AA plays a major role in the inflammatory response, both as a signaling molecule and also as a precursor to multiple pathways of proinflammatory eicosanoids (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). As such, MAGL exerts a bidirectional control on brain inflammation by modulating brain endocannabinoid and arachidonate levels in opposing directions. Therefore, MAGL inhibition potently decreases the proinflammatory eicosanoids and cytokines in the brain<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and enhances 2-AG signaling at CB1/2 receptors. Genetic deletion or pharmacological blockade of MAGL attenuates biomarkers of neuroinflammation,<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10 ref11">(6-11)</a> including cytokines and gliosis, in mouse models of Alzheimer’s disease.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The use of steroids is currently the main therapeutic option to attenuate pronounced brain inflammation; therefore development of potent, selective inhibitors of MAGL represents a research avenue with significant therapeutic potential for the treatment of acute and chronic diseases associated with neuroinflammation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of MAGL in endocannabinoid and arachidonic acid pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">MAGL is a 33 kDa serine hydrolase with an active site containing a classical Ser-His-Asp catalytic triad.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The characteristic reactivity of the active site enables the opportunity for covalent modification of the key serine residue (Ser122). Covalent inhibition is attractive in that it offers the potential for extended duration of pharmacodynamic modulation relative to pharmacokinetic profile of the inhibitor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Thus, a sustained elevated pharmacological response can be achieved without the corresponding sustained exposure, as would be required for a reversible, noncovalent inhibitor. In order to take advantage of these potential attributes, covalent inhibitors require two key elements: (a) sufficient reactivity for the residue that is to be modified in the protein and (b) specific target binding affinity. Serine hydrolases as a class have been successfully inhibited by a number of electrophile-containing molecules that range in their inherent reactivity.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> More specifically, inhibition of MAGL has been accomplished most often in the literature with a carbamate electrophile that efficiently engages Ser122, as observed in JZL-184 (<b>1</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref3 ref17'); return false;" href="javascript:void(0);" class="ref ref3 ref17">(3, 17)</a> but is not susceptible to subsequent catalytic turnover, thus inhibiting the enzyme. In order to facilitate inhibitory acyl transfer with Ser122, these carbamates generally contain an alcoholic subunit with a relatively low p<i>K</i><sub>a</sub> to serve as a suitable leaving group. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, exemplar literature MAGL inhibitors typically employ alcohols such as 4-nitrophenol and hexafluoroisopropyl (HFIP) alcohol.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Literature MAGL inhibitors. Data shown were obtained from in-house assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the requirement of a suitable leaving group, two key structural elements for the inhibition of MAGL can be elucidated in the comparison of the structural features of 2-AG to known inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As illustrated by both the lipophilic arachidonate and bis-dioxolane tail groups in <b>1</b>, significant lipophilicity is required distal to the catalytic serine (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, pink). This lipophilic tail is attached via a linear linker (yellow) that partially recapitulates the alkyl chain of 2-AG. These structural requirements underpin the challenge in developing orally bioavailable MAGL inhibitors suitable for in vivo evaluation: incorporating the requisite lipophilic tail region and leaving group (blue) without dramatically increasing clearance, which is known to be unfavorably impacted by increased lipophilicity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Early optimization of the linker becomes crucial to facilitate subsequent tuning of lipophilicity and molecular weight in the tail region. This communication will describe the identification of efficient core amine systems by monitoring the optimization using lipophilic efficiency (LipE) and fit quality (FQ).<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Arachidonic acid and related pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With the goal of identifying a potent, brain-penetrant, and low clearance MAGL inhibitor, initial efforts for linker optimization occurred via two related approaches enabled by the diversity available from Pfizer’s molecule collection (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The first approach (A) was to utilize small, fragment-like monofunctional amines lacking the lipophilic tail portion of the molecule to prepare HFIP carbamates. The second approach (B) utilized bifunctional monomers, either by incorporating an equivalent lipophilic tail, deprotecting, and then forming the key HFIP carbamate or alternatively by inverting the sequence to introduce the carbamate and subsequent deprotection and incorporation of lipophilicity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Parallel approaches to linker exploration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Whereas the combination of these two approaches significantly broadened the availability of linker architecture, it required a normalization of potency to account for the stark differences in lipophilicity and molecular weight between the two approaches and was ultimately accomplished using LipE and FQ. LipE (calculated as the pIC<sub>50</sub> – log <i>D</i>) distinguishes potency enhancements attributable strictly to increased lipophilicity from those of target-specific interactions. Fit quality (FQ), calculated as the ligand efficiency (LE) of a compound adjusted for its number of heavy atoms, corrects the potency values for the corresponding molecular weight.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The utilization of FQ is particularly important when comparing series and compounds of significant differences in size, as LE alone lends bias to smaller compounds in such a comparison. These two metrics are especially useful for optimizing brain availability, as increases in lipophilicity and MW diminish brain penetration via active efflux.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The LipE and FQ for compounds prepared via these approaches are plotted in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. This analysis revealed that cyclic, secondary amines such as piperidines (blue dots) and azetidines (green diamonds) were preferred cores for MAGL, whereas alternative ring systems or substitution patterns, especially those that were not linear, were generally less efficient. Whereas azetidines and piperidines exhibited similar LipE values, with a number of exemplars of each registering between 5 and 6, a number of azetidines significantly differentiated when gauging FQ.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficiency plots for MAGL inhibitors: (a, left) lipophilic efficiency plot comparing log <i>D</i> (<i>x</i>-axis) vs MAGL pIC<sub>50</sub>; (b, right) fit quality plot comparing number of heavy atoms (<i>x</i>-axis) vs ligand efficiency (LE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Highlighted compounds were screened against MAGL and against FAAH as an initial, albeit imperfect, surrogate for serine hydrolase selectivity to efficiently guide design. Specifically, 3-substituted azetidines emerged as some of the most efficient linkers, as exemplified by <b>3</b>–<b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Oxadiazole <b>3</b> displayed potent inhibition of MAGL (IC<sub>50</sub> = 0.38 nM) nearly equivalent to that of the literature tool KML29 (MAGL IC<sub>50</sub> = 0.19 nM), albeit with significantly decreased molecular weight, as reflected in its high FQ (0.97) and LipE. Pyrimidine <b>4</b> was slightly less potent; however its decreased lipophilicity translated to an improvement in LipE (5.7) relative to <b>3</b> (LipE = 5.2). Moreover, while <b>3</b> maintained the previously observed selectivity for MAGL over FAAH (∼1000-fold), <b>4</b> exhibited enhanced selectivity to >15 000-fold. Piperazine-substituted <b>5</b> displayed similar potency (MAGL IC<sub>50</sub> = 3.2 nM), efficiency (LipE = 5.5, FQ = 0.87), and selectivity over FAAH (781-fold). Pyrazole <b>6</b>, a slightly less polar variant of oxadiazole <b>3</b>, displayed modestly improved potency and a subtle improvement in LipE and FQ.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for <b>3</b>–<b>6</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0011.gif" alt="" id="GRAPHIC-d7e589-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values obtained from MAGL inhibition assay.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last"><i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratio.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> values obtained from FAAH inhibition assay.</p></div></div><div></div></div><div class="NLM_p">Collectively, these lead analogs <b>3</b>–<b>6</b> exemplified useful, efficient scaffolds for further optimization. In general, the diversity in ring structures presented clear synthetic opportunities to grow these subunits in a wide range of vectors. To guide design of the optimal group for the distal end of the MAGL binding pocket, a crystal structure of <b>3</b> bound to the active site of MAGL was obtained (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The HFIP leaving group has clearly been displaced by the active site serine (Ser), resulting in a protein–inhibitor carbamate adduct. The azetidine resides in the opening of the arachidonate port, illustrating the narrow tunnel required and empirically suggested from our initial SAR efforts. The limited rotatable bonds of <b>3</b> efficiently places the phenyl oxadiazolyl substituent into one of the distal pockets, in a similar fashion to the proposed binding mode of compound <b>1</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The hydrophobicity of the pocket surrounding the oxadiazole and phenyl rings reinforces the need for minimal polarity in the tail region of the molecule.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray crystal structure of <b>3</b> bound to the active site serine in MAGL (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1">6AX1</a>). The residues making up the catalytic triad (Ser122, His269, and Asp239) have been shown in stick representation. Hydrogen bonds are indicated by dashed lines. A glycerol molecule (gray) was modeled into electron density seen in the exit tunnel. Glycerol was part of the buffer used to purify the protein and was present in the crystallization drop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recognition of the pyrazole as an efficient linker off of the azetidine suggested modulation of the pyrazole substituent to expand the SAR and understand if further improvements in efficiency were available (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). To gauge the efficiency of the pyrazole itself, the phenyl ring was stripped back and replaced with a simple methyl (<b>7</b>), resulting in a significant attenuation of potency and decreased efficiency. This result further reinforced the structural implication that a lipophilic tail was required. Similarly, the substitution of an additional phenyl ring at the 3-position of the pyrazole (<b>8</b>) maintained potency relative to <b>6</b>, but the additional lipophilicity outpaced the corresponding potency gain, resulting in decreased efficiency. Difluorinated analog <b>9</b> did not impact MAGL potency or efficiency but enhanced selectivity over FAAH. Introduction of a pyrazine in place of the phenyl ring (<b>10</b>) resulted in a minor decrease in MAGL potency, but the significant drop in lipophilicity resulted in a marked improvement in LipE. Homologation to a benzyl-substituted pyrazole loses efficiency at MAGL as well as selectivity over FAAH. An attempt to decrease lipophilicity with the introduction of a 4-substituted tetrahydropyran (<b>12</b>) improved FAAH selectivity but resulted in a 10× loss in MAGL potency. The anticipated decrease in lipophilicity, however, offset the potency loss and resulted in similar LipE as the parent.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Data for <b>7</b>–<b>12</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0013.gif" alt="" id="GRAPHIC-d7e695-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0014.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">MAGL IC<sub>50</sub>: IC<sub>50</sub> values obtained from MAGL inhibition assay. FAAH IC<sub>50</sub>: IC<sub>50</sub> values obtained from FAAH inhibition assay.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>k</i><sub>inact</sub>/<i>K</i><sub>i</sub>.</p></div></div><div></div></div><div class="NLM_p">With an exemplar such as <b>6</b> that was well-optimized for in vitro MAGL potency, we next wanted to get a preliminary gauge of the broader selectivity against the other serine hydrolases. To this end, <b>6</b> was screened against a panel of 42 serine hydrolases at 1 and 10 μM concentrations of inhibitor (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf" class="ext-link">Table S2, Supporting Information</a>). In this panel, <b>6</b> demonstrated significant inhibition (>70%) of ABHD6, CES1, CES2, MAGL, and PLA2G7 at both concentrations tested and FAAH only at the top concentration. To further explore the cellular potency and selectivity profile against other serine hydrolases, click chemistry activity-based protein profiling (CC-ABPP) was utilized.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> As such, an alkyne-containing clickable probe (<b>14</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was prepared from bromophenyl pyrazole <b>13</b>. After installation of the alkyne via Sonagashira reaction with ethynyltrimethylsilane, subsequent deprotection of both the alkyne and azetidine was followed by formation of the azetidinyl HFIP carbamate. Human brain vascular pericytes were treated with increasing concentrations of <b>14</b>, followed by cell lysis and click chemistry with TAMRA-azide. The probe-labeled proteins were visualized by in-gel fluorescence to illustrate MAGL engagement and inhibition (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Plotting the percentage of MAGL inhibition demonstrated a cellular IC<sub>50</sub> of 3 nM. Interesting, at concentrations below the IC<sub>50</sub>, the compound was selective only for MAGL; however at higher concentrations, an off-target protein was labeled corresponding to a molecular weight of ∼40 kDa.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Click chemistry activity-based protein profiling in human brain vascular pericytes. Live cells were treated at various concentrations of <b>14</b> for 1 h at 37 °C. (A) In-gel fluorescence. (B) Normalized MAGL intensity was fitted as a function of the concentration of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With robust potency against recombinant MAGL as well as in human pericytes, compound <b>6</b> was dosed in vivo in an effort to assess the relationship between drug levels and increases in 2-AG levels in the brain. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>, a subcutaneous dose of 10 mg/kg to mouse elicited significant elevations (∼5-fold, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>a) in brain levels of 2-AG out to an 8 h time point. Additionally, compound <b>6</b> showed free access to the CNS in mouse, as measured by an AUC-derived <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> ratio of 0.6. The corresponding exposure for the 10 mg/kg dose exhibited a <i>T</i><sub>max</sub> at 0.5 h (2 nM <i>C</i><sub>b,u</sub>) and had maintained free levels above the measured IC<sub>50</sub> to 8 h (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>b). Further, a lower dose of 1 mg/kg provided a dampened response, with a maximal 3-fold increase of 2-AG occurring at the 0.5 h time point and no clear elevation beyond that time point (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>c). At this dose, the free brain exposure of compound <b>6</b> could only be measured at 0.5 h and was 0.02 nM, 100-fold lower than the 10 mg/kg dose and well below the in vitro IC<sub>50</sub> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>d). Whereas the higher dose confirmed MAGL inhibition with treatment of compound <b>6</b>, collectively, the data were somewhat confounding. First, the modest response at both doses was surprising in comparison to previously run literature compounds with similar potency. Analysis of the juxtaposed PK/PD alone would suggest that <b>6</b> was simply rapidly cleared, and the lack of exposure precluded any opportunity for a 2-AG response. Additionally, however, it was striking that the 1 mg/kg dose showed 100-fold lower free brain exposure than the 10 mg/kg dose. This nonlinear PK suggested that another phenomenon may be occurring as well.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>6</b> on brain 2-AG and corresponding exposure following subcutaneous administration in wild-type mice: (a) 2-AG response following 10 mg/kg dose of <b>6</b>; (b) mean unbound plasma and brain exposure; (c) 2-AG response following 1 mg/kg dose of <b>6</b>; (d) mean unbound plasma and brain exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an effort to understand whether this phenomenon was specific to the azetidine core itself or alternatively the phenyl pyrazole, the corresponding piperidine <b>15</b> was prepared in similar fashion (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>a). Compound <b>15</b> retained similar in vitro activity against MAGL (IC<sub>50</sub> = 2 nM) and serine hydrolase selectivity panel (>70% inhibition of ABHD6, CES2, MAGL at both 1 and 10 μM and CES1, FAAH, PLA2G7 only at 10 μM; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf" class="ext-link">Table S2, Supporting Information</a>). Compound <b>15</b> was then administered in vivo at the same doses as compound <b>6</b>. Again, good brain penetration was observed, with an AUC-derived <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> ratio of 0.5. At both doses a robust, persistent 2-AG elevation was observed. At the lower, 1 mg/kg, dose of <b>15</b> the 2-AG response peaked at 2 h (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>b), similar to the high dose of <b>6</b> albeit achieving a considerably lower <i>C</i><sub>max</sub> (0.14 nM, <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>c). At the higher, 10 mg/kg, dose, <b>15</b> demonstrated a robust 2-AG response out to 24 h (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>d). Interestingly, at neither dose did central, free levels of compound <b>15</b> exceed the IC<sub>50</sub> (2 nM) measured in vitro, yet 2-AG was significantly elevated in both.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Structure of compound <b>15</b>. (b, d) Effect of <b>15</b> on brain 2-AG following subcutaneous administration in wild-type mice of (c) 1 mg/kg and (e) 10 mg/kg doses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In aggregate, the PK/PD data from <b>6</b> and <b>15</b> illustrated a disconnect in the exposure/2-AG elevation relationship for these compounds. Compound <b>6</b> achieved free exposures significantly higher than its in vitro IC<sub>50</sub> but showed only a marginal response, whereas <b>15</b> never exceeded its in vitro value but exhibited a sustained 2-AG elevation. It cannot be discounted that the lack of exquisite selectivity for MAGL as assessed by the serine hydrolase panel could potentially convolute the interpretation of the data. However, the similar selectivity profile observed for both <b>6</b> and <b>15</b> minimizes off-target impacts as cause for the discrepancy, as the same off target hydrolases are engaged to a similar extent. A number of scenarios could potentially help to explain this PK/PD disconnect, including (a) that the compounds were not covalently inhibiting MAGL and instead reverting to a paradigm wherein in vivo inhibition and resulting pharmacodynamics response were driven by AUC coverage of the target or (b) that the inhibitors were indeed covalently modifying MAGL but that the resultant adducts varied in their hydrolytic stability. The combination of the cellular ABPP of <b>14</b> and the crystal structure of <b>3</b> covalently bound to MAGL reinforced to us that the former scenario was unlikely. That same data, however, reinforce the second scenario in that the azetidine carbamates were indeed forming a carbamate adduct with MAGL but that those complexes were less hydrolytically stable than those derived from the corresponding piperidine. To this end, acylated azetidines have been shown to react differently than acyclic or larger ring size amides due to decreased planarity in the amide moiety itself, conveyed by the ring strain associated with the azetidine itself.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Moreover, a comparison of the PK data suggested that in brain, the azetidine carbamate had a much faster rate of clearance than the corresponding piperidine, which could potentially be explained by initial reaction with MAGL, followed by a subsequent hydrolysis step. This, in effect, would suggest that the target for inhibition was also its primary clearance pathway. Efforts to further test this hypothesis, further deconvolute the observed PK/PD disconnect, and improve serine hydrolase selectivity are underway and will be reported in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, highly efficient MAGL inhibitors were identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of piperidine and azetidine-derived carbamates. Through monitoring improvements in FQ and LipE, efforts were focused on the optimization of 3-substituted azetidines, including five- and six-membered heterocycles. The incorporation of a pyrazole served as an efficient linker to facilitate further growth into the distal lipophilic pocket. A crystal structure of <b>3</b> aided in subsequent design of inhibitors and suggested minimizing the exposed polarity on the inhibitor. Replacement of the oxadiazole with a pyrazole, substituted with either a phenyl (<b>6</b>) or pyrazine (<b>10</b>) ring, maximized potency and LipE, respectively. The cellular potency, an exemplar of these compounds, was confirmed using ABPP. An in vivo experiment monitoring the effect of a key exemplar on 2-AG elevation confirmed in vivo MAGL inhibition, but a modest response suggested that the azetidine-derived analogs were exhibiting dampened PD effects than would be expected for a covalent modification of MAGL, whereas the corresponding piperidine <b>15</b> demonstrated a robust 2-AG elevation. Further efforts to understand this phenomenon are ongoing and will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biology. In Vitro Pharmacology</h3><div id="sec4-1-1-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Assessment of MAGL Inhibition (MAGL IC<sub>50</sub>)</h4><div class="NLM_p last">Assessment of MAGL inhibition utilized human recombinant monoacylglycerol lipase and the fluorogenic substrate 7-hydroxycoumarinyl arachidonate (7-HCA, Biomol ST-502). 400 nL of a test compound at decreasing concentration (ranging from 150 μM down to 1.5 nM) was spotted into a 384-well back plate (PerkinElmer, 6007279) using a Labcyte Echo, followed by addition of 10 μL of MAGL enzyme in assay buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.1% Triton X-100, and 25% glycerin). An equal volume of 7-HCA in assay buffer with 10% DMSO was added either immediately (<i>T</i> = 0 min) or after a 30 min incubation (<i>T</i> = 30 min) to initiate the reaction. The final concentration of MAGL enzyme was 88 pM, and 7-HCA substrate was 5 μM. After these dilutions, the final concentration of the test compound ranged from 3 μM to 0.03 nM. The reaction was allowed to progress for 60 min, after which the plate was read at an Ex/Em of 340/465. Percent inhibitions were calculated based on control wells containing no compound (0% inhibition) and a control compound (e.g., a MAGL inhibitor whose activity is known or was previously reported in the literature, such as one with about 100% inhibition). IC<sub>50</sub> values were generated based on a four-parameter fit model using ABASE software from IDBS.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4-1-1-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Assessment of Rate of MAGL Inactivation (MAGL <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub>)</h4><div class="NLM_p last">To measure MAGL inactivation, the same protocol for the (<i>T</i> = 0 min) MAGL inhibition IC<sub>50</sub> assay was performed with data collected every minute to acquire enzyme progress curves at decreasing concentrations of compound. <i>K</i><sub>obs</sub> values were calculated from these data, and <i>k</i><sub>inact</sub>/<i>K</i><sub>I</sub> ratios were determined from a plot of <i>K</i><sub>obs</sub> values vs compound concentrations.</div></div><div id="sec4-1-1-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Assessment of FAAH Inhibition</h4><div class="NLM_p last">Assessment of FAAH inhibition utilizes human recombinant fatty acid amide hydrolase lipase and the fluorogenic substrate arachidonoyl-AMC (Sigma A6855). 400 nL of a test compound at decreasing concentration was spotted into a 384-well back plate (PerkinElmer, 6007279) using a Labcyte Echo, followed by addition of 10 μL of FAAH enzyme (Cayman 10010183) in assay buffer (50 mM Tris, pH 9.0, 1 mM EDTA). After a 30 min incubation at room temperature, 10 μL of arachidonyl-AMC was added in assay buffer with 16% DMSO. Final concentration of FAAH enzyme was 0.0125 unit, and the AAMC substrate was used at a concentration of 5 μM. The final concentration of the test compound ranged from 30 μM to 0.3 nM. The reaction was allowed to progress for 60 min, after which the plate was read at an Ex/Em of 355/460. Percent inhibitions were calculated based on control wells containing no compound (0% inhibition) and a control compound at a concentration known to inhibit FAAH to 100%. IC<sub>50</sub> values were generated based on a four-parameter fit model using ABASE software from IDBS.</div></div></div><div id="sec4-1-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cellular Pharmacology</h3><div class="NLM_p">Human brain vascular pericytes and pericyte growth supplement were purchased from ScienCell Research Laboratories. Media, other supplements for cell culture, and reagents for sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) were purchased from Thermo Fisher Scientific unless otherwise noted. TAMRA azide was purchased from Lumiprobe. DMSO solutions of compound <b>14</b> were prepared, and aliquots were stored at −20 °C.</div><div id="sec4-1-2-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Cell Culture and Treatment</h4><div class="NLM_p last">Human brain vascular pericytes were cultured in Dulbecco’s modified Eagle medium/nutrient mixture F-12 (DMEM/F12), supplemented with 5% heat-inactivated fetal bovine serum (FBS), 1% pericyte growth supplement, and 100 U/mL penicillin–streptomycin in a humidified environment maintained with 5% CO<sub>2</sub> at 37 °C. For labeling with probe <b>14</b>, cells were cultured on six-well plates overnight, and 1000× stock solutions of probe <b>14</b> in DMSO were added to the growth media, and cells were maintained for 1 h at 37 °C. At the end of treatment, cells were washed with 1 mL of cold phosphate buffered saline (PBS) and were scrapped in 1 mL of cold PBS. Cells were pelleted by centrifuging at 10 000<i>g</i> at 37 °C for 1 min. The supernatant was removed, and cell pellets were kept at −80 °C until further analysis.</div></div><div id="sec4-1-2-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Click Chemistry Activity-Based Protein Profiling</h4><div class="NLM_p last">To the cell pellets was added PBS containing 0.25% SDS, and the cells were lysed with gentle sonication. The proteome concentration was measured with bicinchoninic acid (BCA) assay. The proteomes were normalized to 1.0 mg/mL and subject to Cu-catalyzed click chemistry with TAMRA azide following a reported protocol.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The reaction mixtures were diluted with lithium dodecyl sulfate (LDS) sample buffer and NuPAGE reducing agent and were analyzed with 1.0 mm NuPAGE 4–12% Bis-Tris 15-well gels in 2-[<i>N</i>-morpholino]ethanesulfonic acid (MES) running buffer. TAMRA fluorescence signals were collected on a Typhoon FLA 9500 biomolecular imager (GE Healthcare) with 532 nm laser excitation and ≥575 nm long-pass emission filter.</div></div><div id="sec4-1-2-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Data Analysis</h4><div class="NLM_p last">In-gel fluorescence data were visualized with ImageJ software (version 1.47, NIH). Fluorescence intensity was quantified with background subtraction using ImageStudio Lite (version 4.0.21, LI-COR). The intensities of the two MAGL bands were averaged, and data from two biological replicates were plotted as mean ± standard deviation in GraphPad Prism (version 7.02) and were fit to an inhibitor dose–response curve to obtain the cellular IC<sub>50</sub>.</div></div></div><div id="sec4-1-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Experiments</h3><div class="NLM_p">All procedures performed on animals in this study were in accordance with established guidelines and regulations and were reviewed and approved by the Pfizer (or other) Institutional Animal Care and Use Committee.</div><div id="sec4-1-3-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Assessment of 2-AG Elevation</h4><div class="NLM_p last">C57Bl6 mice (7 weeks old) were housed 4 per cage in an environmentally controlled animal facility (12 h light/dark cycle from 6:00 a.m. to 6:00 p.m.; temperature was maintained between 20.5 and 22.0 °C; relative humidity was maintained between 50 and 65%). Food and water were available ad libitum throughout the study. Mice were subcutaneously administered <b>6</b>, <b>14</b>, or vehicle (DMSO/Cremophor/saline at a volume ratio of 5:5:90). Plasma and brain samples of <b>6</b> and <b>14</b> treated mice were collected at 0.5, 1, 2, 4, 8, 12, and 24 h postdose (3 mice per time point). Plasma and brain samples of vehicle treated mice were collected at 1 h postdose. Blood was collected by first anesthetizing mice with isoflurane followed by cardiac puncture. Whole blood was placed into tubes containing NaF and K<sub>2</sub>EDTA (0.5 M, 20 μL per 1 mL of blood) to inhibit plasma hydrolase activity and as an anticoagulant, respectively. Blood was centrifuged at 4000 rcf for 5 min to harvest plasma. Immediately following blood sampling mice were euthanized by cervical dislocation and their brains were removed. Brain and cerebellum were immediately frozen in liquid nitrogen and stored at −80 °C until analysis.</div></div><div id="sec4-1-3-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Pharmacodynamic Measurement</h4><div class="NLM_p">Plasma samples were prepared for 2-AG measurement on wet ice. Briefly, samples were spiked with IS2 (internal standard 2) solution [1 μg/mL d5-2-AG (deuterated 2 arachidonoylglycerol) (Cayman Chemical Ann Arbor, MI) in ACN] followed by precipitation and organic extraction in EtOAC/hexane (v:v 50:50). Samples were then centrifuged at 15 700 rcf for 15 min. Supernatant was removed and dried under nitrogen gas at room temperature. Samples were then reconstituted in ACN and directly injected for LC–MS/MS analysis. Calibration standards and quality control samples were prepared using the same methodology. The 2-AG calibration curve consisted of 2 500 ng/mL of 2-AG in water/PMSF/buffer [100 mM NH<sub>4</sub>OAc in water (pH 2.0 adjusted with formic acid)] (v:v:v 100:5:20). For 2-AG measurement samples were directly injected onto a C 18 UPLC column held at 65 °C at a flow rate of 0.5 mL/min. Retention time for 2-AG was 2.71 min. Retention time for d5-2-AG was 2.70 min. Mass spectrometry was run in positive electrospray ionization (ESI) mode with selected reaction monitoring (SRM) detection. The 2-AG <i>m</i>/<i>z</i> was 379.4/287.3. The d5-2-AG <i>m</i>/<i>z</i> was 384.4/287.4.</div><div class="NLM_p last">Brain samples were prepared on wet ice. Briefly, brain homogenates were prepared by homogenizing brain with 3 volumes (w:v) of homogenization buffer (1% PMSF and 5% 100 mM NH<sub>4</sub>OAc in water, pH 2.0, adjusted with formic acid). The brain homogenates were then spiked with IS2 [1 μg/mL d5-2-AG, (deuterated 2 arachidonoylglycerol) (Cayman Chemical Ann Arbor, MI) in ACN] solution followed by precipitation and organic extraction in ACN. Samples were then centrifuged at 15 700 rcf for 15 min at 4 °C. Supernatant was removed from each sample directly injected for LC–MS/MS analysis. A d5-2-AG internal standard (Cayman Chemical Ann Arbor, MI) was added to each sample. Calibration standards and quality control samples were prepared using the same methodology. The 2-AG calibration curve consisted of 50 50000 ng/mL 2-AG in homogenization buffer. For 2-AG measurement samples were directly injected onto a C 18 UPLC column held at 50 °C at a flow rate of 0.5 mL/min. Retention time for 2-AG was 3.30 min. Retention time for d5-2-AG was 3.29 min. Mass spectrometry was run in positive ESI mode with SRM detection. The 2-AG <i>m</i>/<i>z</i> was 379.4/287.3.</div></div><div id="sec4-1-3-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Analysis of Compound in Plasma and Brain and Pharmacokinetic Parameters</h4><div class="NLM_p last">All samples were quantified via HPLC–MS/MS. Cerebellum samples were thawed, diluted 1:4 (w/v) with water, and homogenized using an H-speed dispersator. Standards and controls were prepared in a similar manner using a brain homogenate prepared from untreated animals. Plasma and brain homogenate samples were prepared for analysis by deproteination with methanol/acetonitrile (1:1, v/v) containing an internal standard. The sample volume for analysis was 10 and 50 μL for the plasma and brain matrices, respectively. The samples were precipitated with 200 μL of methanol/acetonitrile, vortexed, and centrifuged. Following centrifugation, the supernatant was transferred to a clean 96-well injection block and diluted 40× with water containing 0.1% formic acid. A sample volume of 10 μL for the plasma samples and 5 μL for the brain samples was subsequently injected on the LC–MS/MS for analysis. The lower limit of quantification (LLOQ) was 1.0 ng/mL for plasma and 0.5 ng/mL for brain homogenate (conversion to 2.5 ng/g) samples. The upper limit of quantification (ULOQ) was 1000 ng/mL for plasma and 500 ng/mL for brain homogenate (conversion to 2500 ng/g). Pharmacokinetic parameters were determined by noncompartmental analysis using Watson LIMS, version 7.5.</div></div><div id="sec4-1-3-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> X-ray Structure of MAGL Bound to <b>3</b></h4><div class="NLM_p">Synthetic DNA encoding full-length human MAGL (residues 1–303), with an N-terminal 6×-His tag and a C-terminal Strep tag, was cloned into <i>E. coli</i> (Rosetta strain) and expressed and purified essentially as described previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The protein was purified by a combination of nickel ion and streptactin affinity chromatography and concentrated to 50 mg/mL in a final buffer consisting of 15 mM HEPES, pH 8.2, 2 mM TCEP, and 10% glycerol, with hexaethylene glycol monododecyl ether added to 0.1 mM. Crystallization was carried out in sitting drops with 0.30 μL of protein at 20 mg/mL added to 0.30 μL of reservoir solution (0.07 M sodium cacodylate, pH 5.1–5.9 and 33–51% MPD).</div><div class="NLM_p">Apo crystals obtained from these drops were harvested and transferred to a cryoprotectant soaking solution that consisted of 70 mM sodium cacodylate, pH 5.1; 10% MPD; 30% PEG-MME-2K with the addition of 1 mM compound <b>3</b>. Crystals were left to soak overnight (12–18 h) and flash-frozen in liquid nitrogen for data collection.</div><div class="NLM_p last">X-ray diffraction data to 2.26 Å resolution were collected at 100 K with radiation of wavelength 1 Å at beamline 17-ID of the Advanced Photon Source at Argonne, on a Pilatus-6M detector. Data were processed using autoPROC<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> with XDS<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> for data integration and the program Scala from the CCP4 Suite<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> for merging and scaling. The structure was solved by molecular replacement using PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU">3HJU</a><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as the search model, and refined with autoBUSTER.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Model building and fitting were done using Coot.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Data collection and refinement statistics are given in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf" class="ext-link">Table S1</a>.</div></div></div><div id="sec4-2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry. General Methods</h3><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous sodium sulfate. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepRf 4 to 120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Microwave reactions were carried out in a SmithCreator microwave reactor from Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C18 columns, 5 μm, 30 mm × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL of dimethylsulfoxide. Samples were purified by mass triggered collection using a mobile phase of 0.1% trifluoroacetic acid in water and acetonitrile with a starting gradient of 100% aqueous to 100% acetonitrile over 10 min at a flow rate of 20 mL/min. Elemental analyses were performed by QTI, Whitehouse, NJ. All target compounds were analyzed using ultrahigh performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). Unless otherwise noted, all tested compounds were found to be >95% pure by this method.</div></div><div id="sec4-2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> UHPLC/MS Analysis</h3><div class="NLM_p last">The UHPLC was performed on a Waters ACQUITY UHPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters, Milford, MA). Detection was performed on a Waters LCT premier XE mass spectrometry (Waters, Milford, MA). The instrument was fitted with an Acquity BEH (Bridged Ethane Hybrid) C18 column (30 mm × 2.1 mm, 1.7 μm particle size, Waters, Milford, MA) operated at 60 °C.</div></div><div id="sec4-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(3-Phenyl-1,2,4-oxadiazol-5-yl)azetidine-1-carboxylate (<b>3</b>)</h3><div id="sec4-3-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Step 1</h4><div class="NLM_p last">To a solution of <i>N</i>-hydroxybenzenecarboximidamide (6.5 g, 48 mmol), 1-(<i>tert</i>-butoxycarbonyl)azetidine-3-carboxylic acid (11.5 g, 57 mmol), and HATU (21.8 g, 57 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (80 mL) at room temperature was added DIPEA (18.5 g, 143 mmol), and the resulting mixture was stirred for 16 h. The mixture was then portioned with water (40 mL × 3) and then saturated sodium chloride (40 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was dissolved in NMP (80 mL) and heated to 140 °C for 5 h. The mixture was cooled to room temperature, poured onto water, and extracted with ethyl acetate (50 mL × 3). The combined organic layers were washed with water and saturated sodium chloride, dried over sodium sulfate, and concentrated in vacuo. The residue was purified on a silica gel column (gradient, petroleum ether to 1:1 petroleum ether/ethyl acetate) to afford 10.6 g (74% yield) of <i>tert</i>-butyl 3-(3-phenyl-1,2,4-oxadiazol-5-yl)azetidine-1-carboxylate as a yellow oil</div></div><div id="sec4-3-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Step 2</h4><div class="NLM_p last">To a mixture of <i>tert</i>-butyl 3-(3-phenyl-1,2,4-oxadiazol-5-yl)azetidine-1-carboxylate (3.5 g, 11.6 mmol) in ethyl acetate (10 mL) was added a solution of HCl in ethyl acetate (4 M, 40 mL), and the reaction was stirred at room temperature for 30 min. The reaction was then concentrated in vacuo to give 2.62 g (95%) of the HCl salt of 5-(azetidin-3-yl)-3-phenyl-1,2,4-oxadiazole as a white solid.</div></div><div id="sec4-3-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Step 3</h4><div class="NLM_p last">To a solution of bis(trichloromethyl) carbonate (252 mg, 0.84 mmol) in CH<sub>2</sub>Cl<sub>2</sub>(40 mL) were added 1,1,1,3,3,3-hexafluoropropan-2-ol (426 mg, 2.52 mmol) and DIPEA (330 mg, 2.52 mmol) at 0 °C under N<sub>2</sub>. The reaction mixture was stirred at 20 °C for 7 h. A solution of 5-(azetidin-3-yl)-3-phenyl-1,2,4-oxadiazole hydrochloride (600 mg, 2.52 mmol) and DIPEA (1.3 g, 10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added to the mixture and then was stirred at 20 °C for 16 h. The reaction mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water (50 mL × 3) and saturated sodium chloride (50 mL), dried over sodium sulfate, and concentrated in vacuo to give the crude product. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate, 5:1) to give 470 mg (47%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(3-phenyl-1,2,4-oxadiazol-5-yl)azetidine-1-carboxylate (<b>3</b>) as a clear oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.11- 8.07 (m, 2 H), 7.59–7.49 (m, 3 H), 6.12 (dt, <i>J</i> = 12.5 and 6.3 Hz, 1 H), 4.68–4.53 (m, 2 H), 4.51–4.38 (m, 2 H), 4.38–4.30 (m, 1 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.9, 168.7, 151.4, 131.5, 129.0, 127.5, 126.2, 120.5 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 283.2 Hz), 67.8 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.5 Hz), 54.1, 53.4, 26.3. LC/MS (ESI, <i>m</i>/<i>z</i>) 396.0 [M + H]<sup>+</sup>.</div></div></div><div id="sec4-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(2-Morpholinopyrimidin-4-yl)azetidine-1-carboxylate (<b>4</b>)</h3><div class="NLM_p last">To a solution of triphosgene (38 mg, 0.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) were added 1,1,1,3,3,3-hexafluoropropan-2-ol (66 mg, 0.39 mmol) and DIPEA (50 mg, 0.39 mmol) at 0 °C under N<sub>2</sub>. The reaction mixture was stirred at 20 °C for 4 h. To it were added 4-(4-(azetidin-3-yl)pyrimidin-2-yl)morpholine (100 mg, 0.39 mmol) and DIEA (202 mg, 1.56 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and the reaction mixture was stirred at 20 °C for 16 h. The reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub>,(20 mL) and water (30 mL × 3) and then washed with saturated sodium chloride (30 mL), dried over sodium sulfate, concentrated in vacuo to give the crude product which was purified by prep TLC on silica gel (petroleum ether/ethyl acetate, 2:1) to afford 57 mg (35%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(2-morpholinopyrimidin-4-yl)azetidine-1-carboxylate (<b>4</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.26 (d, <i>J</i> = 5.1 Hz, 1 H), 6.54 (d, <i>J</i> = 4.8 Hz, 1 H), 6.09 (spt, <i>J</i> = 6.4 Hz, 1 H), 4.47–4.34 (m, 2 H), 4.34–4.20 (m, 2 H), 3.87–3.82 (m, 1 H), 3.81–3.70 (m, 8 H). LC/MS (ESI, <i>m</i>/<i>z</i>) 415.3 [M + H]<sup>+</sup>.</div></div><div id="sec4-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-[4-(Pyrimidin-2-yl)piperazin-1-yl]azetidine-1-carboxylate (<b>5</b>)</h3><div class="NLM_p last">To a solution of 2-[4-(azetidin-3-yl)piperazin-1-yl]pyrimidine<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (100 mg, 0.30 mmol) and DIPEA (196 mg, 1.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was added a solution of triphosgene, 1,1,1,3,3,3-hexafluoropropan-2-ol, DIPEA, and DMAP in CH<sub>2</sub>Cl<sub>2</sub> dropwise at 0 °C. The mixture was stirred at 16 °C for 3 h. The mixture was concentrated in vacuo and purified by preparative high performance liquid chromatography to give 21 mg (17%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-[4-(pyrimidin-2-yl)piperazin-1-yl]azetidine-1-carboxylate (<b>5</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 4.7 Hz, 2 H), 6.51 (t, <i>J</i> = 4.7 Hz, 1 H), 5.65 (sep, <i>J</i> = 6.2 Hz, 1 H), 4.23–3.97 (m, 4 H), 3.93–3.79 (m, 4 H), 3.29–3.16 (m, 1 H), 2.44–2.39 (m, 4 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 161.5, 157.7, 151.7, 120.6 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 283.2 Hz), 110.2, 67.6 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.5 Hz), 54.2, 54.0, 53.3, 49.4, 43.2. HRMS calculated for C<sub>15</sub>H<sub>17</sub>F<sub>6</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 414.1359, found 414.1361.</div></div><div id="sec4-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>6</b>)</h3><div id="sec4-6-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step 1: <i>tert</i>-Butyl 3-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 3-[(2<i>E</i>)-3-(dimethylamino)prop-2-enoyl]azetidine-1-carboxylate (800 mg, 3.15 mmol) and phenyl hydrazine (340 mg, 3.15 mmol) in EtOH (10 mL) was heated to reflux and stirred for 16 h. The reaction mixture was concentrated in vacuo and purified by silica gel chromatography to give a mixture of <i>tert</i>-butyl 3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (200 mg, 21.25%) and <i>tert</i>-butyl 3-(1-phenyl-1<i>H</i>-pyrazol-5-yl)azetidine-1-carboxylate (280 mg, 29.8%) as a brown solid. Data for <i>tert</i>-butyl 3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.82 (d, <i>J</i> = 2.4 Hz, 1 H), 7.65–7.57 (m, 2 H), 7.37 (t, <i>J</i> = 7.9 Hz, 2 H), 7.24–7.18 (m, 1 H), 6.37 (d, <i>J</i> = 2.4 Hz, 1 H), 4.35–4.19 (m, 2 H), 4.04 (dd, <i>J</i> = 8.4 and 6.2 Hz, 2 H), 3.83 (s, 1 H), 1.45–1.32 (m, 9 H).</div></div><div id="sec4-6-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 2: 3-(Azetidin-3-yl)-1-phenyl-1<i>H</i>-pyrazole</h4><div class="NLM_p last">To a solution of <i>tert-</i>butyl 3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (200 mg, 0.67 mmol) in EtOAc (0.5 mL) was added a solution of HCl in MeOH (1 mL, 4 mmol, 4 M) dropwise at 0 °C. The resulting mixture was stirred at room temperature (25 °C) for 1 h. The reaction was concentrated in vacuo and the residue was triturated with MTBE (20 mL × 3) and evaporated to give the 150 mg (97%) of the crude 3-(azetidin-3-yl)-1-phenyl-1<i>H</i>-pyrazole HCl salt as a dark yellow solid, which was used in the next step directly.</div></div><div id="sec4-6-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 3: 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>6</b>)</h4><div class="NLM_p last">A solution of hexafluoroisopropanol (108 mg, 0.64 mmol), DMAP (8.3 mg, 0.06 mmol), and DIPEA (99 mg, 0.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added dropwise to a solution, precooled (0 °C, under an N2 atm), of triphosgene (63 mg, 0.21 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL). The resulting mixture was stirred at 25 °C for 16 h. This solution was then added to a stirring solution of 3-(azetidin-3-yl)-1-phenyl-1<i>H</i>-pyrazole hydrochloride (150 mg, 0.64 mmol) and DIPEA (248 mg, 1.92 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The resulting mixture was stirred at 25 °C for 6 h. The reaction mixture was quenched with water (20 mL) and extracted with EtOAc (20 mL × 3). The combined organic layer was dried over sodium sulfate, filtered, concentrated in vacuo, and purified by prep-HPLC to give 50 mg (20%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(1-phenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>6</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.91 (d, <i>J</i> = 2.5 Hz, 1 H), 7.67 (d, <i>J</i> = 8.0 Hz, 2 H), 7.46 (s, 2 H), 7.26 (s, 1 H), 6.42 (d, <i>J</i> = 2.5 Hz, 1 H), 5.70 (dt, <i>J</i> = 12.5 and 6.2 Hz, 1 H), 4.59–4.43 (m, 2 H), 4.42–4.25 (m, 2 H), 4.13–3.99 (m, 1 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 153.6, 151.8, 139.9, 129.5, 128.1, 126.6, 120.6 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 282.4 Hz), 119.1, 105.3, 67.6 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.5 Hz), 56.2, 55.5, 28.2. HRMS calculated for C<sub>16</sub>H<sub>13</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 396.0777, found 396.0766.</div></div></div><div id="sec4-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-Methyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>7</b>)</h3><div class="NLM_p last">To a solution of triphosgene (89 mg, 0.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added a solution of 1,1,1,3,3,3-hexafluoropropan-2-ol (153 mg, 0.9 mmol), DIPEA (118 mg, 0.9 mmol), and DMAP (11 mg, 0.09 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) dropwise at −10 °C. To this solution was added a solution of 3-(azetidin-3-yl)-1-methyl-1<i>H</i>-pyrazole (125 mg, 0.9 mmol) and DIPEA (353 mg, 2.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and the resulting mixture was stirred at 15 °C overnight. The reaction mixture was then filtered, concentrated, and purified by prep TLC (30% ethyl acetate in petroleum ether) to give 20 mg (7%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(1-methyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>7</b>). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.82–7.29 (m, 1 H), 6.24 (d, <i>J</i> = 2.2 Hz, 1 H), 6.05 (dquin, <i>J</i> = 12.7 and 6.4 Hz, 1 H), 4.53–4.35 (m, 2 H), 4.24–4.08 (m, 2 H), 3.94 (tt, <i>J</i> = 8.8 and 6.3 Hz, 1 H), 3.85 (s, 3 H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ 153.75, 153.34, 133.44, 104.63, 68.88 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.06 Hz), 57.69, 57.01, 38.87, 29.25, CF<sub>3</sub> carbons not observed. HRMS calculated for C<sub>11</sub>H<sub>11</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 332.0828, found 332.0825.</div></div><div id="sec4-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1,5-Diphenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>8</b>)</h3><div class="NLM_p last">To a solution of triphosgene (31 mg, 0.11 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added 1,1,1,3,3,3-hexafluoroisopropanol (54 mg, 0.32 mmol) and DIPEA (41 mg, 0.32 mmol) at 0 °C under N<sub>2</sub>. The reaction mixture was stirred at 27 °C for 7 h. To this solution was added a solution of 3-(azetidin-3-yl)-1,5-diphenyl-1<i>H</i>-pyrazole (100 mg, 0.32 mmol) and DIPEA (166 mg, 1.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and then the reaction mixture was stirred at 27 °C for 16 h. The reaction mixture was then partitioned between CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and water (50 mL), and the organic layer was washed with water (50 mL × 3) and saturated sodium chloride (50 mL), dried over sodium sulfate, filtered, and concentrated in vacuo to give the crude product, which was purified by prep TLC (petroleum ether/EtOAc 6:1) to give 71 mg (46%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(1,5-diphenyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>8</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 7.64–7.01 (m, 11 H), 6.71–6.53 (m, 1 H), 6.19–5.97 (m, 1 H), 4.61–4.44 (m, 2 H), 4.38–4.22 (m, 2 H), 4.14–3.98 (m, 1 H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 152.6, 151.7, 144.5, 139.8, 130.2, 129.0, 128.6, 128.5, 128.4, 127.6, 125.2, 120.6 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 282.4 Hz), 105.3, 67.6 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.5 Hz), 56.2, 55.6, 28.2. LC/MS (ESI, <i>m</i>/<i>z</i>) 470.0 [M + H]<sup>+</sup>.</div></div><div id="sec4-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-[1-(3,4-Difluorophenyl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>9</b>)</h3><div id="sec4-9-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step 1: <i>tert</i>-Butyl 3-[1-(3,4-Difluorophenyl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>A</b>)</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 3-(1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (200 mg, 0.9 mmol), 3,4-difluorophenylboronic acid (170 mg, 1.1 mmol), Cu(OAc)<sub>2</sub> (244 mg, 1.3 mmol), and pyridine (213 mg, 2.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was stirred at 40 °C for 20 h. The reaction mixture was then filtered, and the filtrate was diluted with water (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL × 3). The combined organic layer was washed with water (20 mL), saturated sodium chloride (20 mL), dried over sodium sulfate, concentrated in vacuo, and purified by silica gel chromatography (ethyl acetate/petroleum ether, gradient 0–10%,) to give 150 mg (50%) of <i>tert</i>-butyl 3-[1-(3,4-difluorophenyl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>A</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.82 (d, <i>J</i> = 2.5 Hz, 1 H), 7.56 (ddd, <i>J</i> = 11.2, 6.9, and 2.5 Hz, 1 H), 7.40- 7.33 (m, 1 H), 7.28–7.11 (m, 1 H), 6.44 (d, <i>J</i> = 2.5 Hz, 1 H), 4.36–4.26 (m, 2 H), 4.13–4.05 (m, 2 H), 3.87 (tt, <i>J</i> = 8.7, 6.1 Hz, 1 H), 1.50–1.41 (m, 9 H).</div></div><div id="sec4-9-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 2: 3-(Azetidin-3-yl)-1-(3,4-difluorophenyl)-1<i>H</i>-pyrazole (<b>B</b>)</h4><div class="NLM_p last">To a solution of <b>A</b> (150 mg, 0.45 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was added a solution of HCl in EtOAc (0.56 mL 2.2 mmol, 4 M) dropwise at 0 °C. The resulting mixture was stirred at room temperature for 1 h and then concentrated in vacuo. The residue was triturated with TBME (10 mL × 3) and then concentrated to give 120 mg (99%) of crude 3-(azetidin-3-yl)-1-(3,4-difluorophenyl)-1<i>H</i>-pyrazole (<b>B</b>) as a white solid, which was used in the next step without purification.</div></div><div id="sec4-9-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Step 3: 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-[1-(3,4-difluorophenyl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>9</b>)</h4><div class="NLM_p last">A solution of hexafluoroisopropanol (66.0 mg, 0.39 mmol), DMAP (4.8 mg, 0.04 mmol), and DIPEA (61 mg, 0.47 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added dropwise to a solution of triphosgene (38.5 mg, 0.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) at 0 °C under a nitrogen atmosphere. The resulting mixture was stirred at 30 °C for 16 h. The solution was then added to a solution of <b>B</b> (120 mg, 0.39 mmol) and DIPEA (152 mg, 1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The resulting mixture was stirred at 30 °C for 6 h. The reaction mixture was quenched with water (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL × 3). The combined organic layer was dried over sodium sulfate, filtered, concentrated in vacuo, and purified by prep-HPLC to give 24 mg (14%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-[1-(3,4-difluorophenyl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>9</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.26–8.14 (m, 1 H), 7.75 (ddd, <i>J</i> = 11.7, 7.1, and 2.6 Hz, 1 H), 7.63–7.52 (m, 1 H), 7.45–7.28 (m, 1 H), 6.51 (d, <i>J</i> = 2.4 Hz, 1 H), 6.16–5.99 (m, 1 H), 4.58–4.40 (m, 2 H), 4.34–4.19 (m, 2 H), 4.05 (tt, <i>J</i> = 8.9 and 6.1 Hz, 1 H). LCMS <i>m</i>/<i>z</i> 430.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec4-10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-[1-(pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>10</b>)</h3><div id="sec4-10-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 1: <i>tert</i>-Butyl 3-[1-(Pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate</h4><div class="NLM_p last">To a mixture of <i>tert</i>-butyl 3-(1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (100 mg, 0.45 mmol), 2-bromopyrazine (92 mg, 0.45 mmol), Pd(OAc)<sub>2</sub> (15 mg, 0.067 mmol), and X-Phos (64 mg, 0.13 mmol) in THF (10 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (292 mg, 0.90 mmol). The reaction mixture was stirred under a N<sub>2</sub> atmosphere and heated to reflux for 18 h. The reaction mixture was then filtered, and filtrate was diluted with EtOAc (20 mL). The solution was then washed with water (20 mL), saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, concentrated in vacuo, and purified by prep TLC (petroleum ether/EtOAc, 1:1) to give 50 mg (37%) of <i>tert</i>-butyl 3-[1-(pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.39–9.04 (m, 1 H), 8.55 (d, <i>J</i> = 2.7 Hz, 1 H), 8.49–8.46 (m, 1 H), 8.44 (dd, <i>J</i> = 2.7 and 1.5 Hz, 1 H), 6.57 (d, <i>J</i> = 2.7 Hz, 1 H), 4.41–4.21 (m, 2 H), 4.16–4.04 (m, 2 H), 4.01–3.85 (m, 1 H) 1.45 (s, 9 H)</div></div><div id="sec4-10-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step 2: 2-[3-(Azetidin-3-yl)-1<i>H</i>-pyrazol-1-yl]pyrazine</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl 3-[1-(pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (50 mg, 0.17 mmol) in HCl/EtOAc (5 mL, 4 M) was stirred at rt for 1 h. The reaction was then concentrated in vacuo to afford 33 mg (96%) of 2-[3-(azetidin-3-yl)-1<i>H</i>-pyrazol-1-yl]pyrazine as a light oil which was used in the next step without further purification.</div></div><div id="sec4-10-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Step 3: 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-[1-(Pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate (<b>10</b>)</h4><div class="NLM_p last">To a solution of triphosgene (16.2 mg, 0.055 mmol) in CH<sub>2</sub>Cl<sub>2</sub>(1 mL) was added a solution of hexafluoroisopropanol (27.6 mg, 0.16 mmol), DIPEA (21.2 mg, 0.16 mmol), and DMAP (0.2 mg, 1.6 μmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) dropwise at 0 °C. The mixture was stirred at rt for 7 h. A solution of 2-[3-(azetidin-3-yl)-1<i>H</i>-pyrazol-1-yl]pyrazine (33 mg, 0.16 mmol) and DIPEA (63.6 mg, 0.49 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was then added to the above solution. The resultant reaction mixture was stirred at rt for an additional 18 h. The reaction mixture was concentrated in vacuo and then dissolved in EtOAc (10 mL), washed with water (10 mL × 2) and saturated sodium chloride, then dried over anhydrous sodium sulfate and filtered. The solution was then concentrated in vacuo and purified by prep-HPLC to afford 18 mg (28%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-[1-(pyrazin-2-yl)-1<i>H</i>-pyrazol-3-yl]azetidine-1-carboxylate as a solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.39–9.04 (m, 1 H), 8.55 (d, <i>J</i> = 2.7 Hz, 1 H), 8.49–8.46 (m, 1 H), 8.44 (dd, <i>J</i> = 2.7 and 1.5 Hz, 1 H), 6.57 (d, <i>J</i> = 2.7 Hz, 1 H), 4.41–4.21 (m, 2 H), 4.16–4.04 (m, 2 H), 4.01–3.85 (m, 1 H), 1.45 (s, 9 H). LCMS <i>m</i>/<i>z</i> 395.7 [M + H]<sup>+</sup>.</div></div></div><div id="sec4-11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-Benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>11</b>)</h3><div id="sec4-11-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Step 1: <i>tert</i>-Butyl 3-(1<i>H</i>-Pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">A mixture of 1-azetidinecarboxylic acid, 3-[(2<i>E</i>)-3-(dimethylamino)-1-oxo-2-propen-1-yl]-, 1,1-dimethylethyl ester<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (1.9 g, 7.5 mmol), and hydrazine hydrate (412 mg, 8.2 mmol) in EtOH (20 mL) was heated to 80 °C and stirred for 16 h. The reaction was concentrated in vacuo to afford 1.8 g (112%) of crude <i>tert</i>-butyl 3-(1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as a brown oil, which was used for next step directly. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.56 (d, <i>J</i> = 2.3 Hz, 1 H), 6.30 (d, <i>J</i> = 2.3 Hz, 1 H), 4.31 (t, J = 8.66 Hz, 2 H), 4.04 (dd, <i>J</i> = 8.5 and 6.0 Hz, 2 H), 3.90–3.79 (m, 1 H), 1.48–1.41 (m, 9 H).</div></div><div id="sec4-11-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step 2: <i>tert</i>-Butyl 3-(1-Benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 3-(1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (300 mg, 1.3 mmol), benzyl bromide (345 mg, 2.0 mmol), cesium carbonate (1.31 g, 4.0 mmol), and potassium iodide (11.2 mg, 0.067 mmol) in CH<sub>3</sub>CN (10 mL) was stirred at 25 °C for 16 h. The reaction mixture was diluted with water, extracted with EtOAc (30 mL × 3), washed with saturated sodium chloride (30 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by prep-HPLC to give 186 mg (44%) of <i>tert</i>-butyl 3-(1-benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as a pale yellow gum.</div></div><div id="sec4-11-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 3: 3-(Azetidin-3-yl)-1-benzyl-1<i>H</i>-pyrazole</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl 3-(1-benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (210 mg, 0.67 mmol) and trifluoroacetic acid (1.5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (6.0 mL) was stirred at 20 °C for 2 h. The reaction mixture was concentrated in vacuo to give 305 mg of 3-(azetidin-3-yl)-1-benzyl-1<i>H</i>-pyrazole as yellow oil, which was directly used in the next step.</div></div><div id="sec4-11-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step 4: 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-Benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>11</b>)</h4><div class="NLM_p last">To a solution of 1,1,1,3,3,3-hexafluoropropan-2-ol (500 mg, 2.98 mmol) in anhydrous CH<sub>3</sub>CN (8 mL) was added bis(perfluorophenyl) carbonate (1.1 g, 2.8 mmol) at 10 °C under a nitrogen atmosphere and was then stirred for 30 min at 22 °C. The reaction was cooled to 5 °C, and Et<sub>3</sub>N (2.27 g, 22 mmol) was added. The reaction was allowed to warm to rt and stirred at 22 °C for 2 h to give a light purple solution. The solution was then cooled to 5 °C and added dropwise to a mixture of 3-(azetidin-3-yl)-1-benzyl-1<i>H</i>-pyrazole (305 mg, 0.69 mmol) and Et<sub>3</sub>N (350 mg, 3.5 mmol) in anhydrous CH<sub>3</sub>CN (8 mL) at 5 °C. The reaction mixture was allowed to warm to rt and stirred at 22 °C for 16 h, then concentrated in vacuo, and the residue was purified by prep-HPLC to give 102 mg (36%) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(1-benzyl-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.40–7.29 (m, 4 H), 7.24–7.18 (m, 2 H), 6.23 (d, <i>J</i> = 2.5 Hz, 1 H), 5.69 (spt, <i>J</i> = 6.3 Hz, 1 H), 5.28 (s, 2 H), 4.47 (dt, <i>J</i> = 12.1 and 9.0 Hz, 2 H), 4.30–4.20 (m, 2 H), 3.97 (tt, <i>J</i> = 8.9 and 6.4 Hz, 1 H). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>15</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub>H<sup>+</sup> [M + H<sup>+</sup>]: 408.1127. Found 408.1141.</div></div></div><div id="sec4-12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>12</b>)</h3><div id="sec4-12-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step 1: <i>tert</i>-Butyl 3-(1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 3-(1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (400 mg, 1.8 mmol) and tetrahydro-2<i>H</i>-pyran-4-yl methanesulfonate (390 mg, 2.2 mmol) in DMF (10 mL) was added cesium carbonate (1.75 g, 5.4 mmol). The resulting mixture was stirred at 120 °C for 16 h. The mixture was then cooled and diluted with water (50 mL), extracted with EtOAc (20 mL × 3), washed with saturated sodium chloride (30 mL), dried over sodium sulfate, filtered, and concentrated to give the crude product which was purified by prep-HPLC to give 230 mg (42%) of <i>tert</i>-butyl 3-(1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate.</div></div><div id="sec4-12-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Step 2: 3-(Azetidin-3-yl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl 3-(1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (220 mg, 0.72 mmol) and trifluoroacetic acid (2.2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (8.0 mL) was stirred at 25 °C for 3 h. The solution was then concentrated in vacuo to give 312 mg of 3-(azetidin-3-yl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole as a yellow oil.</div></div><div id="sec4-12-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 3: 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>12</b>)</h4><div class="NLM_p last">To a solution of 1,1,1,3,3,3-hexafluoropropan-2-ol (540 mg, 3.2 mmol) in anhydrous CH<sub>3</sub>CN (8 mL) was added bis(perfluorophenyl) carbonate (1.1 g, 2.8 mmol) at 10 °C under a nitrogen atmosphere, and the mixture was then stirred for 30 min at 22 °C. The reaction was then cooled to 5 °C, and Et<sub>3</sub>N (1.6 g, 15.8 mmol) was added. The reaction was allowed to warm to rt and stirred for 2 h. This solution was then cooled to 5 °C and added dropwise to a solution of 3-(azetidin-3-yl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole (280 mg, 0.64 mmol) and Et<sub>3</sub>N (325 mg, 3.2 mmol) in anhydrous CH<sub>3</sub>CN (8 mL). The reaction mixture was allowed to warm to rt and stirred at 22 °C for 15 h, then concentrated, and the crude product was purified by prep-HPLC to give 63 mg (24% over 3 steps) of 1,1,1,3,3,3-hexafluoropropan-2-yl 3-(1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as a clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.40 (d, <i>J</i> = 3.0 Hz, 1 H), 6.19 (d, <i>J</i> = 3.0 Hz, 1 H), 5.67 (spt, <i>J</i> = 6.3 Hz, 1 H), 4.48–4.37 (m, 2 H), 4.34–4.25 (m, 1 H), 4.25–4.16 (m, 2 H), 4.12–4.03 (m, 2 H), 3.92 (tt, <i>J</i> = 9.0 and 6.0 Hz, 1 H), 3.56–3.46 (m, 2 H), 2.10–1.96 (m, 4 H). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>17</sub>F<sub>6</sub>N<sub>3</sub>O<sub>3</sub>H<sup>+</sup> [M + H<sup>+</sup>]: 402.1244. Found 402.1247.</div></div></div><div id="sec4-13" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-(4-Ethynylphenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>14</b>)</h3><div id="sec4-13-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step 1: <i>tert</i>-Butyl 3-(1-(4-((Trimethylsilyl)ethynyl)phenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">Nitrogen was bubbled through a solution of <b>13</b> (500 mg, 1.32 mmol) in triethylamine (7 mL) and dimethylformamide (1 mL) for 15 min. To this was added ethynyltrimethylsilane (0.38 mL, 260 mg, 2.6 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (189 mg, 0.264 mmol), and CuI (25 mg, 0.26 mmol), and the reaction was heated to 70 °C. After 3 h, the reaction was cooled to room temperature and poured over water. The mixture was extracted with dichloromethane (3×), and the combined organic fraction was dried with anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by silica gel flash chromatography (EtOAc/heptane) to afford 450 mg (86%) of <i>tert</i>-butyl 3-(1-(4-((trimethylsilyl)ethynyl)phenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 1.6 Hz, 1H), 7.64–7.58 (m, 2H), 7.57–7.51 (m, 2H), 6.45 (d, <i>J</i> = 1.6 Hz, 1H), 4.32 (app t, <i>J</i> = 8.6 Hz, 2H), 4.12–4.06 (m, 2H), 3.95–3.84 (m, 1H), 1.46 (s, 9H), 0.26 (s, 9H). MS ES<sup>+</sup> [2M + H]<sup>+</sup> 791.3.</div></div><div id="sec4-13-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 2: <i>tert</i>-Butyl 3-(1-(4-Ethynylphenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 3-(1-(4-((trimethylsilyl)ethynyl)phenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (430 mg, 1.1 mmol) in methanol (5 mL) was added potassium carbonate (455 mg, 3.26 mmol). The reaction mixture was stirred at room temperature for 1 h and then poured over 1 N KHSO<sub>4</sub>. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), and the combined organic fraction was dried with anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by silica gel flash chromatography (EtOAc/heptane) to afford 298 mg (85%) of <i>tert</i>-butyl 3-(1-(4-ethynylphenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 2.5 Hz, 1H), 7.66–7.62 (m, 2H), 7.59–7.54 (m, 2H), 6.45 (d, <i>J</i> = 2.5 Hz, 1H), 4.32 (app t, <i>J</i> = 8.6 Hz, 2H), 4.10 (dd, <i>J</i> = 6.1, 8.6 Hz, 2H), 3.89 (tt, <i>J</i> = 6.0, 8.8 Hz, 1H), 3.12 (s, 1H), 1.46 (s, 9H). MS ES<sup>+</sup> [M + H]<sup>+</sup> 324.1.</div></div><div id="sec4-13-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-(Azetidin-3-yl)-1-(4-ethynylphenyl)-1<i>H</i>-pyrazole)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 3-(1-(4-ethynylphenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (272 mg, 0.84 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added trifluoroacetic acid (1 mL). The reaction mixture was stirred at rt for 2 h 30 min and then poured over 1 N NaOH. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), and the combined organic fraction was dried with anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford 180 mg (96%) of 3-(azetidin-3-yl)-1-(4-ethynylphenyl)-1<i>H</i>-pyrazole) as a white foam which was used directly in the subsequent step.</div></div></div><div id="sec4-14" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 3-(1-(4-Ethynylphenyl)-1<i>H</i>-pyrazol-3-yl)azetidine-1-carboxylate (<b>14</b>)</h3><div class="NLM_p last">To a solution of 1,1′-carbonyldiimidazole (91 mg, 0.56 mmol) in tetrahydrofuran (4 mL) was added 1,1,1,3,3,3-hexafluoro-2-propanol (0.47 mL, 750 mg, 4.5 mmol). The reaction mixture was stirred at room temperature for 15 min, and then 3-(azetidin-3-yl)-1-(4-ethynylphenyl)-1<i>H</i>-pyrazole) (50 mg, 0.22 mmol) was added in one portion. The reaction mixture was stirred an additional 2 h at room temperature and then concentrated under reduced pressure. The crude pale yellow oil was purified by silica gel flash chromatography (EtOAc/heptane) to afford <b>14</b> (36 mg, 39% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (d, <i>J</i> = 2.3 Hz, 1H), 7.67–7.61 (m, 2H), 7.61–7.54 (m, 2H), 6.42 (d, <i>J</i> = 2.7 Hz, 1H), 5.69 (sep, <i>J</i> = 6.2 Hz, 1H), 4.55–4.44 (m, 2H), 4.38–4.26 (m, 2H), 4.02 (tt, <i>J</i> = 6.2, 9.0 Hz, 1H), 3.13 (s, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 154.02, 151.73, 139.73, 133.36, 128.01, 120.64 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 281.70 Hz), 120.13, 118.50, 105.89, 82.79, 77.98, 67.60 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 34.48 Hz), 56.08, 55.43, 28.19. HRMS calculated for C<sub>18</sub>H<sub>14</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 418.0985, found 418.0984.</div></div><div id="sec4-15" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate (<b>15</b>)</h3><div id="sec4-15-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step 1: <i>tert</i>-Butyl (<i>E</i>)-4-(3-(Dimethylamino)acryloyl)piperidine-1-carboxylate</h4><div class="NLM_p last"><i>tert</i>-Butyl 4-acetylpiperidine-1-carboxylate (1 g, 4.4 mmol) was dissolved in <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (15 mL), and the mixture was warmed to 110 °C and stirred for 40 h. The reaction mixture was then concentrated in vacuo to give 1.24 g of <i>tert</i>-butyl (<i>E</i>)-4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate as brown oil, which was used directly in the next step.</div></div><div id="sec4-15-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Step 2: <i>tert</i>-Butyl 4-(1<i>H</i>-Pyrazol-3-yl)piperidine-1-carboxylate</h4><div class="NLM_p last">Hydrazine monohydrate (659 mg, 6.6 mmol, 50% purity) was added to a solution of crude <i>tert</i>-butyl (<i>E</i>)-4-(3-(dimethylamino)acryloyl)piperidine-1-carboxylate (1240 mg, 4.4 mmol) in ethanol (25 mL) at 15 °C. The reaction mixture was warmed to 85 °C and stirred for 20 h. The mixture was then cooled and concentrated in vacuo, and the resulting residue was purified by silica gel flash chromatography (EtOAc/petroleum ether) to give 610 mg (55%) of <i>tert</i>-butyl 4-(1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate as yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.51 (d, <i>J</i> = 2.5 Hz, 1 H), 6.14 (d, <i>J</i> = 2.5 Hz, 1 H), 4.29–4.10 (m, 2 H), 2.97–2.79 (m, 3 H), 2.03–1.89 (m, 2 H), 1.64 (qd, <i>J</i> = 12.4 and 4.3 Hz, 2 H), 1.54–1.54 (m, 9 H).</div></div><div id="sec4-15-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 3: <i>tert</i>-Butyl 4-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate</h4><div class="NLM_p last">A suspension of phenyl boronic acid (291 mg, 2.4 mmol), copper(II) acetate (21.7 mg, 0.12 mmol), and 4 Å molecular sieves (1.3 g) in CH<sub>2</sub>Cl<sub>2</sub>(15 mL) was stirred at 15 °C for 3 min. To this suspension was added <i>tert</i>-butyl 4-(1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate (300 mg, 1.2 mmol), and the mixture was stirred at 35 °C under O<sub>2</sub> (g) . After 20 h the reaction mixture was concentrated in vacuo. Pyridine (15 mL) and copper(II) acetate (21.7 mg) were then added, and the reaction mixture was heated to 100 °C and stirred under O<sub>2</sub> (g). After 20 h, the mixture was filtered and the filtrate was diluted with water and extracted with EtOAc (3×). The combined organic phase was dried over sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by silica gel flash chromatography (EtOAc/petroleum ether) to afford 180 mg (46%) of <i>tert</i>-butyl 4-(1-phenyl-1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.61 (d, <i>J</i> = 2.0 Hz, 1 H), 7.55–7.36 (m, 5 H), 6.22 (d, <i>J</i> = 2.4 Hz, 1 H), 4.28–4.04 (m, 2 H), 2.89–2.76 (m, 1 H), 2.65 (t, <i>J</i> = 13.4 Hz, 2 H), 1.79 (d, <i>J</i> = 14.7 Hz, 2 H), 1.55 (d, <i>J</i> = 3.9 Hz, 2 H), 1.50–1.41 (m, 9 H).</div></div><div id="sec4-15-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Step 4: 4-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)piperidine</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl 4-(1-phenyl-1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate (180 mg, 0.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was added trifluoroacetic acid (1 mL). The reaction mixture was stirred at 20 °C for 2 h. The mixture was concentrated under reduced pressure to afford 188 mg of 4-(1-phenyl-1<i>H</i>-pyrazol-3-yl)piperidine as a brown gum, which was used directly in the next step.</div></div><div id="sec4-15-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Step 5: 1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(1-Phenyl-1<i>H</i>-pyrazol-3-yl)piperidine-1-carboxylate (<b>15</b>)</h4><div class="NLM_p last">To a solution of 1,1,1,3,3,3,-hexafluoropropan-2-ol (140 mg, 0.83 mmol) in anhydrous acetonitrile (5 mL) were added bis(pentafluorophenyl)carbonate (328 mg, 0.83 mmol) and triethylamine (337 mg, 3.3 mmol) at 0 °C. The solution was stirred at 20 °C under N<sub>2</sub> for 2 h to afford a purple solution. Separately, a solution of 4-(1-phenyl-1<i>H</i>-pyrazol-3-yl)piperidine (188 mg, 0.55 mmol) in anhydrous acetonitrile (5 mL) was treated with triethylamine (279 mg, 2.7 mmol) at 0 °C and stirred for 3 min, and then the above solution was added dropwise. The reaction mixture was stirred at 20 °C for 40 h and then concentrated in vacuo, and the residue was treated with additional 1,1,1,3,3,3-hexafluoropropan-2-yl (perfluorophenyl)carbonate (1.67 mmol in 10 mL of anhydrous acetonitrile), prepared as described above. The reaction mixture was stirred at 20 °C under N<sub>2.</sub> After 16 h, the reaction mixture was concentrated in vacuo and the residue was purified by reversed-phase HPLC (column, Agela Durashell C18 150 mm × 25 mm, 5 μm; mobile phase A of 0.05% NH<sub>4</sub>OH in water (v/v); mobile phase B of 0.05% NH<sub>4</sub>OH in MeCN (v/v); gradient from 58% to 78% B over 10 min, HOLD at 100% B for 2 min; flow rate of 35 mL/min) and then lyophilized to afford 80 mg (34%) of <b>15</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 8.09 (d, <i>J</i> = 2.4 Hz, 1 H), 7.73–7.66 (m, 2 H), 7.46 (t, <i>J</i> = 7.8 Hz, 2 H), 7.33–7.26 (m, 1 H), 6.38 (d, <i>J</i> = 2.9 Hz, 1 H), 6.21–6.11 (m, 1 H), 4.20 (td, <i>J</i> = 8.8 and 3.9 Hz, 2 H), 3.25–3.08 (m, 2 H), 3.01 (tt, <i>J</i> = 11.5 and 3.8 Hz, 1 H), 2.11–2.02 (m, 2 H), 1.82–1.65 (m, 2 H). <sup>13</sup>C NMR (101 MHz, MeOD) δ 158.93, 152.71, 141.51, 130.54, 129.56, 127.45, 123.84, 121.07, 120.20, 106.03, 69.16 (sep, <sup>2</sup><i>J</i><sub>CF</sub> = 33.75 Hz), 46.13, 45.56, 36.51, 32.97, 32.59. HRMS calculated for C<sub>18</sub>H<sub>17</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 422.1298, found 422.1292.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01531">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01531" class="ext-link">10.1021/acs.jmedchem.7b01531</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Data processing and model refinement statistics for MAGL complex with <b>3</b>, replicates of human brain vascular pericytes treated with <b>14</b>, and serine hydrolase selectivity panel for compounds <b>6</b> and <b>15</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf">jm7b01531_si_001.pdf (833.43 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_002.csv">jm7b01531_si_002.csv (0.81 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for compound <b>3</b> bound to the active site serine in MAGL is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1">6AX1</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01531" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Butler</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9bf8f3e9f2e8eff4ebf3fee9b5e9b5f9eeeff7fee9dbebfdf2e1fee9b5f8f4f6"><span class="__cf_email__" data-cfemail="ceada6bca7bdbaa1bea6abbce0bce0acbbbaa2abbc8ebea8a7b4abbce0ada1a3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Harris</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen Huang</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura A. McAllister</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher W. am Ende</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8832-9641" title="Orcid link">http://orcid.org/0000-0001-8832-9641</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Fennell</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy L. Foley</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kari Fonseca</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven J. Hawrylik</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas S. Johnson</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Knafels</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scot Mente</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">G. Stephen Noell</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy B. Phillips</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin R. Piro</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce N. Rogers</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tarek A. Samad</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Wang</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuangyi Wan</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Steven V. O’Neil for helpful discussions in manuscript preparation. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="DEF-LIST-d7e2947-autogenerated"><div id="ac_i66" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i66"> Abbreviations Used</h2><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">2-AG</td><td class="NLM_def"><p class="first last">2-arachidonoylglycerol</p></td></tr><tr><td class="NLM_term">CC-ABPP</td><td class="NLM_def"><p class="first last">click chemistry activity based protein profiling</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">HFIP</td><td class="NLM_def"><p class="first last">hexafluoroisopropanol</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">FQ</td><td class="NLM_def"><p class="first last">fit quality</p></td></tr><tr><td class="NLM_term">MAGL</td><td class="NLM_def"><p class="first last">monoacylglycerol lipase</p></td></tr><tr><td class="NLM_term">PLA2</td><td class="NLM_def"><p class="first last">phospholipase A2</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">How Neuroinflammation Contributes to Neurodegeneration</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1126/science.aag2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1126%2Fscience.aag2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=27540165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2016&pages=777-783&author=R.+M.+Ransohoff&title=How+Neuroinflammation+Contributes+to+Neurodegeneration&doi=10.1126%2Fscience.aag2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How neuroinflammation contributes to neurodegeneration</span></div><div class="casAuthors">Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6301</span>),
    <span class="NLM_cas:pages">777-783</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations.  Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease.  In this Review, I address how the neuron's environment also contributes to neurodegeneration.  Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier.  Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation.  These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohg7Gb9sXnzbVg90H21EOLACvtfcHk0liCVZBz3jczsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCju73I&md5=eaa975b2ac5903376d8ac10fed7b0820</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.aag2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aag2590%26sid%3Dliteratum%253Aachs%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DHow%2520Neuroinflammation%2520Contributes%2520to%2520Neurodegeneration%26jtitle%3DScience%26date%3D2016%26volume%3D353%26spage%3D777%26epage%3D783%26doi%3D10.1126%2Fscience.aag2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chanda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Btesh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strassle, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uveges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteside, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samad, T. A.</span><span> </span><span class="NLM_article-title">Monoacylglycerol Lipase Activity is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span><span class="refDoi"> DOI: 10.1124/mol.110.068304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fmol.110.068304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20855465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=996-1003&author=P.+K.+Chandaauthor=Y.+Gaoauthor=L.+Markauthor=J.+Bteshauthor=B.+W.+Strassleauthor=P.+Luauthor=M.+J.+Pieslaauthor=M.+Y.+Zhangauthor=B.+Binghamauthor=A.+Uvegesauthor=D.+Kowalauthor=D.+Garbeauthor=E.+V.+Kouranovaauthor=R.+H.+Ringauthor=B.+Batesauthor=M.+N.+Pangalosauthor=J.+D.+Kennedyauthor=G.+T.+Whitesideauthor=T.+A.+Samad&title=Monoacylglycerol+Lipase+Activity+is+a+Critical+Modulator+of+the+Tone+and+Integrity+of+the+Endocannabinoid+System&doi=10.1124%2Fmol.110.068304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span></div><div class="casAuthors">Chanda, Pranab K.; Gao, Ying; Mark, Lilly; Btesh, Joan; Strassle, Brian W.; Lu, Peimin; Piesla, Michael J.; Zhang, Mei-Yi; Bingham, Brendan; Uveges, Albert; Kowal, Dianne; Garbe, David; Kouranova, Evguenia V.; Ring, Robert H.; Bates, Brian; Pangalos, Menelas N.; Kennedy, Jeffrey D.; Whiteside, Garth T.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">996-1003</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Endocannabinoids are lipid mols. that serve as natural ligands for the cannabinoid receptors CB1 and CB2.  They modulate a diverse set of physiol. processes such as pain, cognition, appetite, and emotional states, and their levels and functions are tightly regulated by enzymic biosynthesis and degrdn.  2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the brain and is believed to be hydrolyzed primarily by the serine hydrolase monoacylglycerol lipase (MAGL).  Although 2-AG binds and activates cannabinoid receptors in vitro, when administered in vivo, it induces only transient cannabimimetic effects as a result of its rapid catabolism.  Here we show using a mouse model with a targeted disruption of the MAGL gene that MAGL is the major modulator of 2-AG hydrolysis in vivo.  Mice lacking MAGL exhibit dramatically reduced 2-AG hydrolase activity and highly elevated 2-AG levels in the nervous system.  A lack of MAGL activity and subsequent long-term elevation of 2-AG levels lead to desensitization of brain CB1 receptors with a significant redn. of cannabimimetic effects of CB1 agonists.  Also consistent with CB1 desensitization, MAGL-deficient mice do not show alterations in neuropathic and inflammatory pain sensitivity.  These findings provide the first genetic in vivo evidence that MAGL is the major regulator of 2-AG levels and signaling and reveal a pivotal role for 2-AG in modulating CB1 receptor sensitization and endocannabinoid tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXec6NludiW7Vg90H21EOLACvtfcHk0ljX1L-eblE8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF&md5=f6c38107c51f0c6d0f76241043ff988d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068304%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DBtesh%26aufirst%3DJ.%26aulast%3DStrassle%26aufirst%3DB.%2BW.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DBingham%26aufirst%3DB.%26aulast%3DUveges%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGarbe%26aufirst%3DD.%26aulast%3DKouranova%26aufirst%3DE.%2BV.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DMonoacylglycerol%2520Lipase%2520Activity%2520is%2520a%2520Critical%2520Modulator%2520of%2520the%2520Tone%2520and%2520Integrity%2520of%2520the%2520Endocannabinoid%2520System%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D996%26epage%3D1003%26doi%3D10.1124%2Fmol.110.068304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19635411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=744-753&author=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+F.+Cravatt&title=Characterization+of+Monoacylglycerol+Lipase+Inhibition+Reveals+Differences+in+Central+and+Peripheral+Endocannabinoid+Metabolism&doi=10.1016%2Fj.chembiol.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span></div><div class="casAuthors">Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MAGL) is a principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).  The authors recently reported a piperidine carbamate, JZL184, that inhibits MAGL with high potency and selectivity.  Here, the authors describe a comprehensive mechanistic characterization of JZL184.  The authors provide evidence that JZL184 irreversibly inhibits MAGL via carbamoylation of the enzyme's serine nucleophile.  Functional proteomic anal. of mice treated with JZL184 revealed that this inhibitor maintains good selectivity for MAGL across a wide range of central and peripheral tissues.  Interestingly, MAGL blockade produced marked, tissue-specific differences in monoglyceride metab., with brain showing the most dramatic elevations in 2-AG and peripheral tissues often showing greater changes in other monoglycerides.  Collectively, these studies indicate that MAGL exerts tissue-dependent control over endocannabinoid and monoglyceride metab. and designate JZL184 as a selective tool to characterize the functions of MAGL in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-iZXIq9TSLVg90H21EOLACvtfcHk0ljX1L-eblE8Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D&md5=020a5cb6ac9430ba9d3eac3c7b9ba216</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520Monoacylglycerol%2520Lipase%2520Inhibition%2520Reveals%2520Differences%2520in%2520Central%2520and%2520Peripheral%2520Endocannabinoid%2520Metabolism%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D744%26epage%3D753%26doi%3D10.1016%2Fj.chembiol.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dinh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A Role for Monoglyceride Lipase in 2-Arachidonoylglycerol Inactivation</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1016/S0009-3084(02)00150-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2FS0009-3084%2802%2900150-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=12505697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpslans7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2002&pages=149-158&author=T.+P.+Dinhauthor=T.+F.+Freundauthor=D.+Piomelli&title=A+Role+for+Monoglyceride+Lipase+in+2-Arachidonoylglycerol+Inactivation&doi=10.1016%2FS0009-3084%2802%2900150-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation</span></div><div class="casAuthors">Dinh, Thien P.; Freund, Tamas F.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">149-158</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Arachidonoylglycerol (I) is a naturally occurring monoglyceride that activates cannabinoid receptors and meets several key requisites of an endogenous cannabinoid substance.  I is present in the brain (where its levels are 170-fold higher than those of anandamide), is produced by neurons in an activity- and Ca2+-dependent manner, and is rapidly eliminated.  The mechanism of I inactivation is not completely understood, but is thought to involve carrier-mediated transport into cells followed by enzymic hydrolysis.  The authors have examd. the possible role of the serine hydrolase, monoglyceride lipase (II), in brain I inactivation.  The authors have identified by homol. screening a cDNA sequence encoding for a 303-amino acid protein, which conferred II activity upon transfection to COS-7 cells.  Northern blot and in situ hybridization analyses have revealed that II mRNA is unevenly present in the rat brain, with highest levels in regions where CB1 cannabinoid receptors are also expressed (hippocampus, cortex, anterior thalamus, and cerebellum).  Immunohistochem. studies in the hippocampus showed that II distribution has striking laminar specificity, suggesting a presynaptic localization of the enzyme.  Adenovirus-mediated transfer of II cDNA into rat cortical neurons increased the degrdn. of endogenously produced I in these cells, whereas no such effect was obsd. on anandamide degrdn.  These results indicate that I hydrolysis via II may be a primary route of I inactivation in intact neuronal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwAPaOj27MHbVg90H21EOLACvtfcHk0liJCbW9fMmUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpslans7s%253D&md5=e6a07281a0184d1521424bc7719bddbe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2802%2900150-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252802%252900150-0%26sid%3Dliteratum%253Aachs%26aulast%3DDinh%26aufirst%3DT.%2BP.%26aulast%3DFreund%26aufirst%3DT.%2BF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520Role%2520for%2520Monoglyceride%2520Lipase%2520in%25202-Arachidonoylglycerol%2520Inactivation%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2002%26volume%3D121%26spage%3D149%26epage%3D158%26doi%3D10.1016%2FS0009-3084%2802%2900150-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcondes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1126/science.1209200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+Hydrolysis+Generates+Brain+Prostaglandins+That+Promote+Neuroinflammation&doi=10.1126%2Fscience.1209200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0liJCbW9fMmUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520Hydrolysis%2520Generates%2520Brain%2520Prostaglandins%2520That%2520Promote%2520Neuroinflammation%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813%26doi%3D10.1126%2Fscience.1209200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Monoacylglycerol Lipase - a Target for Drug Development?</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1568</span><span class="NLM_x">–</span> <span class="NLM_lpage">1585</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1111%2Fj.1476-5381.2012.01950.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1568-1585&author=C.+J.+Fowler&title=Monoacylglycerol+Lipase+-+a+Target+for+Drug+Development%3F&doi=10.1111%2Fj.1476-5381.2012.01950.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase - a target for drug development?</span></div><div class="casAuthors">Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1585</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid (eCB) system is involved in processes as diverse as control of appetite, perception of pain and the limitation of cancer cell growth and invasion.  The enzymes responsible for eCB breakdown are attractive pharmacol. targets, and fatty acid amide hydrolase inhibitors, which potentiate the levels of the eCB anandamide, are now undergoing pharmaceutical development.  "Drugable" selective inhibitors of monoacylglycerol lipase, a key enzyme regulating the levels of the other main eCB, 2-arachidonoylglycerol, were however not identified until very recently.  Their availability has resulted in a large expansion of our knowledge concerning the pharmacol. consequences of monoacylglycerol lipase inhibition and hence the role(s) played by the enzyme in the body.  In this review, the pharmacol. of monoacylglycerol lipase will be discussed, together with an anal. of the therapeutic potential of monoacylglycerol lipase inhibitors as analgesics and anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hj7DUJaO97Vg90H21EOLACvtfcHk0liJCbW9fMmUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM&md5=b06b843ca0023abbe4e8cb6be83bcd52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01950.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DMonoacylglycerol%2520Lipase%2520-%2520a%2520Target%2520for%2520Drug%2520Development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1568%26epage%3D1585%26doi%3D10.1111%2Fj.1476-5381.2012.01950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Grabner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schicho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taschler, U.</span><span> </span><span class="NLM_article-title">Monoglyceride Lipase as a Drug Target: At the Crossroads of Arachidonic Acid Metabolism and Endocannabinoid Signaling</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.pharmthera.2017.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=28213089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2017&pages=35-46&author=G.+F.+Grabnerauthor=R.+Zimmermannauthor=R.+Schichoauthor=U.+Taschler&title=Monoglyceride+Lipase+as+a+Drug+Target%3A+At+the+Crossroads+of+Arachidonic+Acid+Metabolism+and+Endocannabinoid+Signaling&doi=10.1016%2Fj.pharmthera.2017.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span></div><div class="casAuthors">Grabner, Gernot F.; Zimmermann, Robert; Schicho, Rudolf; Taschler, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoglyerides (MGs) are short-lived, intermediary lipids deriving from the degrdn. of phospho- and neutral lipids, and monoglyceride lipase (MGL), also designated as monoacylglycerol lipase (MAGL), is the major enzyme catalyzing the hydrolysis of MGs into glycerol and fatty acids.  This distinct function enables MGL to regulate a no. of physiol. and pathophysiol. processes since both MGs and fatty acids can act as signaling lipids or precursors thereof.  The most prominent MG species acting as signaling lipid is 2-arachidonoyl glycerol (2-AG) which is the most abundant endogenous agonist of cannabinoid receptors in the body.  Importantly, recent observations demonstrate that 2-AG represents a quant. important source for arachidonic acid, the precursor of prostaglandins and other inflammatory mediators.  Accordingly, MGL-mediated 2-AG degrdn. affects lipid signaling by cannabinoid receptor-dependent and independent mechanisms.  Recent genetic and pharmacol. studies gave important insights into MGL's role in (patho-)physiol. processes, and the enzyme is now considered as a promising drug target for a no. of disorders including cancer, neurodegenerative and inflammatory diseases.  This review summarizes the basics of MG (2-AG) metab. and provides an overview on the therapeutic potential of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGvyCs_XBdLVg90H21EOLACvtfcHk0liJCbW9fMmUmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D&md5=af9f9beaa78954ad700885508e739900</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DGrabner%26aufirst%3DG.%2BF.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DSchicho%26aufirst%3DR.%26aulast%3DTaschler%26aufirst%3DU.%26atitle%3DMonoglyceride%2520Lipase%2520as%2520a%2520Drug%2520Target%253A%2520At%2520the%2520Crossroads%2520of%2520Arachidonic%2520Acid%2520Metabolism%2520and%2520Endocannabinoid%2520Signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D175%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2017.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ignatowska-Jankowska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkerson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive Versus Cannabimimetic Effects in Mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1124/jpet.114.222315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fjpet.114.222315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=25762694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=424-432&author=B.+Ignatowska-Jankowskaauthor=J.+L.+Wilkersonauthor=M.+Mustafaauthor=R.+Abdullahauthor=M.+Niphakisauthor=J.+L.+Wileyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Selective+Monoacylglycerol+Lipase+Inhibitors%3A+Antinociceptive+Versus+Cannabimimetic+Effects+in+Mice&doi=10.1124%2Fjpet.114.222315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice</span></div><div class="casAuthors">Ignatowska-Jankowska, Bogna; Wilkerson, Jenny L.; Mustafa, Mohammed; Abdullah, Rehab; Niphakis, Micah; Wiley, Jenny L.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous cannabinoid 2-arachidonoylglycerol (2-AG) plays an important role in a variety of physiol. processes, but its rapid breakdown by monoacylglycerol lipase (MAGL) results in short-lived actions.  Initial MAGL inhibitors were limited by poor selectivity and low potency.  In this study, we tested JZL184 [4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate] and MJN110 [2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate], MAGL inhibitors that possess increased selectivity and potency, in mouse behavioral assays of neuropathic pain [chronic constriction injury (CCI) of the sciatic nerve], interoceptive cannabimimetic effects (drug-discrimination paradigm), and locomotor activity in an open field test.  MJN110 (1.25 and 2.5 mg/kg) and JZL184 (16 and 40 mg/kg) significantly elevated 2-AG and decreased arachidonic acid but did not affect anandamide in whole brains.  Both MAGL inhibitors significantly reduced CCI-induced mech. allodynia with the following potencies [ED50 (95% confidence limit [CL]) values in mg/kg: MJN110 (0.43 [0.30-0.63]) > JZL184 (17.8 [11.6-27.4])] and also substituted for the potent cannabinoid receptor agonist CP55,940 [2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol] in the drug-discrimination paradigm [ED50 (95% CL) values in mg/kg: MJN110 (0.84 [0.69-1.02]) > JZL184 (24.9 [14.6-42.5])]; however, these compds. elicited differential effects on locomotor behavior.  Similar to cannabinoid 1 (CB1) receptor agonists, JZL184 produced hypomotility, whereas MJN110 increased locomotor behavior and did not produce catalepsy or hypothermia.  Although both drugs substituted for CP55,940 in the drug discrimination assay, MJN110 was more potent in reversing allodynia in the CCI model than in producing CP55,940-like effects.  Overall, these results suggest that MAGL inhibition may alleviate neuropathic pain, while displaying limited cannabimimetic effects compared with direct CB1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquAG_goQ7FM7Vg90H21EOLACvtfcHk0lgAXEH0Ap0ygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOnsbc%253D&md5=c4cdfc7947574e42bf4d5f7b3b14e780</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.222315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.222315%26sid%3Dliteratum%253Aachs%26aulast%3DIgnatowska-Jankowska%26aufirst%3DB.%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DMustafa%26aufirst%3DM.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DNiphakis%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DSelective%2520Monoacylglycerol%2520Lipase%2520Inhibitors%253A%2520Antinociceptive%2520Versus%2520Cannabimimetic%2520Effects%2520in%2520Mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D424%26epage%3D432%26doi%3D10.1124%2Fjpet.114.222315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Repeated Low-dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1124/jpet.112.201426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fjpet.112.201426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23412396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=492-501&author=S.+G.+Kinseyauthor=L.+E.+Wiseauthor=D.+Rameshauthor=R.+Abdullahauthor=D.+E.+Selleyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Repeated+Low-dose+Administration+of+the+Monoacylglycerol+Lipase+Inhibitor+JZL184+Retains+Cannabinoid+Receptor+Type+1-Mediated+Antinociceptive+and+Gastroprotective+Effects&doi=10.1124%2Fjpet.112.201426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span></div><div class="casAuthors">Kinsey, Steven G.; Wise, Laura E.; Ramesh, Divya; Abdullah, Rehab; Selley, Dana E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The monoacylglycerol lipase (MAGL) inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) produces antinociceptive and anti-inflammatory effects.  However, repeated administration of high-dose JZL184 (40 mg/kg) causes dependence, antinociceptive tolerance, cross-tolerance to the pharmacol. effects of cannabinoid receptor agonists, and cannabinoid receptor type 1 (CB1) downregulation and desensitization.  This functional CB1 receptor tolerance poses a hurdle in the development of MAGL inhibitors for therapeutic use.  Consequently, the present study tested whether repeated administration of low-dose JZL184 maintains its antinociceptive actions in the chronic constriction injury of the sciatic nerve neuropathic pain model and protective effects in a model of nonsteroidal anti-inflammatory drug-induced gastric hemorrhages.  Mice given daily injections of high-dose JZL184 (≥16 mg/kg) for 6 days displayed decreased CB1 receptor d. and function in the brain, as assessed in [3H]SR141716A binding and CP55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol]-stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding assays, resp.  In contrast, normal CB1 receptor expression and function were maintained following repeated administration of low-dose JZL184 (≤8 mg/kg).  Likewise, the antinociceptive and gastroprotective effects of high-dose JZL184 underwent tolerance following repeated administration, but these effects were maintained following repeated low-dose JZL184 treatment.  Consistent with these observations, repeated high-dose JZL184, but not repeated low-dose JZL184, elicited cross-tolerance to the common pharmacol. effects of Δ9-tetrahydrocannabinol.  This same pattern of effects was found in a rimonabant [(5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide)]-pptd. withdrawal model of cannabinoid dependence.  Taken together, these results indicate that prolonged, partial MAGL inhibition maintains potentially beneficial antinociceptive and anti-inflammatory effects, without producing functional CB1 receptor tachyphylaxis/tolerance or cannabinoid dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkkceF1Il2rVg90H21EOLACvtfcHk0lgAXEH0Ap0ygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D&md5=ea906c8140fa02a53729ff4fcbdcd8a8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201426%26sid%3Dliteratum%253Aachs%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DRepeated%2520Low-dose%2520Administration%2520of%2520the%2520Monoacylglycerol%2520Lipase%2520Inhibitor%2520JZL184%2520Retains%2520Cannabinoid%2520Receptor%2520Type%25201-Mediated%2520Antinociceptive%2520and%2520Gastroprotective%2520Effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26spage%3D492%26epage%3D501%26doi%3D10.1124%2Fjpet.112.201426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mulvihill, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Monoacylglycerol Lipase Inhibitors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1016/j.lfs.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.lfs.2012.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23142242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=492-497&author=M.+M.+Mulvihillauthor=D.+K.+Nomura&title=Therapeutic+Potential+of+Monoacylglycerol+Lipase+Inhibitors&doi=10.1016%2Fj.lfs.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Mulvihill, Melinda M.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and inflammation.  Both cannabinoids, like marijuana, that exert anti-inflammatory action through stimulating cannabinoid receptors, and cyclooxygenase (COX) inhibitors, like aspirin, that suppress pro-inflammatory eicosanoid prodn. have shown beneficial outcomes in mouse models of neurodegenerative diseases and cancer.  Both cannabinoids and COX inhibitors, however, have untoward effects that discourage their chronic usage, including cognitive deficits and gastrointestinal toxicity, resp.  Recent studies have uncovered that the serine hydrolase monoacylglycerol lipase (MAGL) links the endocannabinoid and eicosanoid systems together through hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) to provide the major arachidonic acid (AA) precursor pools for pro-inflammatory eicosanoid synthesis in specific tissues.  Studies in recent years have shown that MAGL inhibitors elicit anti-nociceptive, anxiolytic, and anti-emetic responses and attenuate pptd. withdrawal symptoms in addiction paradigms through enhancing endocannabinoid signaling.  MAGL inhibitors have also been shown to exert anti-inflammatory action in the brain and protect against neurodegeneration through lowering eicosanoid prodn.  In cancer, MAGL inhibitors have been shown to have anti-cancer properties not only through modulating the endocannabinoid-eicosanoid network, but also by controlling fatty acid release for the synthesis of protumorigenic signaling lipids.  Thus, MAGL serves as a crit. node in simultaneously coordinating multiple lipid signaling pathways in both physiol. and disease contexts.  This review will discuss the diverse (patho)physiol. roles of MAGL and the therapeutic potential of MAGL inhibitors in treating a vast array of complex human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojyVx1YSerrVg90H21EOLACvtfcHk0lgAXEH0Ap0ygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O&md5=cb44625201730a7849701df80fadb708</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BM.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DTherapeutic%2520Potential%2520of%2520Monoacylglycerol%2520Lipase%2520Inhibitors%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D492%26epage%3D497%26doi%3D10.1016%2Fj.lfs.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">The Serine Hydrolases MAGL, ABHD6 and ABHD12 as Guardians of 2-Arachidonoylglycerol Signalling through Cannabinoid Receptors</span> <span class="citation_source-journal">Acta Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1111/j.1748-1716.2011.02280.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1111%2Fj.1748-1716.2011.02280.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21418147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1eiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2012&pages=267-276&author=J.+R.+Savinainenauthor=S.+M.+Saarioauthor=J.+T.+Laitinen&title=The+Serine+Hydrolases+MAGL%2C+ABHD6+and+ABHD12+as+Guardians+of+2-Arachidonoylglycerol+Signalling+through+Cannabinoid+Receptors&doi=10.1111%2Fj.1748-1716.2011.02280.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors</span></div><div class="casAuthors">Savinainen, J. R.; Saario, S. M.; Laitinen, J. T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-276</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid 2-arachidonoylglycerol (2-AG) is a lipid mediator involved in various physiol. processes.  In response to neural activity, 2-AG is synthesized post-synaptically, then activates pre-synaptic cannabinoid CB1 receptors (CB1Rs) in a retrograde manner, resulting in transient and long-lasting redn. of neurotransmitter release.  The signalling competence of 2-AG is tightly regulated by the balanced action between "on demand" biosynthesis and degrdn.  We review recent research on monoacylglycerol lipase (MAGL), ABHD6 and ABHD12, three serine hydrolases that together account for approx. 99% of brain 2-AG hydrolase activity.  MAGL is responsible for approx. 85% of 2-AG hydrolysis and colocalizes with CB1R in axon terminals.  It is therefore ideally positioned to terminate 2-AG-CB1R signalling regardless of the source of this endocannabinoid.  Its acute pharmacol. inhibition leads to 2-AG accumulation and CB1R-mediated behavioral responses.  Chronic MAGL inactivation results in 2-AG overload, desensitization of CB1R signalling and behavioral tolerance.  ABHD6 accounts for approx. 4% of brain 2-AG hydrolase activity but in neurons it rivals MAGL in efficacy.  Neuronal ABHD6 resides post-synaptically, often juxtaposed with CB1Rs, and its acute inhibition leads to activity-dependent accumulation of 2-AG.  In cortical slices, selective ABHD6 blockade facilitates CB1R-dependent long-term synaptic depression.  ABHD6 is therefore positioned to guard intracellular pools of 2-AG at the site of generation.  ABHD12 is highly expressed in microglia and accounts for approx. 9% of total brain 2-AG hydrolysis.  Mutations in ABHD12 gene are causally linked to a neurodegenerative disease called PHARC.  Whether ABHD12 qualifies as a bona fide member to the endocannabinoid system remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBgLJavyxUbVg90H21EOLACvtfcHk0lghuhQAa2t9Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1eiuro%253D&md5=399f8c1e38ae5fd12886573245bec0ba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1748-1716.2011.02280.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1748-1716.2011.02280.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520Serine%2520Hydrolases%2520MAGL%252C%2520ABHD6%2520and%2520ABHD12%2520as%2520Guardians%2520of%25202-Arachidonoylglycerol%2520Signalling%2520through%2520Cannabinoid%2520Receptors%26jtitle%3DActa%2520Physiol.%26date%3D2012%26volume%3D204%26spage%3D267%26epage%3D276%26doi%3D10.1111%2Fj.1748-1716.2011.02280.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Piro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerr, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samad, T. A.</span><span> </span><span class="NLM_article-title">A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.celrep.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22813736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=617-623&author=J.+R.+Piroauthor=D.+I.+Benjaminauthor=J.+M.+Duerrauthor=Y.+Piauthor=C.+Gonzalesauthor=K.+M.+Woodauthor=J.+W.+Schwartzauthor=D.+K.+Nomuraauthor=T.+A.+Samad&title=A+Dysregulated+Endocannabinoid-Eicosanoid+Network+Supports+Pathogenesis+in+a+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.celrep.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Piro, Justin R.; Benjamin, Daniel I.; Duerr, James M.; Pi, YeQing; Gonzales, Cathleen; Wood, Kathleen M.; Schwartz, Joel W.; Nomura, Daniel K.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-623</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although inflammation in the brain is meant as a defense mechanism against neurotoxic stimuli, increasing evidence suggests that uncontrolled, chronic, and persistent inflammation contributes to neurodegeneration.  Most neurodegenerative diseases have now been assocd. with chronic inflammation, including Alzheimer's disease (AD).  Whether anti-inflammatory approaches can be used to treat AD, however, is a major unanswered question.  We recently demonstrated that monoacylglycerol lipase (MAGL) hydrolyzes endocannabinoids to generate the primary arachidonic acid pool for neuroinflammatory prostaglandins.  In this study, we show that genetic inactivation of MAGL attenuates neuroinflammation and lowers amyloid β levels and plaques in an AD mouse model.  We also find that pharmacol. blockade of MAGL recapitulates the cytokine-lowering effects through reduced prostaglandin prodn., rather than enhanced endocannabinoid signaling.  Our findings thus reveal a role of MAGL in modulating neuroinflammation and amyloidosis in AD etiol. and put forth MAGL inhibitors as a potential next-generation strategy for combating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhEmpHXwNVC7Vg90H21EOLACvtfcHk0lghuhQAa2t9Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM&md5=a84bec802e0b547d6e06052f39d1db0f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DDuerr%26aufirst%3DJ.%2BM.%26aulast%3DPi%26aufirst%3DY.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BW.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DA%2520Dysregulated%2520Endocannabinoid-Eicosanoid%2520Network%2520Supports%2520Pathogenesis%2520in%2520a%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26spage%3D617%26epage%3D623%26doi%3D10.1016%2Fj.celrep.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">Structural Basis for Human Monoglyceride Lipase Inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.jmb.2009.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19962385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=663-673&author=T.+Bertrandauthor=F.+Augeauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Valleeauthor=V.+Mikolauthor=P.+F.+Berneauthor=N.+Michotauthor=D.+Cheuretauthor=C.+Hoornaertauthor=M.+Mathieu&title=Structural+Basis+for+Human+Monoglyceride+Lipase+Inhibition&doi=10.1016%2Fj.jmb.2009.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Human Monoglyceride Lipase Inhibition</span></div><div class="casAuthors">Bertrand, T.; Auge, F.; Houtmann, J.; Rak, A.; Vallee, F.; Mikol, V.; Berne, P. F.; Michot, N.; Cheuret, D.; Hoornaert, C.; Mathieu, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyzes 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol.  2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiol. processes in the brain.  We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629.  MGL shares the classic fold of the α/β hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end.  Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG.  The bound structure of SAR629 highlights the key interactions for productive binding with MGL.  The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiDWkFIBQObVg90H21EOLACvtfcHk0lghuhQAa2t9Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D&md5=149fa9052c872b50c71e4d95d3c967d7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DAuge%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCheuret%26aufirst%3DD.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DStructural%2520Basis%2520for%2520Human%2520Monoglyceride%2520Lipase%2520Inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D663%26epage%3D673%26doi%3D10.1016%2Fj.jmb.2009.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The Resurgence of Covalent Drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+Resurgence+of+Covalent+Drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0liYbGMPJLk9GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520Resurgence%2520of%2520Covalent%2520Drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bachovchin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The Pharmacological Landscape and Therapeutic Potential of Serine Hydrolases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/nrd3620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnrd3620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22212679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=52-68&author=D.+A.+Bachovchinauthor=B.+F.+Cravatt&title=The+Pharmacological+Landscape+and+Therapeutic+Potential+of+Serine+Hydrolases&doi=10.1038%2Fnrd3620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological landscape and therapeutic potential of serine hydrolases</span></div><div class="casAuthors">Bachovchin, Daniel A.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-68</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases perform crucial roles in many biol. processes, and several of these enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's disease and infectious diseases.  Despite this, most of the human serine hydrolases (of which there are more than 200) remain poorly characterized with respect to their physiol. substrates and functions, and the vast majority lack selective, in vivo-active inhibitors.  Here, we review the current state of pharmacol. for mammalian serine hydrolases, including marketed drugs, compds. that are under clin. investigation and selective inhibitors emerging from academic probe development efforts.  We also highlight recent methodol. advances that have accelerated the rate of inhibitor discovery and optimization for serine hydrolases, which we anticipate will aid in their biol. characterization and, in some cases, therapeutic validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsWC4iV3Xc57Vg90H21EOLACvtfcHk0liYbGMPJLk9GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D&md5=4fde1e23117ad11848a9c2eef85376b7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd3620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3620%26sid%3Dliteratum%253Aachs%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520Pharmacological%2520Landscape%2520and%2520Therapeutic%2520Potential%2520of%2520Serine%2520Hydrolases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D52%26epage%3D68%26doi%3D10.1038%2Fnrd3620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The Metabolic Serine Hydrolases and their Functions in Mammalian Physiology and Disease</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6022</span><span class="NLM_x">–</span> <span class="NLM_lpage">6063</span><span class="refDoi"> DOI: 10.1021/cr200075y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200075y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFagtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6022-6063&author=J.+Z.+Longauthor=B.+F.+Cravatt&title=The+Metabolic+Serine+Hydrolases+and+their+Functions+in+Mammalian+Physiology+and+Disease&doi=10.1021%2Fcr200075y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolic serine hydrolases and their functions in mammalian physiology and disease</span></div><div class="casAuthors">Long, Jonathan Z.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6022-6063</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases (SHs) consist of >200 enzymes in humans which are characterized by the presence of an active site Ser residue that is used for the hydrolysis of substrates.  The membership of this enzyme class is nearly equally split between serine proteases (trypsin/chymotrypsin/subtilisin enzymes) and "metabolic" SHs that cleave ester, amide, or thioester bonds in small mols., peptides, or proteins.  The focus of this review is on the metabolic SHs.  Here, the authors attempt to provide a comprehensive summary that captures the state of knowledge about metabolic SHs in their entirety, including those enzymes that remain mostly or completely uncharacterized.  Particular emphasis is placed on relating the biochem. and enzymol. of individual SHs to the physiol. substrates and products they regulate in living systems, and how SHs, through the regulation of specific metabolic pathways impact health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5UaSiI-yXi7Vg90H21EOLACvtfcHk0liYbGMPJLk9GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFagtb8%253D&md5=c978f77bd911d5877df4ba97fc09e4b3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcr200075y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200075y%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520Metabolic%2520Serine%2520Hydrolases%2520and%2520their%2520Functions%2520in%2520Mammalian%2520Physiology%2520and%2520Disease%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6022%26epage%3D6063%26doi%3D10.1021%2Fcr200075y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavon, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective Blockade of 2-Arachidonoylglycerol Hydrolysis Produces Cannabinoid Behavioral Effects</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1038/nchembio.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnchembio.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19029917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=37-44&author=J.+Z.+Longauthor=W.+Liauthor=L.+Bookerauthor=J.+J.+Burstonauthor=S.+G.+Kinseyauthor=J.+E.+Schlosburgauthor=F.+J.+Pavonauthor=A.+M.+Serranoauthor=D.+E.+Selleyauthor=L.+H.+Parsonsauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Selective+Blockade+of+2-Arachidonoylglycerol+Hydrolysis+Produces+Cannabinoid+Behavioral+Effects&doi=10.1038%2Fnchembio.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span></div><div class="casAuthors">Long, Jonathan Z.; Li, Weiwei; Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Pavon, Franciso J.; Serrano, Antonia M.; Selley, Dana E.; Parsons, Loren H.; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2.  Endocannabinoid signaling is terminated by enzymic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL).  FAAH inhibitors produce a select subset of the behavioral effects obsd. with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo.  Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metab.  Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide.  JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility.  These data indicate that 2-AG endogenously modulates several behavioral processes classically assocd. with the pharmacol. of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1sK0ulYFK7Vg90H21EOLACvtfcHk0lgTZb_pzhmunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F&md5=1ffee44019b0e52db5da38fe30a6e4d0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.129%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DPavon%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%2BM.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520Blockade%2520of%25202-Arachidonoylglycerol%2520Hydrolysis%2520Produces%2520Cannabinoid%2520Behavioral%2520Effects%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D37%26epage%3D44%26doi%3D10.1038%2Fnchembio.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bartsch, R.; Cheuret, D.; Even, L.; Hoornaert, C.; Jeunesse, J.; Marguet, F.</span><span> </span><span class="NLM_article-title">Hexafluoroisopropyl Carbamate Derivatives, Especially Aryl- and Heteroaryl-piperidinecarboxylates and Analogs, Their Preparation and Use as Selective Monoacyl Glycerol Lipase (MGL) Inhibitors or Mixed MGL and Fatty Acid Amide Hydrolase Inhibitors</span>. WO2011151808 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Bartsch&author=D.+Cheuret&author=L.+Even&author=C.+Hoornaert&author=J.+Jeunesse&author=F.+Marguet&title=Hexafluoroisopropyl+Carbamate+Derivatives%2C+Especially+Aryl-+and+Heteroaryl-piperidinecarboxylates+and+Analogs%2C+Their+Preparation+and+Use+as+Selective+Monoacyl+Glycerol+Lipase+%28MGL%29+Inhibitors+or+Mixed+MGL+and+Fatty+Acid+Amide+Hydrolase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBartsch%26aufirst%3DR.%26atitle%3DHexafluoroisopropyl%2520Carbamate%2520Derivatives%252C%2520Especially%2520Aryl-%2520and%2520Heteroaryl-piperidinecarboxylates%2520and%2520Analogs%252C%2520Their%2520Preparation%2520and%2520Use%2520as%2520Selective%2520Monoacyl%2520Glycerol%2520Lipase%2520%2528MGL%2529%2520Inhibitors%2520or%2520Mixed%2520MGL%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that is Bioisosteric with Endocannabinoid Substrates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+Selective+Inhibitors+of+Monoacylglycerol+Lipase+Bearing+a+Reactive+Group+that+is+Bioisosteric+with+Endocannabinoid+Substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0lgTZb_pzhmunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520Selective%2520Inhibitors%2520of%2520Monoacylglycerol%2520Lipase%2520Bearing%2520a%2520Reactive%2520Group%2520that%2520is%2520Bioisosteric%2520with%2520Endocannabinoid%2520Substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Grancha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstykh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escoubet, J.</span><span> </span><span class="NLM_article-title">Selective Blockade of the Hydrolysis of the Endocannabinoid 2-Arachidonoylglycerol Impairs Learning and Memory Performance while Producing Antinociceptive Activity in Rodents</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=7642&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beeskeauthor=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Franconauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Valleeauthor=N.+Michotauthor=F.+Augeauthor=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+Blockade+of+the+Hydrolysis+of+the+Endocannabinoid+2-Arachidonoylglycerol+Impairs+Learning+and+Memory+Performance+while+Producing+Antinociceptive+Activity+in+Rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lgTZb_pzhmunA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeeske%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFrancon%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAuge%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520Blockade%2520of%2520the%2520Hydrolysis%2520of%2520the%2520Endocannabinoid%25202-Arachidonoylglycerol%2520Impairs%2520Learning%2520and%2520Memory%2520Performance%2520while%2520Producing%2520Antinociceptive%2520Activity%2520in%2520Rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D7642%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><div class="note"><p class="first last">Additionally, triazole ureas have been reported as potent MAGL inhibitors:</p></div><span class="NLM_contrib-group">Aaltonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönkkö, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korhonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häyrinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantsar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppänen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23521796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=379-390&author=N.+Aaltonenauthor=J.+R.+Savinainenauthor=C.+R.+Ribasauthor=J.+R%C3%B6nkk%C3%B6author=A.+Kuusistoauthor=J.+Korhonenauthor=D.+Navia-Paldaniusauthor=J.+H%C3%A4yrinenauthor=P.+Takabeauthor=H.+K%C3%A4sn%C3%A4nenauthor=T.+Pantsarauthor=T.+Laitinenauthor=M.+Lehtonenauthor=S.+Pasonen-Sepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainenauthor=J.+T.+Laitinen&title=Piperazine+and+Piperidine+Triazole+Ureas+as+Ultrapotent+and+Highly+Selective+Inhibitors+of+Monoacylglycerol+Lipase&doi=10.1016%2Fj.chembiol.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span></div><div class="casAuthors">Aaltonen, Niina; Savinainen, Juha R.; Ribas, Casandra Riera; Ronkko, Jani; Kuusisto, Anne; Korhonen, Jani; Navia-Paldanius, Dina; Hayrinen, Jukka; Takabe, Piia; Kasnanen, Heikki; Pantsar, Tatu; Laitinen, Tuomo; Lehtonen, Marko; Pasonen-Seppanen, Sanna; Poso, Antti; Nevalainen, Tapio; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-390</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) terminates the signaling function of the endocannabinoid, 2-arachidonoylglycerol (2-AG).  During 2-AG hydrolysis, MAGL liberates arachidonic acid, feeding the principal substrate for the neuroinflammatory prostaglandins.  In cancer cells, MAGL redirects lipid stores toward protumorigenic signaling lipids.  Thus MAGL inhibitors may have great therapeutic potential.  Although potent and increasingly selective MAGL inhibitors have been described, their no. is still limited.  Here, we have characterized piperazine and piperidine triazole ureas that combine the high potency attributable to the triazole leaving group together with the bulky arom. benzodioxolyl moiety required for selectivity, culminating in compd. JJKK-048 that potently (IC50 < 0.4 nM) inhibited human and rodent MAGL.  JJKK-048 displayed low cross-reactivity with other endocannabinoid targets.  Activity-based protein profiling of mouse brain and human melanoma cell proteomes suggested high specificity also among the metabolic serine hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDOxKwD3xf7Vg90H21EOLACvtfcHk0lhV0ITzV9IASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D&md5=3061a03d341bfb1de6b25c8d925b5b9f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DAaltonen%26aufirst%3DN.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DRibas%26aufirst%3DC.%2BR.%26aulast%3DR%25C3%25B6nkk%25C3%25B6%26aufirst%3DJ.%26aulast%3DKuusisto%26aufirst%3DA.%26aulast%3DKorhonen%26aufirst%3DJ.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DH%25C3%25A4yrinen%26aufirst%3DJ.%26aulast%3DTakabe%26aufirst%3DP.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DPantsar%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPasonen-Sepp%25C3%25A4nen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DPiperazine%2520and%2520Piperidine%2520Triazole%2520Ureas%2520as%2520Ultrapotent%2520and%2520Highly%2520Selective%2520Inhibitors%2520of%2520Monoacylglycerol%2520Lipase%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D379%26epage%3D390%26doi%3D10.1016%2Fj.chembiol.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lhV0ITzV9IASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">Ligand Efficiency and Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1016/j.drudis.2008.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.drudis.2008.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19073276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=278-283&author=S.+D.+Bembenekauthor=B.+A.+Toungeauthor=C.+H.+Reynolds&title=Ligand+Efficiency+and+Fragment-Based+Drug+Discovery&doi=10.1016%2Fj.drudis.2008.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency and fragment-based drug discovery</span></div><div class="casAuthors">Bembenek, Scott D.; Tounge, Brett A.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of fragment-based drug discovery (FBDD) has increased in recent years since it is more likely to produce a better optimized compd. of lower mol. wt.  Ligand efficiency (LE) has become important for assessing fragments, HTS hits, and resulting optimized ligands.  LE is useful for comparing ligands of equal mol. wt., but is ineffective for comparisons of ligands of differing mol. wt.  LE has a strong dependence on mol. size, which has led us to develop a size-independent efficiency score termed fit quality.  Evaluating FBDD examples from the literature using LE and fit quality, we find that, in general, the LEs of starting fragments are greater than those of larger, more elaborated, structures.  Fit quality scores, however, tend to improve upon optimization of the fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIWfRm1zWl87Vg90H21EOLACvtfcHk0lhV0ITzV9IASg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht78%253D&md5=55b35499fb26249d535bbe586f74f38f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DLigand%2520Efficiency%2520and%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D278%26epage%3D283%26doi%3D10.1016%2Fj.drudis.2008.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The Role of Molecular Size in Ligand Efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+Role+of+Molecular+Size+in+Ligand+Efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0lg5I24Qrl-DrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520Role%2520of%2520Molecular%2520Size%2520in%2520Ligand%2520Efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving Beyond Rules: the Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+the+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lg5I24Qrl-DrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520the%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.4155/fmc.10.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+Discovering+and+Derisking+Covalent%2C+Irreversible+Enzyme+Inhibitors&doi=10.4155%2Ffmc.10.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lg5I24Qrl-DrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520Discovering%2520and%2520Derisking%2520Covalent%252C%2520Irreversible%2520Enzyme%2520Inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964%26doi%3D10.4155%2Ffmc.10.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Palkowitz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R. A.</span><span> </span><span class="NLM_article-title">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2270</span><span class="NLM_x">–</span> <span class="NLM_lpage">2273</span><span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+Diverse+N-Acryloyl+Azetidines+and+Evaluation+of+Their+Enhanced+Thiol+Reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0ljZqz2FX6wn1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520Diverse%2520N-Acryloyl%2520Azetidines%2520and%2520Evaluation%2520of%2520Their%2520Enhanced%2520Thiol%2520Reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. D.</span><span> </span><span class="NLM_article-title">A Fluorescence-Based Assay for Monoacylglycerol Lipase Compatible with Inhibitor Screening</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1089/adt.2007.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1089%2Fadt.2007.122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=387-393&author=Y.+Wangauthor=P.+Chandaauthor=P.+G.+Jonesauthor=J.+D.+Kennedy&title=A+Fluorescence-Based+Assay+for+Monoacylglycerol+Lipase+Compatible+with+Inhibitor+Screening&doi=10.1089%2Fadt.2007.122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Fluorescence-Based%2520Assay%2520for%2520Monoacylglycerol%2520Lipase%2520Compatible%2520with%2520Inhibitor%2520Screening%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D387%26epage%3D393%26doi%3D10.1089%2Fadt.2007.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.1021/cb400261h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400261h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1590-1599&author=J.+W.+Changauthor=A.+B.+Cognettaauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Proteome-Wide+Reactivity+Profiling+Identifies+Diverse+Carbamate+Chemotypes+Tuned+for+Serine+Hydrolase+Inhibition&doi=10.1021%2Fcb400261h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span></div><div class="casAuthors">Chang, Jae Won; Cognetta, Armand B., III; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1590-1599</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are one of the largest and most diverse enzyme classes in Nature.  Inhibitors of serine hydrolases are used to treat many diseases, including obesity, diabetes, cognitive dementia, and bacterial and viral infections.  Nonetheless, the majority of the 200+ serine hydrolases in mammals still lack selective inhibitors for their functional characterization.  We and others have shown that activated carbamates, through covalent reaction with the conserved serine nucleophile of serine hydrolases, can serve as useful inhibitors for members of this enzyme family.  The extent to which carbamates, however, cross-react with other protein classes remains mostly unexplored.  Here, we address this problem by investigating the proteome-wide reactivity of a diverse set of activated carbamates in vitro and in vivo, using a combination of competitive and click chem. (CC)-activity-based protein profiling (ABPP).  We identify multiple classes of carbamates, including O-aryl, O-hexafluoroisopropyl (HFIP), and O-N-hydroxysuccinimidyl (NHS) carbamates that react selectively with serine hydrolases across entire mouse tissue proteomes in vivo.  We exploit the proteome-wide specificity of HFIP carbamates to create in situ imaging probes for the endocannabinoid hydrolases monoacylglycerol lipase (MAGL) and α-β hydrolase-6 (ABHD6).  These findings, taken together, designate the carbamate as a privileged reactive group for serine hydrolases that can accommodate diverse structural modifications to produce inhibitors that display exceptional potency and selectivity across the mammalian proteome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-176v-DnJrVg90H21EOLACvtfcHk0ljZqz2FX6wn1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D&md5=7286011459791bcdea13f918b9ef97c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcb400261h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400261h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-Wide%2520Reactivity%2520Profiling%2520Identifies%2520Diverse%2520Carbamate%2520Chemotypes%2520Tuned%2520for%2520Serine%2520Hydrolase%2520Inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1590%26epage%3D1599%26doi%3D10.1021%2Fcb400261h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1002/cbic.200900621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1002%2Fcbic.200900621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19957260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=218-227&author=G.+Labarauthor=C.+Bauvoisauthor=F.+Borelauthor=J.-L.+Ferrerauthor=J.+Woutersauthor=D.+M.+Lambert&title=Crystal+Structure+of+the+Human+Monoacylglycerol+Lipase%2C+a+Key+Actor+in+Endocannabinoid+Signaling&doi=10.1002%2Fcbic.200900621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Borel, Franck; Ferrer, Jean-Luc; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol plays a major role in endocannabinoid signaling, and is tightly regulated by monoacylglycerol lipase (MAGL).  Here, the authors report the crystal structure of human MAGL.  The protein crystd. as a dimer, and despite structural homologies to haloperoxidases and esterases, it distinguished itself by a wide and hydrophobic access to the catalytic site.  An apolar helix covering the active site also gave structural insight into the amphotropic character of MAGL, and likely explains how MAGL interacts with membranes to recruit its substrate.  Docking of 2-arachidonoylglycerol highlighted a hydrophobic and a hydrophilic cavity that accommodated the lipid into the catalytic site.  Moreover, the authors identified Cys-201 as the crucial residue in MAGL inhibition by N-arachidonylmaleimide, a SH group-reactive compd.  In addn. to the advance in the knowledge of endocannabinoids degrdn. routes, the structure of MAGL paves the way for future medicinal chem. results aimed at the design of new drugs exploiting 2-arachidonoylglycerol transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomb-R4j6WugrVg90H21EOLACvtfcHk0ljZqz2FX6wn1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D&md5=3caddaf36eb688fa3aeea940f6441b36</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900621%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.-L.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Monoacylglycerol%2520Lipase%252C%2520a%2520Key%2520Actor%2520in%2520Endocannabinoid%2520Signaling%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D218%26epage%3D227%26doi%3D10.1002%2Fcbic.200900621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data Processing and Analysis with the AutoPROC tool box</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+Processing+and+Analysis+with+the+AutoPROC+tool+box&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520Processing%2520and%2520Analysis%2520with%2520the%2520AutoPROC%2520tool%2520box%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kabsch, W.</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kabsch%2C+W.Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+2010%2C+66%2C+125%E2%80%93132+10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljH5Wpa_BG1QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0ljH5Wpa_BG1QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljH5Wpa_BG1QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chevalier, K. M.; Dax, S. L.; Flores, C. M.; Liu, L.; Macielag, M. J.; McDonnell, M. E.; Nelen, M. I.; Prouty, S.; Todd, M.; Zhang, S.-P.; Zhu, B.; Nulton, E. L.; Clemente, J.</span><span> </span><span class="NLM_article-title">Preparation of (Hetero)aromatic Piperazinyl Azetdinyl Amides as Monoacylglycerol Lipase (MGL) Inhibitors</span>. WO2010124121,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+M.+Chevalier&author=S.+L.+Dax&author=C.+M.+Flores&author=L.+Liu&author=M.+J.+Macielag&author=M.+E.+McDonnell&author=M.+I.+Nelen&author=S.+Prouty&author=M.+Todd&author=S.-P.+Zhang&author=B.+Zhu&author=E.+L.+Nulton&author=J.+Clemente&title=Preparation+of+%28Hetero%29aromatic+Piperazinyl+Azetdinyl+Amides+as+Monoacylglycerol+Lipase+%28MGL%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChevalier%26aufirst%3DK.%2BM.%26atitle%3DPreparation%2520of%2520%2528Hetero%2529aromatic%2520Piperazinyl%2520Azetdinyl%2520Amides%2520as%2520Monoacylglycerol%2520Lipase%2520%2528MGL%2529%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Claffey, M. M.; Helal, C. J.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Amino-heterocyclic Compounds Used as PDE9 Inhibitors</span>. WO2010084438,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+M.+Claffey&author=C.+J.+Helal&author=P.+R.+Verhoest&title=Amino-heterocyclic+Compounds+Used+as+PDE9+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26atitle%3DAmino-heterocyclic%2520Compounds%2520Used%2520as%2520PDE9%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lu Hou, Jian Rong, Ahmed Haider, Daisuke Ogasawara, Cassis Varlow, Michael A. Schafroth, Linjing Mu, Jiefeng Gan, Hao Xu, Christopher J. Fowler, Ming-Rong Zhang, Neil Vasdev, Simon Ametamey, Benjamin F. Cravatt, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 123-149. <a href="https://doi.org/10.1021/acs.jmedchem.0c01459" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bof%252Bthe%252BEndocannabinoid%252BSystem%25253A%252BOpportunities%252Band%252BChallenges%252Bin%252BRadiotracer%252BDevelopment%26aulast%3DHou%26aufirst%3DLu%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D21082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D123%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Wei, Wuqiang Wen, Li Rao, Yunyuan Huang, Mengting Lei, Kai Liu, Saiya Hu, Rongrong Song, Yanliang Ren, <span class="NLM_string-name hlFld-ContribAuthor">Jian Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (9)
                                     , 4388-4402. <a href="https://doi.org/10.1021/acs.jcim.9b01197" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b01197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b01197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b01197%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCov_FB3D%25253A%252BA%252BDe%252BNovo%252BCovalent%252BDrug%252BDesign%252BProtocol%252BIntegrating%252Bthe%252BBA-SAMP%252BStrategy%252Band%252BMachine-Learning-Based%252BSynthetic%252BTractability%252BEvaluation%26aulast%3DWei%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D27122019%26date%3D09042020%26date%3D01042020%26volume%3D60%26issue%3D9%26spage%3D4388%26epage%3D4402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">William
D. Lambert, Yinzhi Fang, Subham Mahapatra, Zhen Huang, Christopher W. am Ende, <span class="NLM_string-name hlFld-ContribAuthor">Joseph M. Fox</span>. </span><span class="cited-content_cbyCitation_article-title">Installation of Minimal Tetrazines through Silver-Mediated Liebeskind–Srogl Coupling with Arylboronic Acids. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (43)
                                     , 17068-17074. <a href="https://doi.org/10.1021/jacs.9b08677" title="DOI URL">https://doi.org/10.1021/jacs.9b08677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08677%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DInstallation%252Bof%252BMinimal%252BTetrazines%252Bthrough%252BSilver-Mediated%252BLiebeskind%2525E2%252580%252593Srogl%252BCoupling%252Bwith%252BArylboronic%252BAcids%26aulast%3DLambert%26aufirst%3DWilliam%2BD.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11082019%26date%3D22102019%26date%3D11102019%26volume%3D141%26issue%3D43%26spage%3D17068%26epage%3D17074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiang Luo, Xianheng Song, Wenfang Xiong, Jianheng Li, Mingkang Li, Zefeng Zhu, Shuxian Wei, Albert S. C. Chan, <span class="NLM_string-name hlFld-ContribAuthor">Yong Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed C–H Carbamoyloxylation of Aryl Carboxamides with CO2 and Amines at Ambient Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (7)
                                     , 2013-2018. <a href="https://doi.org/10.1021/acs.orglett.9b00122" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00122%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BC%2525E2%252580%252593H%252BCarbamoyloxylation%252Bof%252BAryl%252BCarboxamides%252Bwith%252BCO2%252Band%252BAmines%252Bat%252BAmbient%252BConditions%26aulast%3DLuo%26aufirst%3DXiang%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10012019%26date%3D28022019%26volume%3D21%26issue%3D7%26spage%3D2013%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, Giulia Bononi, Cristina Licari, Giulio Poli, Maguie el Boustani, Isabella Caligiuri, Flavio Rizzolio, Jürg Gertsch, Marco Macchia, Filippo Minutolo, Tiziano Tuccinardi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Chicca</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1932-1958. <a href="https://doi.org/10.1021/acs.jmedchem.8b01483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Ba%252BBenzoylpiperidine%252BClass%252BIdentifies%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BReversible%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BInhibitor%26aulast%3DGranchi%26aufirst%3DCarlotta%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D24092018%26date%3D11022019%26date%3D04022019%26volume%3D62%26issue%3D4%26spage%3D1932%26epage%3D1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Justin S. Cisar, Olivia D. Weber, Jason R. Clapper, Jacqueline L. Blankman, Cassandra L. Henry, Gabriel M. Simon, Jessica P. Alexander, Todd K. Jones, R. Alan B. Ezekowitz, Gary P. O’Neill, <span class="NLM_string-name hlFld-ContribAuthor">Cheryl A. Grice</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9062-9084. <a href="https://doi.org/10.1021/acs.jmedchem.8b00951" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00951%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BABX-1431%25252C%252Ba%252BSelective%252BInhibitor%252Bof%252BMonoacylglycerol%252BLipase%252Band%252BClinical%252BCandidate%252Bfor%252BTreatment%252Bof%252BNeurological%252BDisorders%26aulast%3DCisar%26aufirst%3DJustin%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D14062018%26date%3D23082018%26date%3D01082018%26volume%3D61%26issue%3D20%26spage%3D9062%26epage%3D9084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Laura A. McAllister, Christopher R. Butler, Scot Mente, Steven V. O’Neil, Kari R. Fonseca, Justin R. Piro, Julie A. Cianfrogna, Timothy L. Foley, Adam M. Gilbert, Anthony R. Harris, Christopher J. Helal, Douglas S. Johnson, Justin I. Montgomery, Deane M. Nason, Stephen Noell, Jayvardhan Pandit, Bruce N. Rogers, Tarek A. Samad, Christopher L. Shaffer, Rafael G. da Silva, Daniel P. Uccello, Damien Webb, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Brodney</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 3008-3026. <a href="https://doi.org/10.1021/acs.jmedchem.8b00070" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTrifluoromethyl%252BGlycol%252BCarbamates%252Bas%252BPotent%252Band%252BSelective%252BCovalent%252BMonoacylglycerol%252BLipase%252B%252528MAGL%252529%252BInhibitors%252Bfor%252BTreatment%252Bof%252BNeuroinflammation%26aulast%3DMcAllister%26aufirst%3DLaura%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15012018%26date%3D15032018%26date%3D02032018%26volume%3D61%26issue%3D7%26spage%3D3008%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ran Cheng, Wakana Mori, Longle Ma, Mireille Alhouayek, Akiko Hatori, Yiding Zhang, Daisuke Ogasawara, Gengyang Yuan, Zhen Chen, Xiaofei Zhang, Hang Shi, Tomoteru Yamasaki, Lin Xie, Katsushi Kumata, Masayuki Fujinaga, Yuji Nagai, Takafumi Minamimoto, Mona Svensson, Lu Wang, Yunfei Du, Mary Jo Ondrechen, Neil Vasdev, Benjamin F. Cravatt, Christopher Fowler, Ming-Rong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2278-2291. <a href="https://doi.org/10.1021/acs.jmedchem.7b01400" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01400%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B11C-Labeled%252BAzetidinecarboxylates%252Bfor%252BImaging%252BMonoacylglycerol%252BLipase%252Bby%252BPET%252BImaging%252BStudies%26aulast%3DCheng%26aufirst%3DRan%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21092017%26date%3D09032018%26date%3D26022018%26volume%3D61%26issue%3D6%26spage%3D2278%26epage%3D2291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Michael A.  Schafroth</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Richard S.  Van</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Atsuto  Hiraishi</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Jiahui  Chen</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Kuan  Hu</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Jiyun  Sun</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Yu</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Collier</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 1686-1695. <a href="https://doi.org/10.1016/j.apsb.2021.01.021" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Ba%252Bhighly-specific%252B18F-labeled%252Birreversible%252Bpositron%252Bemission%252Btomography%252Btracer%252Bfor%252Bmonoacylglycerol%252Blipase%252Bmapping%26aulast%3DChen%26aufirst%3DZhen%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D1686%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Čikoš</span>, <span class="hlFld-ContribAuthor ">Snježana  Dragojević</span>, <span class="hlFld-ContribAuthor ">Adrijana  Kubiček</span>. </span><span class="cited-content_cbyCitation_article-title">Degradation Products of Azetidine Core G334089 - Isolation, Structure Elucidation and Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2021,</strong> <em>22 </em>, 114232. <a href="https://doi.org/10.1016/j.jpba.2021.114232" title="DOI URL">https://doi.org/10.1016/j.jpba.2021.114232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2021.114232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2021.114232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DDegradation%252BProducts%252Bof%252BAzetidine%252BCore%252BG334089%252B-%252BIsolation%25252C%252BStructure%252BElucidation%252Band%252BPathway%26aulast%3D%25C4%258Ciko%25C5%25A1%26aufirst%3DAna%26date%3D2021%26volume%3D22%26spage%3D114232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haseeb  Mughal</span>, <span class="hlFld-ContribAuthor ">Michal  Szostak</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and reactivity of azetidines: strain-driven character of the four-membered heterocycle. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (15)
                                     , 3274-3286. <a href="https://doi.org/10.1039/D1OB00061F" title="DOI URL">https://doi.org/10.1039/D1OB00061F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00061F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00061F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Breactivity%252Bof%252Bazetidines%25253A%252Bstrain-driven%252Bcharacter%252Bof%252Bthe%252Bfour-membered%252Bheterocycle%26aulast%3DMughal%26aufirst%3DHaseeb%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D15%26spage%3D3274%26epage%3D3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuele  Maramai</span>, <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (21)
                                     , 1985-2003. <a href="https://doi.org/10.1002/cmdc.202000310" title="DOI URL">https://doi.org/10.1002/cmdc.202000310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000310%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252BEndocannabinoid%252BMetabolism%25253A%252Ban%252BArrow%252Bwith%252BMultiple%252BTips%252BAgainst%252BMultiple%252BSclerosis%26aulast%3DMaramai%26aufirst%3DSamuele%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D21%26spage%3D1985%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Yun‐Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Ming‐Kuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              ‐Selective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (42)
                                     , 18900-18906. <a href="https://doi.org/10.1002/ange.202008498" title="DOI URL">https://doi.org/10.1002/ange.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D42%26spage%3D18900%26epage%3D18906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Yun‐Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Ming‐Kuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              ‐Selective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (42)
                                     , 18741-18747. <a href="https://doi.org/10.1002/anie.202008498" title="DOI URL">https://doi.org/10.1002/anie.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D42%26spage%3D18741%26epage%3D18747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixin  Xie</span>, <span class="hlFld-ContribAuthor ">Yinzhi  Fang</span>, <span class="hlFld-ContribAuthor ">Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Amanda M.  Tallon</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Fox</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Synthesis of Monosubstituted and Unsymmetrical 3,6‐Disubstituted Tetrazines from Carboxylic Ester Precursors. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (39)
                                     , 16967-16973. <a href="https://doi.org/10.1002/anie.202005569" title="DOI URL">https://doi.org/10.1002/anie.202005569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202005569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202005569%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDivergent%252BSynthesis%252Bof%252BMonosubstituted%252Band%252BUnsymmetrical%252B3%25252C6%2525E2%252580%252590Disubstituted%252BTetrazines%252Bfrom%252BCarboxylic%252BEster%252BPrecursors%26aulast%3DXie%26aufirst%3DYixin%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D39%26spage%3D16967%26epage%3D16973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixin  Xie</span>, <span class="hlFld-ContribAuthor ">Yinzhi  Fang</span>, <span class="hlFld-ContribAuthor ">Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Amanda M.  Tallon</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Fox</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent Synthesis of Monosubstituted and Unsymmetrical 3,6‐Disubstituted Tetrazines from Carboxylic Ester Precursors. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (39)
                                     , 17115-17121. <a href="https://doi.org/10.1002/ange.202005569" title="DOI URL">https://doi.org/10.1002/ange.202005569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202005569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202005569%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDivergent%252BSynthesis%252Bof%252BMonosubstituted%252Band%252BUnsymmetrical%252B3%25252C6%2525E2%252580%252590Disubstituted%252BTetrazines%252Bfrom%252BCarboxylic%252BEster%252BPrecursors%26aulast%3DXie%26aufirst%3DYixin%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D39%26spage%3D17115%26epage%3D17121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily  Kabeiseman</span>, <span class="hlFld-ContribAuthor ">Riley  Paulsen</span>, <span class="hlFld-ContribAuthor ">Brian D.  Burrell</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of a monoacylglycerol lipase in the medicinal leech, Hirudo verbana. </span><span class="cited-content_cbyCitation_journal-name">Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology</span><span> <strong>2020,</strong> <em>243-244 </em>, 110433. <a href="https://doi.org/10.1016/j.cbpb.2020.110433" title="DOI URL">https://doi.org/10.1016/j.cbpb.2020.110433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpb.2020.110433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpb.2020.110433%26sid%3Dliteratum%253Aachs%26jtitle%3DComparative%2520Biochemistry%2520and%2520Physiology%2520Part%2520B%253A%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DCharacterization%252Bof%252Ba%252Bmonoacylglycerol%252Blipase%252Bin%252Bthe%252Bmedicinal%252Bleech%25252C%252BHirudo%252Bverbana%26aulast%3DKabeiseman%26aufirst%3DEmily%26date%3D2020%26volume%3D243-244%26spage%3D110433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina A.  Dahabiyeh</span>, <span class="hlFld-ContribAuthor ">Eman Y.  Abu-rish</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2020,</strong> <em>72 </em>
                                    (2)
                                     , 435-442. <a href="https://doi.org/10.1007/s43440-019-00013-0" title="DOI URL">https://doi.org/10.1007/s43440-019-00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43440-019-00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43440-019-00013-0%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DInhibition%252Bof%252Bmonoglyceride%252Blipase%252Bby%252Bproton%252Bpump%252Binhibitors%25253A%252Binvestigation%252Busing%252Bdocking%252Band%252Bin%252Bvitro%252Bexperiments%26aulast%3DDahabiyeh%26aufirst%3DLina%2BA.%26date%3D2020%26date%3D2019%26volume%3D72%26issue%3D2%26spage%3D435%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 582-602. <a href="https://doi.org/10.1016/j.apsb.2019.10.006" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DMonoacylglycerol%252Blipase%252Binhibitors%25253A%252Bmodulators%252Bfor%252Blipid%252Bmetabolism%252Bin%252Bcancer%252Bmalignancy%25252C%252Bneurological%252Band%252Bmetabolic%252Bdisorders%26aulast%3DDeng%26aufirst%3DHui%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D582%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natasha L.  Grimsey</span>, <span class="hlFld-ContribAuthor ">Juha R.  Savinainen</span>, <span class="hlFld-ContribAuthor ">Bala  Attili</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>. </span><span class="cited-content_cbyCitation_article-title">Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 330-343. <a href="https://doi.org/10.1016/j.drudis.2019.10.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRegulating%252Bmembrane%252Blipid%252Blevels%252Bat%252Bthe%252Bsynapse%252Bby%252Bsmall-molecule%252Binhibitors%252Bof%252Bmonoacylglycerol%252Blipase%25253A%252Bnew%252Bdevelopments%252Bin%252Btherapeutic%252Band%252BPET%252Bimaging%252Bapplications%26aulast%3DGrimsey%26aufirst%3DNatasha%2BL.%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D330%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Yusuke  Kurihara</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Kuan  Hu</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[11C]carboxylate. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3568-3573. <a href="https://doi.org/10.1016/j.bmc.2019.06.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bmonoacylglycerol%252Blipase%252Bradiotracer%25253A%252B1%25252C1%25252C1%25252C3%25252C3%25252C3-hexafluoropropan-2-yl-3-%2525281-benzyl-1H-pyrazol-3-yl%252529azetidine-1-%25255B11C%25255Dcarboxylate%26aulast%3DMori%26aufirst%3DWakana%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3568%26epage%3D3573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali Reza  Sardarian</span>, <span class="hlFld-ContribAuthor ">Iman  Dindarloo Inaloo</span>, <span class="hlFld-ContribAuthor ">Milad  Zangiabadi</span>. </span><span class="cited-content_cbyCitation_article-title">An Fe
              3
              O
              4
              @SiO
              2
              /Schiff base/Cu(
              ii
              ) complex as an efficient recyclable magnetic nanocatalyst for selective mono
              N
              -arylation of primary
              O
              -alkyl thiocarbamates and primary
              O
              -alkyl carbamates with aryl halides and arylboronic acids. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2019,</strong> <em>43 </em>
                                    (22)
                                     , 8557-8565. <a href="https://doi.org/10.1039/C9NJ00028C" title="DOI URL">https://doi.org/10.1039/C9NJ00028C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NJ00028C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NJ00028C%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DAn%252BFe%252B3%252BO%252B4%252B%252540SiO%252B2%252B%25252FSchiff%252Bbase%25252FCu%252528%252Bii%252B%252529%252Bcomplex%252Bas%252Ban%252Befficient%252Brecyclable%252Bmagnetic%252Bnanocatalyst%252Bfor%252Bselective%252Bmono%252BN%252B-arylation%252Bof%252Bprimary%252BO%252B-alkyl%252Bthiocarbamates%252Band%252Bprimary%252BO%252B-alkyl%252Bcarbamates%252Bwith%252Baryl%252Bhalides%252Band%252Barylboronic%252Bacids%26aulast%3DSardarian%26aufirst%3DAli%2BReza%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D22%26spage%3D8557%26epage%3D8565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina A.  Dahabiyeh</span>, <span class="hlFld-ContribAuthor ">Yasser  Bustanji</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">The herbicide quinclorac as potent lipase inhibitor: Discovery via virtual screening and in vitro/in vivo validation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (5)
                                     , 787-797. <a href="https://doi.org/10.1111/cbdd.13463" title="DOI URL">https://doi.org/10.1111/cbdd.13463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13463%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DThe%252Bherbicide%252Bquinclorac%252Bas%252Bpotent%252Blipase%252Binhibitor%25253A%252BDiscovery%252Bvia%252Bvirtual%252Bscreening%252Band%252Bin%252Bvitro%25252Fin%252Bvivo%252Bvalidation%26aulast%3DDahabiyeh%26aufirst%3DLina%2BA.%26date%3D2019%26date%3D2019%26volume%3D93%26issue%3D5%26spage%3D787%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katerina  Otrubova</span>, <span class="hlFld-ContribAuthor ">Shreyosree  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Srijana  Ghimire</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Dale L.  Boger</span>. </span><span class="cited-content_cbyCitation_article-title">N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (8)
                                     , 1693-1703. <a href="https://doi.org/10.1016/j.bmc.2019.03.020" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN-Acyl%252Bpyrazoles%25253A%252BEffective%252Band%252Btunable%252Binhibitors%252Bof%252Bserine%252Bhydrolases%26aulast%3DOtrubova%26aufirst%3DKaterina%26date%3D2019%26volume%3D27%26issue%3D8%26spage%3D1693%26epage%3D1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ankit  Seth</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anupam G.  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sushant K.  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2019,</strong> <em>174 </em>, 53-89. <a href="https://doi.org/10.1016/j.pneurobio.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DComprehensive%252Breview%252Bof%252Bmechanisms%252Bof%252Bpathogenesis%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bpotential%252Btherapeutic%252Bstrategies%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason R.  Clapper</span>, <span class="hlFld-ContribAuthor ">Cassandra L.  Henry</span>, <span class="hlFld-ContribAuthor ">Micah J.  Niphakis</span>, <span class="hlFld-ContribAuthor ">Anna M.  Knize</span>, <span class="hlFld-ContribAuthor ">Aundrea R.  Coppola</span>, <span class="hlFld-ContribAuthor ">Gabriel M.  Simon</span>, <span class="hlFld-ContribAuthor ">Nhi  Ngo</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Herbst</span>, <span class="hlFld-ContribAuthor ">Dylan M.  Herbst</span>, <span class="hlFld-ContribAuthor ">Alex W.  Reed</span>, <span class="hlFld-ContribAuthor ">Justin S.  Cisar</span>, <span class="hlFld-ContribAuthor ">Olivia D.  Weber</span>, <span class="hlFld-ContribAuthor ">Andreu  Viader</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Alexander</span>, <span class="hlFld-ContribAuthor ">Mark L.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Todd K.  Jones</span>, <span class="hlFld-ContribAuthor ">Iain P.  Fraser</span>, <span class="hlFld-ContribAuthor ">Cheryl A.  Grice</span>, <span class="hlFld-ContribAuthor ">R. Alan B.  Ezekowitz</span>, <span class="hlFld-ContribAuthor ">Gary P.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Jacqueline L.  Blankman</span>. </span><span class="cited-content_cbyCitation_article-title">Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2018,</strong> <em>367 </em>
                                    (3)
                                     , 494-508. <a href="https://doi.org/10.1124/jpet.118.252296" title="DOI URL">https://doi.org/10.1124/jpet.118.252296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.252296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.252296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DMonoacylglycerol%252BLipase%252BInhibition%252Bin%252BHuman%252Band%252BRodent%252BSystems%252BSupports%252BClinical%252BEvaluation%252Bof%252BEndocannabinoid%252BModulators%26aulast%3DClapper%26aufirst%3DJason%2BR.%26date%3D2018%26date%3D2018%26volume%3D367%26issue%3D3%26spage%3D494%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Gil-Ordóñez</span>, <span class="hlFld-ContribAuthor ">Mar  Martín-Fontecha</span>, <span class="hlFld-ContribAuthor ">Silvia  Ortega-Gutiérrez</span>, <span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>. </span><span class="cited-content_cbyCitation_article-title">Monoacylglycerol lipase (MAGL) as a promising therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>157 </em>, 18-32. <a href="https://doi.org/10.1016/j.bcp.2018.07.036" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.07.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.07.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMonoacylglycerol%252Blipase%252B%252528MAGL%252529%252Bas%252Ba%252Bpromising%252Btherapeutic%252Btarget%26aulast%3DGil-Ord%25C3%25B3%25C3%25B1ez%26aufirst%3DAna%26date%3D2018%26volume%3D157%26spage%3D18%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of MAGL in endocannabinoid and arachidonic acid pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Literature MAGL inhibitors. Data shown were obtained from in-house assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Arachidonic acid and related pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Parallel approaches to linker exploration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Efficiency plots for MAGL inhibitors: (a, left) lipophilic efficiency plot comparing log <i>D</i> (<i>x</i>-axis) vs MAGL pIC<sub>50</sub>; (b, right) fit quality plot comparing number of heavy atoms (<i>x</i>-axis) vs ligand efficiency (LE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray crystal structure of <b>3</b> bound to the active site serine in MAGL (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1">6AX1</a>). The residues making up the catalytic triad (Ser122, His269, and Asp239) have been shown in stick representation. Hydrogen bonds are indicated by dashed lines. A glycerol molecule (gray) was modeled into electron density seen in the exit tunnel. Glycerol was part of the buffer used to purify the protein and was present in the crystallization drop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Click chemistry activity-based protein profiling in human brain vascular pericytes. Live cells were treated at various concentrations of <b>14</b> for 1 h at 37 °C. (A) In-gel fluorescence. (B) Normalized MAGL intensity was fitted as a function of the concentration of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effect of <b>6</b> on brain 2-AG and corresponding exposure following subcutaneous administration in wild-type mice: (a) 2-AG response following 10 mg/kg dose of <b>6</b>; (b) mean unbound plasma and brain exposure; (c) 2-AG response following 1 mg/kg dose of <b>6</b>; (d) mean unbound plasma and brain exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/medium/jm-2017-01531x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Structure of compound <b>15</b>. (b, d) Effect of <b>15</b> on brain 2-AG following subcutaneous administration in wild-type mice of (c) 1 mg/kg and (e) 10 mg/kg doses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b01531/20171208/images/large/jm-2017-01531x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01531&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ransohoff, R. M.</span><span> </span><span class="NLM_article-title">How Neuroinflammation Contributes to Neurodegeneration</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">783</span><span class="refDoi"> DOI: 10.1126/science.aag2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1126%2Fscience.aag2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=27540165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCju73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2016&pages=777-783&author=R.+M.+Ransohoff&title=How+Neuroinflammation+Contributes+to+Neurodegeneration&doi=10.1126%2Fscience.aag2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How neuroinflammation contributes to neurodegeneration</span></div><div class="casAuthors">Ransohoff, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">6301</span>),
    <span class="NLM_cas:pages">777-783</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations.  Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease.  In this Review, I address how the neuron's environment also contributes to neurodegeneration.  Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier.  Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation.  These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohg7Gb9sXnzbVg90H21EOLACvtfcHk0lg_KpxjEWOp1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCju73I&md5=eaa975b2ac5903376d8ac10fed7b0820</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.aag2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aag2590%26sid%3Dliteratum%253Aachs%26aulast%3DRansohoff%26aufirst%3DR.%2BM.%26atitle%3DHow%2520Neuroinflammation%2520Contributes%2520to%2520Neurodegeneration%26jtitle%3DScience%26date%3D2016%26volume%3D353%26spage%3D777%26epage%3D783%26doi%3D10.1126%2Fscience.aag2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chanda, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Btesh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strassle, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bingham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uveges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouranova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteside, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samad, T. A.</span><span> </span><span class="NLM_article-title">Monoacylglycerol Lipase Activity is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span><span class="refDoi"> DOI: 10.1124/mol.110.068304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fmol.110.068304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20855465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2010&pages=996-1003&author=P.+K.+Chandaauthor=Y.+Gaoauthor=L.+Markauthor=J.+Bteshauthor=B.+W.+Strassleauthor=P.+Luauthor=M.+J.+Pieslaauthor=M.+Y.+Zhangauthor=B.+Binghamauthor=A.+Uvegesauthor=D.+Kowalauthor=D.+Garbeauthor=E.+V.+Kouranovaauthor=R.+H.+Ringauthor=B.+Batesauthor=M.+N.+Pangalosauthor=J.+D.+Kennedyauthor=G.+T.+Whitesideauthor=T.+A.+Samad&title=Monoacylglycerol+Lipase+Activity+is+a+Critical+Modulator+of+the+Tone+and+Integrity+of+the+Endocannabinoid+System&doi=10.1124%2Fmol.110.068304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system</span></div><div class="casAuthors">Chanda, Pranab K.; Gao, Ying; Mark, Lilly; Btesh, Joan; Strassle, Brian W.; Lu, Peimin; Piesla, Michael J.; Zhang, Mei-Yi; Bingham, Brendan; Uveges, Albert; Kowal, Dianne; Garbe, David; Kouranova, Evguenia V.; Ring, Robert H.; Bates, Brian; Pangalos, Menelas N.; Kennedy, Jeffrey D.; Whiteside, Garth T.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">996-1003</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Endocannabinoids are lipid mols. that serve as natural ligands for the cannabinoid receptors CB1 and CB2.  They modulate a diverse set of physiol. processes such as pain, cognition, appetite, and emotional states, and their levels and functions are tightly regulated by enzymic biosynthesis and degrdn.  2-Arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the brain and is believed to be hydrolyzed primarily by the serine hydrolase monoacylglycerol lipase (MAGL).  Although 2-AG binds and activates cannabinoid receptors in vitro, when administered in vivo, it induces only transient cannabimimetic effects as a result of its rapid catabolism.  Here we show using a mouse model with a targeted disruption of the MAGL gene that MAGL is the major modulator of 2-AG hydrolysis in vivo.  Mice lacking MAGL exhibit dramatically reduced 2-AG hydrolase activity and highly elevated 2-AG levels in the nervous system.  A lack of MAGL activity and subsequent long-term elevation of 2-AG levels lead to desensitization of brain CB1 receptors with a significant redn. of cannabimimetic effects of CB1 agonists.  Also consistent with CB1 desensitization, MAGL-deficient mice do not show alterations in neuropathic and inflammatory pain sensitivity.  These findings provide the first genetic in vivo evidence that MAGL is the major regulator of 2-AG levels and signaling and reveal a pivotal role for 2-AG in modulating CB1 receptor sensitization and endocannabinoid tone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXec6NludiW7Vg90H21EOLACvtfcHk0lg_KpxjEWOp1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgu7jF&md5=f6c38107c51f0c6d0f76241043ff988d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.068304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.068304%26sid%3Dliteratum%253Aachs%26aulast%3DChanda%26aufirst%3DP.%2BK.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DMark%26aufirst%3DL.%26aulast%3DBtesh%26aufirst%3DJ.%26aulast%3DStrassle%26aufirst%3DB.%2BW.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DBingham%26aufirst%3DB.%26aulast%3DUveges%26aufirst%3DA.%26aulast%3DKowal%26aufirst%3DD.%26aulast%3DGarbe%26aufirst%3DD.%26aulast%3DKouranova%26aufirst%3DE.%2BV.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DBates%26aufirst%3DB.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DMonoacylglycerol%2520Lipase%2520Activity%2520is%2520a%2520Critical%2520Modulator%2520of%2520the%2520Tone%2520and%2520Integrity%2520of%2520the%2520Endocannabinoid%2520System%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D78%26spage%3D996%26epage%3D1003%26doi%3D10.1124%2Fmol.110.068304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2009.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19635411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=744-753&author=J.+Z.+Longauthor=D.+K.+Nomuraauthor=B.+F.+Cravatt&title=Characterization+of+Monoacylglycerol+Lipase+Inhibition+Reveals+Differences+in+Central+and+Peripheral+Endocannabinoid+Metabolism&doi=10.1016%2Fj.chembiol.2009.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism</span></div><div class="casAuthors">Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Monoacylglycerol lipase (MAGL) is a principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).  The authors recently reported a piperidine carbamate, JZL184, that inhibits MAGL with high potency and selectivity.  Here, the authors describe a comprehensive mechanistic characterization of JZL184.  The authors provide evidence that JZL184 irreversibly inhibits MAGL via carbamoylation of the enzyme's serine nucleophile.  Functional proteomic anal. of mice treated with JZL184 revealed that this inhibitor maintains good selectivity for MAGL across a wide range of central and peripheral tissues.  Interestingly, MAGL blockade produced marked, tissue-specific differences in monoglyceride metab., with brain showing the most dramatic elevations in 2-AG and peripheral tissues often showing greater changes in other monoglycerides.  Collectively, these studies indicate that MAGL exerts tissue-dependent control over endocannabinoid and monoglyceride metab. and designate JZL184 as a selective tool to characterize the functions of MAGL in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-iZXIq9TSLVg90H21EOLACvtfcHk0ljl0S2LusQTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsLY%253D&md5=020a5cb6ac9430ba9d3eac3c7b9ba216</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DCharacterization%2520of%2520Monoacylglycerol%2520Lipase%2520Inhibition%2520Reveals%2520Differences%2520in%2520Central%2520and%2520Peripheral%2520Endocannabinoid%2520Metabolism%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D744%26epage%3D753%26doi%3D10.1016%2Fj.chembiol.2009.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dinh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A Role for Monoglyceride Lipase in 2-Arachidonoylglycerol Inactivation</span> <span class="citation_source-journal">Chem. Phys. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span><span class="refDoi"> DOI: 10.1016/S0009-3084(02)00150-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2FS0009-3084%2802%2900150-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=12505697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpslans7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2002&pages=149-158&author=T.+P.+Dinhauthor=T.+F.+Freundauthor=D.+Piomelli&title=A+Role+for+Monoglyceride+Lipase+in+2-Arachidonoylglycerol+Inactivation&doi=10.1016%2FS0009-3084%2802%2900150-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation</span></div><div class="casAuthors">Dinh, Thien P.; Freund, Tamas F.; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry and Physics of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">149-158</span>CODEN:
                <span class="NLM_cas:coden">CPLIA4</span>;
        ISSN:<span class="NLM_cas:issn">0009-3084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Arachidonoylglycerol (I) is a naturally occurring monoglyceride that activates cannabinoid receptors and meets several key requisites of an endogenous cannabinoid substance.  I is present in the brain (where its levels are 170-fold higher than those of anandamide), is produced by neurons in an activity- and Ca2+-dependent manner, and is rapidly eliminated.  The mechanism of I inactivation is not completely understood, but is thought to involve carrier-mediated transport into cells followed by enzymic hydrolysis.  The authors have examd. the possible role of the serine hydrolase, monoglyceride lipase (II), in brain I inactivation.  The authors have identified by homol. screening a cDNA sequence encoding for a 303-amino acid protein, which conferred II activity upon transfection to COS-7 cells.  Northern blot and in situ hybridization analyses have revealed that II mRNA is unevenly present in the rat brain, with highest levels in regions where CB1 cannabinoid receptors are also expressed (hippocampus, cortex, anterior thalamus, and cerebellum).  Immunohistochem. studies in the hippocampus showed that II distribution has striking laminar specificity, suggesting a presynaptic localization of the enzyme.  Adenovirus-mediated transfer of II cDNA into rat cortical neurons increased the degrdn. of endogenously produced I in these cells, whereas no such effect was obsd. on anandamide degrdn.  These results indicate that I hydrolysis via II may be a primary route of I inactivation in intact neuronal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwAPaOj27MHbVg90H21EOLACvtfcHk0ljl0S2LusQTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpslans7s%253D&md5=e6a07281a0184d1521424bc7719bddbe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0009-3084%2802%2900150-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-3084%252802%252900150-0%26sid%3Dliteratum%253Aachs%26aulast%3DDinh%26aufirst%3DT.%2BP.%26aulast%3DFreund%26aufirst%3DT.%2BF.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520Role%2520for%2520Monoglyceride%2520Lipase%2520in%25202-Arachidonoylglycerol%2520Inactivation%26jtitle%3DChem.%2520Phys.%2520Lipids%26date%3D2002%26volume%3D121%26spage%3D149%26epage%3D158%26doi%3D10.1016%2FS0009-3084%2802%2900150-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcondes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1126/science.1209200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+Hydrolysis+Generates+Brain+Prostaglandins+That+Promote+Neuroinflammation&doi=10.1126%2Fscience.1209200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0ljl0S2LusQTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520Hydrolysis%2520Generates%2520Brain%2520Prostaglandins%2520That%2520Promote%2520Neuroinflammation%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813%26doi%3D10.1126%2Fscience.1209200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Monoacylglycerol Lipase - a Target for Drug Development?</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1568</span><span class="NLM_x">–</span> <span class="NLM_lpage">1585</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01950.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1111%2Fj.1476-5381.2012.01950.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1568-1585&author=C.+J.+Fowler&title=Monoacylglycerol+Lipase+-+a+Target+for+Drug+Development%3F&doi=10.1111%2Fj.1476-5381.2012.01950.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Monoacylglycerol lipase - a target for drug development?</span></div><div class="casAuthors">Fowler, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1568-1585</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid (eCB) system is involved in processes as diverse as control of appetite, perception of pain and the limitation of cancer cell growth and invasion.  The enzymes responsible for eCB breakdown are attractive pharmacol. targets, and fatty acid amide hydrolase inhibitors, which potentiate the levels of the eCB anandamide, are now undergoing pharmaceutical development.  "Drugable" selective inhibitors of monoacylglycerol lipase, a key enzyme regulating the levels of the other main eCB, 2-arachidonoylglycerol, were however not identified until very recently.  Their availability has resulted in a large expansion of our knowledge concerning the pharmacol. consequences of monoacylglycerol lipase inhibition and hence the role(s) played by the enzyme in the body.  In this review, the pharmacol. of monoacylglycerol lipase will be discussed, together with an anal. of the therapeutic potential of monoacylglycerol lipase inhibitors as analgesics and anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2hj7DUJaO97Vg90H21EOLACvtfcHk0ljoKwld33bH6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOku7rM&md5=b06b843ca0023abbe4e8cb6be83bcd52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01950.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01950.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DMonoacylglycerol%2520Lipase%2520-%2520a%2520Target%2520for%2520Drug%2520Development%253F%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1568%26epage%3D1585%26doi%3D10.1111%2Fj.1476-5381.2012.01950.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Grabner, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schicho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taschler, U.</span><span> </span><span class="NLM_article-title">Monoglyceride Lipase as a Drug Target: At the Crossroads of Arachidonic Acid Metabolism and Endocannabinoid Signaling</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.pharmthera.2017.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=28213089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2017&pages=35-46&author=G.+F.+Grabnerauthor=R.+Zimmermannauthor=R.+Schichoauthor=U.+Taschler&title=Monoglyceride+Lipase+as+a+Drug+Target%3A+At+the+Crossroads+of+Arachidonic+Acid+Metabolism+and+Endocannabinoid+Signaling&doi=10.1016%2Fj.pharmthera.2017.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling</span></div><div class="casAuthors">Grabner, Gernot F.; Zimmermann, Robert; Schicho, Rudolf; Taschler, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-46</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoglyerides (MGs) are short-lived, intermediary lipids deriving from the degrdn. of phospho- and neutral lipids, and monoglyceride lipase (MGL), also designated as monoacylglycerol lipase (MAGL), is the major enzyme catalyzing the hydrolysis of MGs into glycerol and fatty acids.  This distinct function enables MGL to regulate a no. of physiol. and pathophysiol. processes since both MGs and fatty acids can act as signaling lipids or precursors thereof.  The most prominent MG species acting as signaling lipid is 2-arachidonoyl glycerol (2-AG) which is the most abundant endogenous agonist of cannabinoid receptors in the body.  Importantly, recent observations demonstrate that 2-AG represents a quant. important source for arachidonic acid, the precursor of prostaglandins and other inflammatory mediators.  Accordingly, MGL-mediated 2-AG degrdn. affects lipid signaling by cannabinoid receptor-dependent and independent mechanisms.  Recent genetic and pharmacol. studies gave important insights into MGL's role in (patho-)physiol. processes, and the enzyme is now considered as a promising drug target for a no. of disorders including cancer, neurodegenerative and inflammatory diseases.  This review summarizes the basics of MG (2-AG) metab. and provides an overview on the therapeutic potential of MGL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGvyCs_XBdLVg90H21EOLACvtfcHk0ljoKwld33bH6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kmt7k%253D&md5=af9f9beaa78954ad700885508e739900</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DGrabner%26aufirst%3DG.%2BF.%26aulast%3DZimmermann%26aufirst%3DR.%26aulast%3DSchicho%26aufirst%3DR.%26aulast%3DTaschler%26aufirst%3DU.%26atitle%3DMonoglyceride%2520Lipase%2520as%2520a%2520Drug%2520Target%253A%2520At%2520the%2520Crossroads%2520of%2520Arachidonic%2520Acid%2520Metabolism%2520and%2520Endocannabinoid%2520Signaling%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D175%26spage%3D35%26epage%3D46%26doi%3D10.1016%2Fj.pharmthera.2017.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ignatowska-Jankowska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkerson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive Versus Cannabimimetic Effects in Mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1124/jpet.114.222315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fjpet.114.222315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=25762694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=424-432&author=B.+Ignatowska-Jankowskaauthor=J.+L.+Wilkersonauthor=M.+Mustafaauthor=R.+Abdullahauthor=M.+Niphakisauthor=J.+L.+Wileyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Selective+Monoacylglycerol+Lipase+Inhibitors%3A+Antinociceptive+Versus+Cannabimimetic+Effects+in+Mice&doi=10.1124%2Fjpet.114.222315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice</span></div><div class="casAuthors">Ignatowska-Jankowska, Bogna; Wilkerson, Jenny L.; Mustafa, Mohammed; Abdullah, Rehab; Niphakis, Micah; Wiley, Jenny L.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The endogenous cannabinoid 2-arachidonoylglycerol (2-AG) plays an important role in a variety of physiol. processes, but its rapid breakdown by monoacylglycerol lipase (MAGL) results in short-lived actions.  Initial MAGL inhibitors were limited by poor selectivity and low potency.  In this study, we tested JZL184 [4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate] and MJN110 [2,5-dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate], MAGL inhibitors that possess increased selectivity and potency, in mouse behavioral assays of neuropathic pain [chronic constriction injury (CCI) of the sciatic nerve], interoceptive cannabimimetic effects (drug-discrimination paradigm), and locomotor activity in an open field test.  MJN110 (1.25 and 2.5 mg/kg) and JZL184 (16 and 40 mg/kg) significantly elevated 2-AG and decreased arachidonic acid but did not affect anandamide in whole brains.  Both MAGL inhibitors significantly reduced CCI-induced mech. allodynia with the following potencies [ED50 (95% confidence limit [CL]) values in mg/kg: MJN110 (0.43 [0.30-0.63]) > JZL184 (17.8 [11.6-27.4])] and also substituted for the potent cannabinoid receptor agonist CP55,940 [2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol] in the drug-discrimination paradigm [ED50 (95% CL) values in mg/kg: MJN110 (0.84 [0.69-1.02]) > JZL184 (24.9 [14.6-42.5])]; however, these compds. elicited differential effects on locomotor behavior.  Similar to cannabinoid 1 (CB1) receptor agonists, JZL184 produced hypomotility, whereas MJN110 increased locomotor behavior and did not produce catalepsy or hypothermia.  Although both drugs substituted for CP55,940 in the drug discrimination assay, MJN110 was more potent in reversing allodynia in the CCI model than in producing CP55,940-like effects.  Overall, these results suggest that MAGL inhibition may alleviate neuropathic pain, while displaying limited cannabimimetic effects compared with direct CB1 receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquAG_goQ7FM7Vg90H21EOLACvtfcHk0ljoKwld33bH6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOnsbc%253D&md5=c4cdfc7947574e42bf4d5f7b3b14e780</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.222315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.222315%26sid%3Dliteratum%253Aachs%26aulast%3DIgnatowska-Jankowska%26aufirst%3DB.%26aulast%3DWilkerson%26aufirst%3DJ.%2BL.%26aulast%3DMustafa%26aufirst%3DM.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DNiphakis%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DSelective%2520Monoacylglycerol%2520Lipase%2520Inhibitors%253A%2520Antinociceptive%2520Versus%2520Cannabimimetic%2520Effects%2520in%2520Mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D424%26epage%3D432%26doi%3D10.1124%2Fjpet.114.222315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdullah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Repeated Low-dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains Cannabinoid Receptor Type 1-Mediated Antinociceptive and Gastroprotective Effects</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">345</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1124/jpet.112.201426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1124%2Fjpet.112.201426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23412396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2013&pages=492-501&author=S.+G.+Kinseyauthor=L.+E.+Wiseauthor=D.+Rameshauthor=R.+Abdullahauthor=D.+E.+Selleyauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Repeated+Low-dose+Administration+of+the+Monoacylglycerol+Lipase+Inhibitor+JZL184+Retains+Cannabinoid+Receptor+Type+1-Mediated+Antinociceptive+and+Gastroprotective+Effects&doi=10.1124%2Fjpet.112.201426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects</span></div><div class="casAuthors">Kinsey, Steven G.; Wise, Laura E.; Ramesh, Divya; Abdullah, Rehab; Selley, Dana E.; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">492-501</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The monoacylglycerol lipase (MAGL) inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) produces antinociceptive and anti-inflammatory effects.  However, repeated administration of high-dose JZL184 (40 mg/kg) causes dependence, antinociceptive tolerance, cross-tolerance to the pharmacol. effects of cannabinoid receptor agonists, and cannabinoid receptor type 1 (CB1) downregulation and desensitization.  This functional CB1 receptor tolerance poses a hurdle in the development of MAGL inhibitors for therapeutic use.  Consequently, the present study tested whether repeated administration of low-dose JZL184 maintains its antinociceptive actions in the chronic constriction injury of the sciatic nerve neuropathic pain model and protective effects in a model of nonsteroidal anti-inflammatory drug-induced gastric hemorrhages.  Mice given daily injections of high-dose JZL184 (≥16 mg/kg) for 6 days displayed decreased CB1 receptor d. and function in the brain, as assessed in [3H]SR141716A binding and CP55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol]-stimulated guanosine 5'-O-(3-[35S]thio)triphosphate binding assays, resp.  In contrast, normal CB1 receptor expression and function were maintained following repeated administration of low-dose JZL184 (≤8 mg/kg).  Likewise, the antinociceptive and gastroprotective effects of high-dose JZL184 underwent tolerance following repeated administration, but these effects were maintained following repeated low-dose JZL184 treatment.  Consistent with these observations, repeated high-dose JZL184, but not repeated low-dose JZL184, elicited cross-tolerance to the common pharmacol. effects of Δ9-tetrahydrocannabinol.  This same pattern of effects was found in a rimonabant [(5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide)]-pptd. withdrawal model of cannabinoid dependence.  Taken together, these results indicate that prolonged, partial MAGL inhibition maintains potentially beneficial antinociceptive and anti-inflammatory effects, without producing functional CB1 receptor tachyphylaxis/tolerance or cannabinoid dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZkkceF1Il2rVg90H21EOLACvtfcHk0liIhGF6YpZRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOgsL0%253D&md5=ea906c8140fa02a53729ff4fcbdcd8a8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.201426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.201426%26sid%3Dliteratum%253Aachs%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DWise%26aufirst%3DL.%2BE.%26aulast%3DRamesh%26aufirst%3DD.%26aulast%3DAbdullah%26aufirst%3DR.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DRepeated%2520Low-dose%2520Administration%2520of%2520the%2520Monoacylglycerol%2520Lipase%2520Inhibitor%2520JZL184%2520Retains%2520Cannabinoid%2520Receptor%2520Type%25201-Mediated%2520Antinociceptive%2520and%2520Gastroprotective%2520Effects%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D345%26spage%3D492%26epage%3D501%26doi%3D10.1124%2Fjpet.112.201426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mulvihill, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Monoacylglycerol Lipase Inhibitors</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1016/j.lfs.2012.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.lfs.2012.10.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23142242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2013&pages=492-497&author=M.+M.+Mulvihillauthor=D.+K.+Nomura&title=Therapeutic+Potential+of+Monoacylglycerol+Lipase+Inhibitors&doi=10.1016%2Fj.lfs.2012.10.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of monoacylglycerol lipase inhibitors</span></div><div class="casAuthors">Mulvihill, Melinda M.; Nomura, Daniel K.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">492-497</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Marijuana and aspirin have been used for millennia to treat a wide range of maladies including pain and inflammation.  Both cannabinoids, like marijuana, that exert anti-inflammatory action through stimulating cannabinoid receptors, and cyclooxygenase (COX) inhibitors, like aspirin, that suppress pro-inflammatory eicosanoid prodn. have shown beneficial outcomes in mouse models of neurodegenerative diseases and cancer.  Both cannabinoids and COX inhibitors, however, have untoward effects that discourage their chronic usage, including cognitive deficits and gastrointestinal toxicity, resp.  Recent studies have uncovered that the serine hydrolase monoacylglycerol lipase (MAGL) links the endocannabinoid and eicosanoid systems together through hydrolysis of the endocannabinoid 2-arachidonoylglycerol (2-AG) to provide the major arachidonic acid (AA) precursor pools for pro-inflammatory eicosanoid synthesis in specific tissues.  Studies in recent years have shown that MAGL inhibitors elicit anti-nociceptive, anxiolytic, and anti-emetic responses and attenuate pptd. withdrawal symptoms in addiction paradigms through enhancing endocannabinoid signaling.  MAGL inhibitors have also been shown to exert anti-inflammatory action in the brain and protect against neurodegeneration through lowering eicosanoid prodn.  In cancer, MAGL inhibitors have been shown to have anti-cancer properties not only through modulating the endocannabinoid-eicosanoid network, but also by controlling fatty acid release for the synthesis of protumorigenic signaling lipids.  Thus, MAGL serves as a crit. node in simultaneously coordinating multiple lipid signaling pathways in both physiol. and disease contexts.  This review will discuss the diverse (patho)physiol. roles of MAGL and the therapeutic potential of MAGL inhibitors in treating a vast array of complex human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojyVx1YSerrVg90H21EOLACvtfcHk0liIhGF6YpZRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKqsL7O&md5=cb44625201730a7849701df80fadb708</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2012.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2012.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BM.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26atitle%3DTherapeutic%2520Potential%2520of%2520Monoacylglycerol%2520Lipase%2520Inhibitors%26jtitle%3DLife%2520Sci.%26date%3D2013%26volume%3D92%26spage%3D492%26epage%3D497%26doi%3D10.1016%2Fj.lfs.2012.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">The Serine Hydrolases MAGL, ABHD6 and ABHD12 as Guardians of 2-Arachidonoylglycerol Signalling through Cannabinoid Receptors</span> <span class="citation_source-journal">Acta Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1111/j.1748-1716.2011.02280.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1111%2Fj.1748-1716.2011.02280.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21418147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1eiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2012&pages=267-276&author=J.+R.+Savinainenauthor=S.+M.+Saarioauthor=J.+T.+Laitinen&title=The+Serine+Hydrolases+MAGL%2C+ABHD6+and+ABHD12+as+Guardians+of+2-Arachidonoylglycerol+Signalling+through+Cannabinoid+Receptors&doi=10.1111%2Fj.1748-1716.2011.02280.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors</span></div><div class="casAuthors">Savinainen, J. R.; Saario, S. M.; Laitinen, J. T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-276</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid 2-arachidonoylglycerol (2-AG) is a lipid mediator involved in various physiol. processes.  In response to neural activity, 2-AG is synthesized post-synaptically, then activates pre-synaptic cannabinoid CB1 receptors (CB1Rs) in a retrograde manner, resulting in transient and long-lasting redn. of neurotransmitter release.  The signalling competence of 2-AG is tightly regulated by the balanced action between "on demand" biosynthesis and degrdn.  We review recent research on monoacylglycerol lipase (MAGL), ABHD6 and ABHD12, three serine hydrolases that together account for approx. 99% of brain 2-AG hydrolase activity.  MAGL is responsible for approx. 85% of 2-AG hydrolysis and colocalizes with CB1R in axon terminals.  It is therefore ideally positioned to terminate 2-AG-CB1R signalling regardless of the source of this endocannabinoid.  Its acute pharmacol. inhibition leads to 2-AG accumulation and CB1R-mediated behavioral responses.  Chronic MAGL inactivation results in 2-AG overload, desensitization of CB1R signalling and behavioral tolerance.  ABHD6 accounts for approx. 4% of brain 2-AG hydrolase activity but in neurons it rivals MAGL in efficacy.  Neuronal ABHD6 resides post-synaptically, often juxtaposed with CB1Rs, and its acute inhibition leads to activity-dependent accumulation of 2-AG.  In cortical slices, selective ABHD6 blockade facilitates CB1R-dependent long-term synaptic depression.  ABHD6 is therefore positioned to guard intracellular pools of 2-AG at the site of generation.  ABHD12 is highly expressed in microglia and accounts for approx. 9% of total brain 2-AG hydrolysis.  Mutations in ABHD12 gene are causally linked to a neurodegenerative disease called PHARC.  Whether ABHD12 qualifies as a bona fide member to the endocannabinoid system remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBgLJavyxUbVg90H21EOLACvtfcHk0liIhGF6YpZRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1eiuro%253D&md5=399f8c1e38ae5fd12886573245bec0ba</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1748-1716.2011.02280.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1748-1716.2011.02280.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520Serine%2520Hydrolases%2520MAGL%252C%2520ABHD6%2520and%2520ABHD12%2520as%2520Guardians%2520of%25202-Arachidonoylglycerol%2520Signalling%2520through%2520Cannabinoid%2520Receptors%26jtitle%3DActa%2520Physiol.%26date%3D2012%26volume%3D204%26spage%3D267%26epage%3D276%26doi%3D10.1111%2Fj.1748-1716.2011.02280.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Piro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerr, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samad, T. A.</span><span> </span><span class="NLM_article-title">A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.celrep.2012.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22813736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2012&pages=617-623&author=J.+R.+Piroauthor=D.+I.+Benjaminauthor=J.+M.+Duerrauthor=Y.+Piauthor=C.+Gonzalesauthor=K.+M.+Woodauthor=J.+W.+Schwartzauthor=D.+K.+Nomuraauthor=T.+A.+Samad&title=A+Dysregulated+Endocannabinoid-Eicosanoid+Network+Supports+Pathogenesis+in+a+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.celrep.2012.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Piro, Justin R.; Benjamin, Daniel I.; Duerr, James M.; Pi, YeQing; Gonzales, Cathleen; Wood, Kathleen M.; Schwartz, Joel W.; Nomura, Daniel K.; Samad, Tarek A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">617-623</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although inflammation in the brain is meant as a defense mechanism against neurotoxic stimuli, increasing evidence suggests that uncontrolled, chronic, and persistent inflammation contributes to neurodegeneration.  Most neurodegenerative diseases have now been assocd. with chronic inflammation, including Alzheimer's disease (AD).  Whether anti-inflammatory approaches can be used to treat AD, however, is a major unanswered question.  We recently demonstrated that monoacylglycerol lipase (MAGL) hydrolyzes endocannabinoids to generate the primary arachidonic acid pool for neuroinflammatory prostaglandins.  In this study, we show that genetic inactivation of MAGL attenuates neuroinflammation and lowers amyloid β levels and plaques in an AD mouse model.  We also find that pharmacol. blockade of MAGL recapitulates the cytokine-lowering effects through reduced prostaglandin prodn., rather than enhanced endocannabinoid signaling.  Our findings thus reveal a role of MAGL in modulating neuroinflammation and amyloidosis in AD etiol. and put forth MAGL inhibitors as a potential next-generation strategy for combating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhEmpHXwNVC7Vg90H21EOLACvtfcHk0liIhGF6YpZRFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrsrvM&md5=a84bec802e0b547d6e06052f39d1db0f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DPiro%26aufirst%3DJ.%2BR.%26aulast%3DBenjamin%26aufirst%3DD.%2BI.%26aulast%3DDuerr%26aufirst%3DJ.%2BM.%26aulast%3DPi%26aufirst%3DY.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DSchwartz%26aufirst%3DJ.%2BW.%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DSamad%26aufirst%3DT.%2BA.%26atitle%3DA%2520Dysregulated%2520Endocannabinoid-Eicosanoid%2520Network%2520Supports%2520Pathogenesis%2520in%2520a%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D1%26spage%3D617%26epage%3D623%26doi%3D10.1016%2Fj.celrep.2012.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheuret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoornaert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">Structural Basis for Human Monoglyceride Lipase Inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.jmb.2009.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19962385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=2010&pages=663-673&author=T.+Bertrandauthor=F.+Augeauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Valleeauthor=V.+Mikolauthor=P.+F.+Berneauthor=N.+Michotauthor=D.+Cheuretauthor=C.+Hoornaertauthor=M.+Mathieu&title=Structural+Basis+for+Human+Monoglyceride+Lipase+Inhibition&doi=10.1016%2Fj.jmb.2009.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Human Monoglyceride Lipase Inhibition</span></div><div class="casAuthors">Bertrand, T.; Auge, F.; Houtmann, J.; Rak, A.; Vallee, F.; Mikol, V.; Berne, P. F.; Michot, N.; Cheuret, D.; Hoornaert, C.; Mathieu, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyzes 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol.  2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiol. processes in the brain.  We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629.  MGL shares the classic fold of the α/β hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end.  Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG.  The bound structure of SAR629 highlights the key interactions for productive binding with MGL.  The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiDWkFIBQObVg90H21EOLACvtfcHk0licCib43UiW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1yls74%253D&md5=149fa9052c872b50c71e4d95d3c967d7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DAuge%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DCheuret%26aufirst%3DD.%26aulast%3DHoornaert%26aufirst%3DC.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DStructural%2520Basis%2520for%2520Human%2520Monoglyceride%2520Lipase%2520Inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D396%26spage%3D663%26epage%3D673%26doi%3D10.1016%2Fj.jmb.2009.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The Resurgence of Covalent Drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+Resurgence+of+Covalent+Drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0licCib43UiW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520Resurgence%2520of%2520Covalent%2520Drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bachovchin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The Pharmacological Landscape and Therapeutic Potential of Serine Hydrolases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/nrd3620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnrd3620" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22212679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=52-68&author=D.+A.+Bachovchinauthor=B.+F.+Cravatt&title=The+Pharmacological+Landscape+and+Therapeutic+Potential+of+Serine+Hydrolases&doi=10.1038%2Fnrd3620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacological landscape and therapeutic potential of serine hydrolases</span></div><div class="casAuthors">Bachovchin, Daniel A.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-68</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases perform crucial roles in many biol. processes, and several of these enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's disease and infectious diseases.  Despite this, most of the human serine hydrolases (of which there are more than 200) remain poorly characterized with respect to their physiol. substrates and functions, and the vast majority lack selective, in vivo-active inhibitors.  Here, we review the current state of pharmacol. for mammalian serine hydrolases, including marketed drugs, compds. that are under clin. investigation and selective inhibitors emerging from academic probe development efforts.  We also highlight recent methodol. advances that have accelerated the rate of inhibitor discovery and optimization for serine hydrolases, which we anticipate will aid in their biol. characterization and, in some cases, therapeutic validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsWC4iV3Xc57Vg90H21EOLACvtfcHk0licCib43UiW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOktA%253D%253D&md5=4fde1e23117ad11848a9c2eef85376b7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrd3620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3620%26sid%3Dliteratum%253Aachs%26aulast%3DBachovchin%26aufirst%3DD.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520Pharmacological%2520Landscape%2520and%2520Therapeutic%2520Potential%2520of%2520Serine%2520Hydrolases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D52%26epage%3D68%26doi%3D10.1038%2Fnrd3620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">The Metabolic Serine Hydrolases and their Functions in Mammalian Physiology and Disease</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6022</span><span class="NLM_x">–</span> <span class="NLM_lpage">6063</span><span class="refDoi"> DOI: 10.1021/cr200075y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr200075y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFagtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6022-6063&author=J.+Z.+Longauthor=B.+F.+Cravatt&title=The+Metabolic+Serine+Hydrolases+and+their+Functions+in+Mammalian+Physiology+and+Disease&doi=10.1021%2Fcr200075y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The metabolic serine hydrolases and their functions in mammalian physiology and disease</span></div><div class="casAuthors">Long, Jonathan Z.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6022-6063</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Serine hydrolases (SHs) consist of >200 enzymes in humans which are characterized by the presence of an active site Ser residue that is used for the hydrolysis of substrates.  The membership of this enzyme class is nearly equally split between serine proteases (trypsin/chymotrypsin/subtilisin enzymes) and "metabolic" SHs that cleave ester, amide, or thioester bonds in small mols., peptides, or proteins.  The focus of this review is on the metabolic SHs.  Here, the authors attempt to provide a comprehensive summary that captures the state of knowledge about metabolic SHs in their entirety, including those enzymes that remain mostly or completely uncharacterized.  Particular emphasis is placed on relating the biochem. and enzymol. of individual SHs to the physiol. substrates and products they regulate in living systems, and how SHs, through the regulation of specific metabolic pathways impact health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5UaSiI-yXi7Vg90H21EOLACvtfcHk0ljOtKccK8eZHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFagtb8%253D&md5=c978f77bd911d5877df4ba97fc09e4b3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcr200075y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200075y%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DThe%2520Metabolic%2520Serine%2520Hydrolases%2520and%2520their%2520Functions%2520in%2520Mammalian%2520Physiology%2520and%2520Disease%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6022%26epage%3D6063%26doi%3D10.1021%2Fcr200075y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burston, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosburg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavon, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Selective Blockade of 2-Arachidonoylglycerol Hydrolysis Produces Cannabinoid Behavioral Effects</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1038/nchembio.129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fnchembio.129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19029917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=37-44&author=J.+Z.+Longauthor=W.+Liauthor=L.+Bookerauthor=J.+J.+Burstonauthor=S.+G.+Kinseyauthor=J.+E.+Schlosburgauthor=F.+J.+Pavonauthor=A.+M.+Serranoauthor=D.+E.+Selleyauthor=L.+H.+Parsonsauthor=A.+H.+Lichtmanauthor=B.+F.+Cravatt&title=Selective+Blockade+of+2-Arachidonoylglycerol+Hydrolysis+Produces+Cannabinoid+Behavioral+Effects&doi=10.1038%2Fnchembio.129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects</span></div><div class="casAuthors">Long, Jonathan Z.; Li, Weiwei; Booker, Lamont; Burston, James J.; Kinsey, Steven G.; Schlosburg, Joel E.; Pavon, Franciso J.; Serrano, Antonia M.; Selley, Dana E.; Parsons, Loren H.; Lichtman, Aron H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-44</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol (2-AG) and anandamide are endocannabinoids that activate the cannabinoid receptors CB1 and CB2.  Endocannabinoid signaling is terminated by enzymic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL).  FAAH inhibitors produce a select subset of the behavioral effects obsd. with CB1 agonists, which suggests a functional segregation of endocannabinoid signaling pathways in vivo.  Testing this hypothesis, however, requires specific tools to independently block anandamide and 2-AG metab.  Here, we report a potent and selective inhibitor of MAGL called JZL184 that, upon administration to mice, raises brain 2-AG by eight-fold without altering anandamide.  JZL184-treated mice exhibited a broad array of CB1-dependent behavioral effects, including analgesia, hypothermia and hypomotility.  These data indicate that 2-AG endogenously modulates several behavioral processes classically assocd. with the pharmacol. of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY1sK0ulYFK7Vg90H21EOLACvtfcHk0ljOtKccK8eZHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWgsr3F&md5=1ffee44019b0e52db5da38fe30a6e4d0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.129%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DBurston%26aufirst%3DJ.%2BJ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DSchlosburg%26aufirst%3DJ.%2BE.%26aulast%3DPavon%26aufirst%3DF.%2BJ.%26aulast%3DSerrano%26aufirst%3DA.%2BM.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DSelective%2520Blockade%2520of%25202-Arachidonoylglycerol%2520Hydrolysis%2520Produces%2520Cannabinoid%2520Behavioral%2520Effects%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D37%26epage%3D44%26doi%3D10.1038%2Fnchembio.129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bartsch, R.; Cheuret, D.; Even, L.; Hoornaert, C.; Jeunesse, J.; Marguet, F.</span><span> </span><span class="NLM_article-title">Hexafluoroisopropyl Carbamate Derivatives, Especially Aryl- and Heteroaryl-piperidinecarboxylates and Analogs, Their Preparation and Use as Selective Monoacyl Glycerol Lipase (MGL) Inhibitors or Mixed MGL and Fatty Acid Amide Hydrolase Inhibitors</span>. WO2011151808 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Bartsch&author=D.+Cheuret&author=L.+Even&author=C.+Hoornaert&author=J.+Jeunesse&author=F.+Marguet&title=Hexafluoroisopropyl+Carbamate+Derivatives%2C+Especially+Aryl-+and+Heteroaryl-piperidinecarboxylates+and+Analogs%2C+Their+Preparation+and+Use+as+Selective+Monoacyl+Glycerol+Lipase+%28MGL%29+Inhibitors+or+Mixed+MGL+and+Fatty+Acid+Amide+Hydrolase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBartsch%26aufirst%3DR.%26atitle%3DHexafluoroisopropyl%2520Carbamate%2520Derivatives%252C%2520Especially%2520Aryl-%2520and%2520Heteroaryl-piperidinecarboxylates%2520and%2520Analogs%252C%2520Their%2520Preparation%2520and%2520Use%2520as%2520Selective%2520Monoacyl%2520Glycerol%2520Lipase%2520%2528MGL%2529%2520Inhibitors%2520or%2520Mixed%2520MGL%2520and%2520Fatty%2520Acid%2520Amide%2520Hydrolase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niessen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buczynski, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Highly Selective Inhibitors of Monoacylglycerol Lipase Bearing a Reactive Group that is Bioisosteric with Endocannabinoid Substrates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2012.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=579-588&author=J.+W.+Changauthor=M.+J.+Niphakisauthor=K.+M.+Lumauthor=A.+B.+Cognettaauthor=C.+Wangauthor=M.+L.+Matthewsauthor=S.+Niessenauthor=M.+W.+Buczynskiauthor=L.+H.+Parsonsauthor=B.+F.+Cravatt&title=Highly+Selective+Inhibitors+of+Monoacylglycerol+Lipase+Bearing+a+Reactive+Group+that+is+Bioisosteric+with+Endocannabinoid+Substrates&doi=10.1016%2Fj.chembiol.2012.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates</span></div><div class="casAuthors">Chang, Jae Won; Niphakis, Micah J.; Lum, Kenneth M.; Cognetta, Armand B.; Wang, Chu; Matthews, Megan L.; Niessen, Sherry; Buczynski, Matthew W.; Parsons, Loren H.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), resp.  The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo.  Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biol. studies.  Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH.  These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWEmTTUlQHCLVg90H21EOLACvtfcHk0ljOtKccK8eZHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1antLs%253D&md5=d318d890c4c799d1579daab2e2c201f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DLum%26aufirst%3DK.%2BM.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMatthews%26aufirst%3DM.%2BL.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DHighly%2520Selective%2520Inhibitors%2520of%2520Monoacylglycerol%2520Lipase%2520Bearing%2520a%2520Reactive%2520Group%2520that%2520is%2520Bioisosteric%2520with%2520Endocannabinoid%2520Substrates%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D579%26epage%3D588%26doi%3D10.1016%2Fj.chembiol.2012.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Griebel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeske, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Grancha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolstykh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brittain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallee, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auge, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergis, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avenet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escoubet, J.</span><span> </span><span class="NLM_article-title">Selective Blockade of the Hydrolysis of the Endocannabinoid 2-Arachidonoylglycerol Impairs Learning and Memory Performance while Producing Antinociceptive Activity in Rodents</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">7642</span><span class="refDoi"> DOI: 10.1038/srep07642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1038%2Fsrep07642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=25560837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=7642&author=G.+Griebelauthor=P.+Pichatauthor=S.+Beeskeauthor=T.+Leroyauthor=N.+Redonauthor=A.+Jacquetauthor=D.+Franconauthor=L.+Bertauthor=L.+Evenauthor=M.+Lopez-Granchaauthor=T.+Tolstykhauthor=F.+Sunauthor=Q.+Yuauthor=S.+Brittainauthor=H.+Arltauthor=T.+Heauthor=B.+Zhangauthor=D.+Wiederschainauthor=T.+Bertrandauthor=J.+Houtmannauthor=A.+Rakauthor=F.+Valleeauthor=N.+Michotauthor=F.+Augeauthor=V.+Menetauthor=O.+E.+Bergisauthor=P.+Georgeauthor=P.+Avenetauthor=V.+Mikolauthor=M.+Didierauthor=J.+Escoubet&title=Selective+Blockade+of+the+Hydrolysis+of+the+Endocannabinoid+2-Arachidonoylglycerol+Impairs+Learning+and+Memory+Performance+while+Producing+Antinociceptive+Activity+in+Rodents&doi=10.1038%2Fsrep07642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents</span></div><div class="casAuthors">Griebel, Guy; Pichat, Philippe; Beeske, Sandra; Leroy, Thibaud; Redon, Nicolas; Jacquet, Agnes; Francon, Dominique; Bert, Lionel; Even, Luc; Lopez-Grancha, Mati; Tolstykh, Tatiana; Sun, Fangxian; Yu, Qunyan; Brittain, Scott; Arlt, Heike; He, Timothy; Zhang, Bailin; Wiederschain, Dmitri; Bertrand, Thomas; Houtmann, Jacques; Rak, Alexey; Vallee, Francois; Michot, Nadine; Auge, Franck; Menet, Veronique; Bergis, Olivier E.; George, Pascal; Avenet, Patrick; Mikol, Vincent; Didier, Michel; Escoubet, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7642</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) represents a primary degrdn. enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG).  This study reports a potent covalent MAGL inhibitor, SAR127303.  The compd. behaves as a selective and competitive inhibitor of mouse and human MAGL, which potently elevates hippocampal levels of 2-AG in mice.  In vivo, SAR127303 produces antinociceptive effects in assays of inflammatory and visceral pain.  In addn., the drug alters learning performance in several assays related to episodic, working and spatial memory.  Moreover, long term potentiation (LTP) of CA1 synaptic transmission and acetylcholine release in the hippocampus, two hallmarks of memory function, are both decreased by SAR127303.  Although inactive in acute seizure tests, repeated administration of SAR127303 delays the acquisition and decreases kindled seizures in mice, indicating that the drug slows down epileptogenesis, a finding deserving further investigation to evaluate the potential of MAGL inhibitors as antiepileptics.  However, the observation that 2-AG hydrolysis blockade alters learning and memory performance, suggests that such drugs may have limited value as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiPpgk18M26bVg90H21EOLACvtfcHk0lio6JbnT_LrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGgurrL&md5=4160ed016b730ea80abb5c093e66a284</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsrep07642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep07642%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPichat%26aufirst%3DP.%26aulast%3DBeeske%26aufirst%3DS.%26aulast%3DLeroy%26aufirst%3DT.%26aulast%3DRedon%26aufirst%3DN.%26aulast%3DJacquet%26aufirst%3DA.%26aulast%3DFrancon%26aufirst%3DD.%26aulast%3DBert%26aufirst%3DL.%26aulast%3DEven%26aufirst%3DL.%26aulast%3DLopez-Grancha%26aufirst%3DM.%26aulast%3DTolstykh%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DBrittain%26aufirst%3DS.%26aulast%3DArlt%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DMichot%26aufirst%3DN.%26aulast%3DAuge%26aufirst%3DF.%26aulast%3DMenet%26aufirst%3DV.%26aulast%3DBergis%26aufirst%3DO.%2BE.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DDidier%26aufirst%3DM.%26aulast%3DEscoubet%26aufirst%3DJ.%26atitle%3DSelective%2520Blockade%2520of%2520the%2520Hydrolysis%2520of%2520the%2520Endocannabinoid%25202-Arachidonoylglycerol%2520Impairs%2520Learning%2520and%2520Memory%2520Performance%2520while%2520Producing%2520Antinociceptive%2520Activity%2520in%2520Rodents%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D7642%26doi%3D10.1038%2Fsrep07642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><div class="note"><p class="first last">Additionally, triazole ureas have been reported as potent MAGL inhibitors:</p></div><span class="NLM_contrib-group">Aaltonen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savinainen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribas, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rönkkö, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuusisto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korhonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navia-Paldanius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häyrinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takabe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Käsnänen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantsar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasonen-Seppänen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laitinen, J. T.</span><span> </span><span class="NLM_article-title">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.chembiol.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=23521796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=379-390&author=N.+Aaltonenauthor=J.+R.+Savinainenauthor=C.+R.+Ribasauthor=J.+R%C3%B6nkk%C3%B6author=A.+Kuusistoauthor=J.+Korhonenauthor=D.+Navia-Paldaniusauthor=J.+H%C3%A4yrinenauthor=P.+Takabeauthor=H.+K%C3%A4sn%C3%A4nenauthor=T.+Pantsarauthor=T.+Laitinenauthor=M.+Lehtonenauthor=S.+Pasonen-Sepp%C3%A4nenauthor=A.+Posoauthor=T.+Nevalainenauthor=J.+T.+Laitinen&title=Piperazine+and+Piperidine+Triazole+Ureas+as+Ultrapotent+and+Highly+Selective+Inhibitors+of+Monoacylglycerol+Lipase&doi=10.1016%2Fj.chembiol.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Piperazine and Piperidine Triazole Ureas as Ultrapotent and Highly Selective Inhibitors of Monoacylglycerol Lipase</span></div><div class="casAuthors">Aaltonen, Niina; Savinainen, Juha R.; Ribas, Casandra Riera; Ronkko, Jani; Kuusisto, Anne; Korhonen, Jani; Navia-Paldanius, Dina; Hayrinen, Jukka; Takabe, Piia; Kasnanen, Heikki; Pantsar, Tatu; Laitinen, Tuomo; Lehtonen, Marko; Pasonen-Seppanen, Sanna; Poso, Antti; Nevalainen, Tapio; Laitinen, Jarmo T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">379-390</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monoacylglycerol lipase (MAGL) terminates the signaling function of the endocannabinoid, 2-arachidonoylglycerol (2-AG).  During 2-AG hydrolysis, MAGL liberates arachidonic acid, feeding the principal substrate for the neuroinflammatory prostaglandins.  In cancer cells, MAGL redirects lipid stores toward protumorigenic signaling lipids.  Thus MAGL inhibitors may have great therapeutic potential.  Although potent and increasingly selective MAGL inhibitors have been described, their no. is still limited.  Here, we have characterized piperazine and piperidine triazole ureas that combine the high potency attributable to the triazole leaving group together with the bulky arom. benzodioxolyl moiety required for selectivity, culminating in compd. JJKK-048 that potently (IC50 < 0.4 nM) inhibited human and rodent MAGL.  JJKK-048 displayed low cross-reactivity with other endocannabinoid targets.  Activity-based protein profiling of mouse brain and human melanoma cell proteomes suggested high specificity also among the metabolic serine hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIDOxKwD3xf7Vg90H21EOLACvtfcHk0lio6JbnT_LrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFOlur0%253D&md5=3061a03d341bfb1de6b25c8d925b5b9f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DAaltonen%26aufirst%3DN.%26aulast%3DSavinainen%26aufirst%3DJ.%2BR.%26aulast%3DRibas%26aufirst%3DC.%2BR.%26aulast%3DR%25C3%25B6nkk%25C3%25B6%26aufirst%3DJ.%26aulast%3DKuusisto%26aufirst%3DA.%26aulast%3DKorhonen%26aufirst%3DJ.%26aulast%3DNavia-Paldanius%26aufirst%3DD.%26aulast%3DH%25C3%25A4yrinen%26aufirst%3DJ.%26aulast%3DTakabe%26aufirst%3DP.%26aulast%3DK%25C3%25A4sn%25C3%25A4nen%26aufirst%3DH.%26aulast%3DPantsar%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DPasonen-Sepp%25C3%25A4nen%26aufirst%3DS.%26aulast%3DPoso%26aufirst%3DA.%26aulast%3DNevalainen%26aufirst%3DT.%26aulast%3DLaitinen%26aufirst%3DJ.%2BT.%26atitle%3DPiperazine%2520and%2520Piperidine%2520Triazole%2520Ureas%2520as%2520Ultrapotent%2520and%2520Highly%2520Selective%2520Inhibitors%2520of%2520Monoacylglycerol%2520Lipase%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D379%26epage%3D390%26doi%3D10.1016%2Fj.chembiol.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Waring, M. J.</span><span> </span><span class="NLM_article-title">Lipophilicity in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1517/17460441003605098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1517%2F17460441003605098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=22823020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=235-248&author=M.+J.+Waring&title=Lipophilicity+in+drug+discovery&doi=10.1517%2F17460441003605098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilicity in drug discovery</span></div><div class="casAuthors">Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-248</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The role of lipophilicity in detg. the overall quality of candidate drug mols. is of paramount importance.  Recent developments suggest that, as well as detg. pre-clin. ADMET (absorption, distribution, metab., elimination and toxicol.) properties, compds. of optimal lipophilicity might have increased chances of success in development.  Areas covered in this review: The review covers aspects of methods of prediction of lipophilicity in frequent use and describes the most relevant literature analyses linking individual ADMET parameters and more composite measures of overall compd.  Quality' with lipophilicity.  What the reader will gain: The aim is to provide an overview of the relevant literature in an attempt to summarise where the optimum region of lipophilicity lies and to highlight which particular issues and risks might be expected when operating outside this region.  Take home message: The review of the data shows that this optimal space is defined by a narrow range of logD between ∼ 1 and 3.  Some of the implications of this for medicinal chem. optimization are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZJrmVgvPaZLVg90H21EOLACvtfcHk0lio6JbnT_LrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFOjtbc%253D&md5=94424042ea49fcf5fcc7f1e4b17c10d6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441003605098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441003605098%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DLipophilicity%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D235%26epage%3D248%26doi%3D10.1517%2F17460441003605098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">Ligand Efficiency and Fragment-Based Drug Discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1016/j.drudis.2008.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.drudis.2008.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19073276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=278-283&author=S.+D.+Bembenekauthor=B.+A.+Toungeauthor=C.+H.+Reynolds&title=Ligand+Efficiency+and+Fragment-Based+Drug+Discovery&doi=10.1016%2Fj.drudis.2008.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency and fragment-based drug discovery</span></div><div class="casAuthors">Bembenek, Scott D.; Tounge, Brett A.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of fragment-based drug discovery (FBDD) has increased in recent years since it is more likely to produce a better optimized compd. of lower mol. wt.  Ligand efficiency (LE) has become important for assessing fragments, HTS hits, and resulting optimized ligands.  LE is useful for comparing ligands of equal mol. wt., but is ineffective for comparisons of ligands of differing mol. wt.  LE has a strong dependence on mol. size, which has led us to develop a size-independent efficiency score termed fit quality.  Evaluating FBDD examples from the literature using LE and fit quality, we find that, in general, the LEs of starting fragments are greater than those of larger, more elaborated, structures.  Fit quality scores, however, tend to improve upon optimization of the fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIWfRm1zWl87Vg90H21EOLACvtfcHk0li4T0AKY7Zkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Sht78%253D&md5=55b35499fb26249d535bbe586f74f38f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DLigand%2520Efficiency%2520and%2520Fragment-Based%2520Drug%2520Discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D278%26epage%3D283%26doi%3D10.1016%2Fj.drudis.2008.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bembenek, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span> </span><span class="NLM_article-title">The Role of Molecular Size in Ligand Efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4258</span><span class="NLM_x">–</span> <span class="NLM_lpage">4261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.05.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1016%2Fj.bmcl.2007.05.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=17532632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4258-4261&author=C.+H.+Reynoldsauthor=S.+D.+Bembenekauthor=B.+A.+Tounge&title=The+Role+of+Molecular+Size+in+Ligand+Efficiency&doi=10.1016%2Fj.bmcl.2007.05.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The role of molecular size in ligand efficiency</span></div><div class="casAuthors">Reynolds, Charles H.; Bembenek, Scott D.; Tounge, Brett A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4258-4261</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ligand efficiency is a simple metric for assessing whether a ligand derives its potency from optimal fit with the protein target or simply by virtue of making many contacts.  Comparison of protein-ligand binding affinities for over 8000 ligands with 28 protein targets shows conclusively that the av. ligand binding affinities are not linear with mol. size.  It is therefore important to scale ligand efficiencies by the size of the ligand, particularly where small ligands (e.g., fragments) are involved.  The authors propose a simple 'fit quality' metric that removes this dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnIaZs8-gK1rVg90H21EOLACvtfcHk0li4T0AKY7Zkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVKntbo%253D&md5=2f95a0b64b1da0755d7f624dad18b2bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.05.038%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26atitle%3DThe%2520Role%2520of%2520Molecular%2520Size%2520in%2520Ligand%2520Efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4258%26epage%3D4261%26doi%3D10.1016%2Fj.bmcl.2007.05.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving Beyond Rules: the Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+the+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+to+Enable+Alignment+of+Druglike+Properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0li4T0AKY7Zkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520the%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520to%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.4155/fmc.10.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+Discovering+and+Derisking+Covalent%2C+Irreversible+Enzyme+Inhibitors&doi=10.4155%2Ffmc.10.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lj3Ms4YfqJX9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520Discovering%2520and%2520Derisking%2520Covalent%252C%2520Irreversible%2520Enzyme%2520Inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964%26doi%3D10.4155%2Ffmc.10.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Palkowitz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R. A.</span><span> </span><span class="NLM_article-title">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2270</span><span class="NLM_x">–</span> <span class="NLM_lpage">2273</span><span class="refDoi"> DOI: 10.1021/acs.orglett.7b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.7b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=2270-2273&author=M.+D.+Palkowitzauthor=B.+Tanauthor=H.+Huauthor=K.+Rothauthor=R.+A.+Bauer&title=Synthesis+of+Diverse+N-Acryloyl+Azetidines+and+Evaluation+of+Their+Enhanced+Thiol+Reactivities&doi=10.1021%2Facs.orglett.7b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities</span></div><div class="casAuthors">Palkowitz, Maximilian D.; Tan, Bo; Hu, Haitao; Roth, Kenneth; Bauer, Renato A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2270-2273</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl azetidines exhibit nonplanar hybridization, leading to lower amide-like character of the corresponding (O)C-N bonds.  This impacts N-acryloyl azetidines by producing enhanced electrophilicy at appended Michael acceptors.  Herein, reactivity data are reported in the presence of glutathione (GSH) in phosphate buffer (pH 7.4) at 37 °C.  Wide reactivity ranges are obsd. by varying substitution at the Michael acceptor or by modulating the electron-withdrawing character of substituents at the C3 position of the azetidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUFdHgOWgc7Vg90H21EOLACvtfcHk0lj3Ms4YfqJX9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1KqtLw%253D&md5=d65414bda2976c07bc76cd0df6d4a38d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.7b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.7b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPalkowitz%26aufirst%3DM.%2BD.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DK.%26aulast%3DBauer%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520of%2520Diverse%2520N-Acryloyl%2520Azetidines%2520and%2520Evaluation%2520of%2520Their%2520Enhanced%2520Thiol%2520Reactivities%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D2270%26epage%3D2273%26doi%3D10.1021%2Facs.orglett.7b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. D.</span><span> </span><span class="NLM_article-title">A Fluorescence-Based Assay for Monoacylglycerol Lipase Compatible with Inhibitor Screening</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1089/adt.2007.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1089%2Fadt.2007.122" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=387-393&author=Y.+Wangauthor=P.+Chandaauthor=P.+G.+Jonesauthor=J.+D.+Kennedy&title=A+Fluorescence-Based+Assay+for+Monoacylglycerol+Lipase+Compatible+with+Inhibitor+Screening&doi=10.1089%2Fadt.2007.122"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChanda%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DP.%2BG.%26aulast%3DKennedy%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Fluorescence-Based%2520Assay%2520for%2520Monoacylglycerol%2520Lipase%2520Compatible%2520with%2520Inhibitor%2520Screening%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D387%26epage%3D393%26doi%3D10.1089%2Fadt.2007.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cognetta, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1590</span><span class="NLM_x">–</span> <span class="NLM_lpage">1599</span><span class="refDoi"> DOI: 10.1021/cb400261h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400261h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1590-1599&author=J.+W.+Changauthor=A.+B.+Cognettaauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Proteome-Wide+Reactivity+Profiling+Identifies+Diverse+Carbamate+Chemotypes+Tuned+for+Serine+Hydrolase+Inhibition&doi=10.1021%2Fcb400261h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Reactivity Profiling Identifies Diverse Carbamate Chemotypes Tuned for Serine Hydrolase Inhibition</span></div><div class="casAuthors">Chang, Jae Won; Cognetta, Armand B., III; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1590-1599</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Serine hydrolases are one of the largest and most diverse enzyme classes in Nature.  Inhibitors of serine hydrolases are used to treat many diseases, including obesity, diabetes, cognitive dementia, and bacterial and viral infections.  Nonetheless, the majority of the 200+ serine hydrolases in mammals still lack selective inhibitors for their functional characterization.  We and others have shown that activated carbamates, through covalent reaction with the conserved serine nucleophile of serine hydrolases, can serve as useful inhibitors for members of this enzyme family.  The extent to which carbamates, however, cross-react with other protein classes remains mostly unexplored.  Here, we address this problem by investigating the proteome-wide reactivity of a diverse set of activated carbamates in vitro and in vivo, using a combination of competitive and click chem. (CC)-activity-based protein profiling (ABPP).  We identify multiple classes of carbamates, including O-aryl, O-hexafluoroisopropyl (HFIP), and O-N-hydroxysuccinimidyl (NHS) carbamates that react selectively with serine hydrolases across entire mouse tissue proteomes in vivo.  We exploit the proteome-wide specificity of HFIP carbamates to create in situ imaging probes for the endocannabinoid hydrolases monoacylglycerol lipase (MAGL) and α-β hydrolase-6 (ABHD6).  These findings, taken together, designate the carbamate as a privileged reactive group for serine hydrolases that can accommodate diverse structural modifications to produce inhibitors that display exceptional potency and selectivity across the mammalian proteome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-176v-DnJrVg90H21EOLACvtfcHk0ljzmGkXQLxSyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Sru7k%253D&md5=7286011459791bcdea13f918b9ef97c3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcb400261h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400261h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DCognetta%26aufirst%3DA.%2BB.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DProteome-Wide%2520Reactivity%2520Profiling%2520Identifies%2520Diverse%2520Carbamate%2520Chemotypes%2520Tuned%2520for%2520Serine%2520Hydrolase%2520Inhibition%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1590%26epage%3D1599%26doi%3D10.1021%2Fcb400261h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Labar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauvois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. M.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1002/cbic.200900621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1002%2Fcbic.200900621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=19957260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=218-227&author=G.+Labarauthor=C.+Bauvoisauthor=F.+Borelauthor=J.-L.+Ferrerauthor=J.+Woutersauthor=D.+M.+Lambert&title=Crystal+Structure+of+the+Human+Monoacylglycerol+Lipase%2C+a+Key+Actor+in+Endocannabinoid+Signaling&doi=10.1002%2Fcbic.200900621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling</span></div><div class="casAuthors">Labar, Geoffray; Bauvois, Cedric; Borel, Franck; Ferrer, Jean-Luc; Wouters, Johan; Lambert, Didier M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2-Arachidonoylglycerol plays a major role in endocannabinoid signaling, and is tightly regulated by monoacylglycerol lipase (MAGL).  Here, the authors report the crystal structure of human MAGL.  The protein crystd. as a dimer, and despite structural homologies to haloperoxidases and esterases, it distinguished itself by a wide and hydrophobic access to the catalytic site.  An apolar helix covering the active site also gave structural insight into the amphotropic character of MAGL, and likely explains how MAGL interacts with membranes to recruit its substrate.  Docking of 2-arachidonoylglycerol highlighted a hydrophobic and a hydrophilic cavity that accommodated the lipid into the catalytic site.  Moreover, the authors identified Cys-201 as the crucial residue in MAGL inhibition by N-arachidonylmaleimide, a SH group-reactive compd.  In addn. to the advance in the knowledge of endocannabinoids degrdn. routes, the structure of MAGL paves the way for future medicinal chem. results aimed at the design of new drugs exploiting 2-arachidonoylglycerol transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomb-R4j6WugrVg90H21EOLACvtfcHk0ljzmGkXQLxSyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSktLk%253D&md5=3caddaf36eb688fa3aeea940f6441b36</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200900621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200900621%26sid%3Dliteratum%253Aachs%26aulast%3DLabar%26aufirst%3DG.%26aulast%3DBauvois%26aufirst%3DC.%26aulast%3DBorel%26aufirst%3DF.%26aulast%3DFerrer%26aufirst%3DJ.-L.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BM.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Monoacylglycerol%2520Lipase%252C%2520a%2520Key%2520Actor%2520in%2520Endocannabinoid%2520Signaling%26jtitle%3DChemBioChem%26date%3D2010%26volume%3D11%26spage%3D218%26epage%3D227%26doi%3D10.1002%2Fcbic.200900621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data Processing and Analysis with the AutoPROC tool box</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span><span class="refDoi"> DOI: 10.1107/S0907444911007773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+Processing+and+Analysis+with+the+AutoPROC+tool+box&doi=10.1107%2FS0907444911007773"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520Processing%2520and%2520Analysis%2520with%2520the%2520AutoPROC%2520tool%2520box%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302%26doi%3D10.1107%2FS0907444911007773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kabsch, W.</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kabsch%2C+W.Acta+Crystallogr.%2C+Sect.+D%3A+Biol.+Crystallogr.+2010%2C+66%2C+125%E2%80%93132+10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljzmGkXQLxSyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lg3xTjnnN2PGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER; <span class="NLM_publisher-name">Global Phasing Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lg3xTjnnN2PGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chevalier, K. M.; Dax, S. L.; Flores, C. M.; Liu, L.; Macielag, M. J.; McDonnell, M. E.; Nelen, M. I.; Prouty, S.; Todd, M.; Zhang, S.-P.; Zhu, B.; Nulton, E. L.; Clemente, J.</span><span> </span><span class="NLM_article-title">Preparation of (Hetero)aromatic Piperazinyl Azetdinyl Amides as Monoacylglycerol Lipase (MGL) Inhibitors</span>. WO2010124121,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+M.+Chevalier&author=S.+L.+Dax&author=C.+M.+Flores&author=L.+Liu&author=M.+J.+Macielag&author=M.+E.+McDonnell&author=M.+I.+Nelen&author=S.+Prouty&author=M.+Todd&author=S.-P.+Zhang&author=B.+Zhu&author=E.+L.+Nulton&author=J.+Clemente&title=Preparation+of+%28Hetero%29aromatic+Piperazinyl+Azetdinyl+Amides+as+Monoacylglycerol+Lipase+%28MGL%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChevalier%26aufirst%3DK.%2BM.%26atitle%3DPreparation%2520of%2520%2528Hetero%2529aromatic%2520Piperazinyl%2520Azetdinyl%2520Amides%2520as%2520Monoacylglycerol%2520Lipase%2520%2528MGL%2529%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Claffey, M. M.; Helal, C. J.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Amino-heterocyclic Compounds Used as PDE9 Inhibitors</span>. WO2010084438,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+M.+Claffey&author=C.+J.+Helal&author=P.+R.+Verhoest&title=Amino-heterocyclic+Compounds+Used+as+PDE9+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26atitle%3DAmino-heterocyclic%2520Compounds%2520Used%2520as%2520PDE9%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1','PDB','6AX1'); return false;">PDB: 6AX1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HJU','PDB','3HJU'); return false;">PDB: 3HJU</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01531">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37241"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01531">10.1021/acs.jmedchem.7b01531</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Data processing and model refinement statistics for MAGL complex with <b>3</b>, replicates of human brain vascular pericytes treated with <b>14</b>, and serine hydrolase selectivity panel for compounds <b>6</b> and <b>15</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_001.pdf">jm7b01531_si_001.pdf (833.43 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01531/suppl_file/jm7b01531_si_002.csv">jm7b01531_si_002.csv (0.81 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB code for compound <b>3</b> bound to the active site serine in MAGL is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6AX1">6AX1</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01531&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01531%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01531" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998e4f0f3622d8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
